Roles for the E3 Ligase Itch in Immune Response Modulation by Sahota, Sukhvinder Kaur
Rockefeller University
Digital Commons @ RU
Student Theses and Dissertations
2004
Roles for the E3 Ligase Itch in Immune Response
Modulation
Sukhvinder Kaur Sahota
Follow this and additional works at: http://digitalcommons.rockefeller.edu/
student_theses_and_dissertations
Part of the Life Sciences Commons
This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and
Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact mcsweej@mail.rockefeller.edu.
Recommended Citation
Sahota, Sukhvinder Kaur, "Roles for the E3 Ligase Itch in Immune Response Modulation" (2004). Student Theses and Dissertations.
Paper 39.
19 o r \"fi 
T H E N" 
ROCKEFELLER 
UNIVERSITY/^ 
Roles for the E3 ligase Itch in I m m u n e Response Modulation 
A thesis presented to the faculty of 
The Rockefeller University 
in partial fulfillment of the requirements for 
the degree of doctor of Philosophy 
by 
Sukhvinder Kaur Sahota 
under the supervision of 
Dr. Alexander Tarakhovsky 
December 2004 
Copyright by Sukhvinder Kaur Sahota, 2004 
Dedicated to 
Hayley Elizabeth Thomson, 
for reminding me why I started this journey in the first place. 
Acknowledgements 
So many people have contributed so much to the generation of this thesis that if I 
begin thanking all of them as much as they deserve, this acknowledgements section will 
far overshadow the thesis itself. In the interest of brevity, I will mention everyone only in 
passing, but be assured, gentle reader, that this thesis is as much a testament to the good 
will and generosity of the people I have known these past years as it is to the scientific 
training I have received. 
I must begin by thanking my parents, Hardave Singh and Amarjit Kaur Sahota, 
without whom I would never have made it this far. To my father I am indebted for 
teaching me to think independently, and to my mother, I am equally indebted for 
endowing me with perseverance. I must thank my brother Gurmukh, whose unshakeable 
faith in my abilities helped carry me through when my own faith was lacking. And in 
the category of family I also place Dr. Dewey Royal, whose love of life and science 
inspired me to begin this journey in the first place. 
As to the thesis years themselves, I must first and foremost acknowledge my 
mentor Dr. Alexander (Sasha) Tarakhovsky. Like any excellent coach, he knew how to 
push me to my limits without breaking me in the process. In addition to a stimulating 
intellectual environment, Sasha also provided the warmth and guidance (and well-
meaning Terrorism) one normally associates with families. His continual concern over 
my growth as an individual, at a scientific, intellectual, and emotional level, has left me 
with many tender memories over the last four years. 
This thesis unequivocally would not have been possible without my dear friend 
Marc-Werner Dobenecker. A seasoned graduate student when I joined the lab, Marc 
took me under his wings immediately, and has been the wind beneath my wings ever 
since I managed to pipette accurately ("NEIN!"). As much as I have learned from Marc 
regarding scientific techniques (and I have learned pretty much everything from him) and 
from sparring with him regarding designs of experiments, it is his lessons regarding 
kindness, patience, and selflessness that leave me forever in his debt. Namas te. 
There are a number of people who I need to acknowledge for providing help 
above and beyond the call of duty. I am grateful to Ingrid Mecklenbrauker for always 
providing excellent scientific advice and detailed protocols whenever I have gone to her. 
In addition, I am grateful for the revisions to my thesis figures, which have made them a 
much more refined presentation of my data! I am truly indebted to Laura Donlin, who has 
been instrumental in my sleeping properly these last few months. Her cheerful help with 
experiments that I was running out of time to do and her detailed and careful reading of 
my thesis leave me profoundly in her debt. I am deeply grateful to Tetyana Obukhanycb 
for performing retroorbial injections for me that provided critical data for this thesis. To 
Christian Schmedt, I am grateful foralways taking an interest in my work and providing 
technical advice even when I hadn't thought to ask for it! And also for making TAT-Cre 
for our laboratory. 
I would like to acknowledge the NIH funded M S T P for my stipend. I would like 
to thank the Tri-Institutional MD/PhD program (and by this I mean Ruth Gotian, Renee 
Dotson and Elaine Vasquez), and especially the director Dr. Olaf Anderson, for first of 
all giving m e this opportunity to learn here, and also for providing an outstanding support 
structure for students in the program. Dr. Anderson I would like to thank further for his 
ii 
compassion, wisdom, and guidance in helping me choose my ultimate thesis lab and 
project. 
I would like to thank my internal committee members, Dr. Ralph Steinman and 
Dr. Michel Nussenzweig, for not only providing excellent scientific input into my 
project, but for also for taking a genuine interest in my training as a future physician-
scientist. I am grateful to my external committee member Dr. Hua Gu for his 
accommodating the many hiccups in the presentation of the thesis and for his insightful 
comments during the defense. 
I am grateful to our lab manager, Angela Santana, who has worked tirelessly to 
ensure that reagents are always there when we need them and in places where we can find 
them. I would like to acknowledge Dr. Krista La Perle and the L A R C Phenotyping Core 
for providing the histological analysis found in this thesis, and Svetlana Mazel for her 
help in sorting cells at the FACS Core facility. I would like to acknowledge the staff at 
L A R C for taking care of the day-to-day husbandry of the research animals. In addition I 
would like to thank the Dean's office for their support during the writing of this thesis. 
And this leaves me with a long list of labmates and friends who I haven't yet 
mentioned but who have been instrumental to my mental sanity for the last few years. I 
would like to acknowledge my fellow md/phd classmates Marianna Ruzinova, Svetlana 
Gorokhova, and Makoto Ishii for their support and friendship throughout this program. 
In addition, I am deeply indebted to Cyrus Badshah and Holly Vanni for taking on the 
role of therapist as well as friend throughout the last six years. Anna Panek, to well-
needed and much enjoyed coffee breaks. Revati, for our always-engaging discussions, 
scientific and otherwise, and also for hugs when they were needed. Alina, for her moral 
support throughout and for help in my presentations. Jesse, for sharing his artistic eye 
and philosophical mind. Ulli, for making lab such an enjoyable place to be and for 
making m e feel special in it. Stefan, for keeping me on my toes. SriHari, for "keeping it 
real" I-hsin, for looking out for me and keeping me humble! Kaoru, for always making 
me smile. Donal, for words of comfort when they were needed, and for words in general 
when they were not! Kelly, for providing a fellow conspirator against difficult lab 
meetings. You all have provided such memories! 
I am grateful to Kristina Jonsson for having generated the Itch fl/fl mice on which 
this thesis is based. Last, but certainly not least, I would like to acknowledge the 
thousands of mice that gave their lives, however unwittingly, for the work presented here. 
This work truly would not have been possible without their sacrifice. 
in 
Table of Contents 
LIST OF FIGURES viii 
LIST OF TABLES ix 
ABSTRACT 1 
CHAPTER 1: INTRODUCTION 3 
l.A Tolerance in the immune system: 3 
l.A.l Deletion: 3 
1.A.2 Ignorance: 3 
1.A.3 T cell anergy: 4 
1.A.4 Regulatory T cells: 6 
l.B Atopic Diseases: 16 
I .B.l The role ofTh2 immune responses in atopic diseases: 16 
1.B.2 The Generation ofTh2 effector T cells: 17 
l.B.3 Instructive versus Selective signals for Thelper differentiation: 18 
1.B.4 The role of Cytokines in T helper differentiation: 19 
1.B.5 Transcriptional regulation ofThl versus Th2 differentiation: 19 
1.B.6 Cell cycle progression and T helper differentiation: 25 
l.B.7 Co-stimulatory ligands and Thl versus Th2 differentiation: 25 
1.B.8 TCR signaling and Thl versus Th2 differentiation: 27 
l.C. CD8+ Memory T cells Maintenance and Generation: 29 
I.C.I Central versus Effector Memory C D 8 + Tcells: 31 
1.C.2 Progressive versus Linear models for C D 8 + Memory Cell Generation: 33 
l.C.3 The impact of Proliferation on C D 8 + Memory Cell Development: 35 
1.C.4 The effect of Antigen Dose on C D 8 + Memory cell Generation: 36 
l.C.5 The role of co-stimulatory ligands in C D 8 + memory cell generation: 37 
1.C.6 Proliferation per se and C D 8 + memory cell generation: 39 
l.C.7 Cell Survival Factors and C D 8 + Memory Cell Development: 40 
1.C.8 Homeostatic proliferation of memory C D 8 + cells: 43 
1.C.9 Biochemical pathways involved in C D 8 + memory cell generation and maintenance: 45 
l.D. Ubiquitination: 46 
l.D.l Types of ubiquitination: 47 
l.D.2 The roles of ubiquitination: 48 
l.D.3 The enzymatic reactions of ubiquitination: 48 
1.D.4 U b o x E 3 ligases: 49 
I. D. 5 RING finger E3 ligases: 50 
1.D.6 S O C S E3 ligases: 50 
1.D.7 The HECTfamily ofE3 ligases: 50 
1.D.8 Roles for Ubiquitin in the Immune System: 52 
1.D.9 The role of Itch in the immune system: 53 
l.D.10 Generation of mice with cell specific inactivation of Itch: 54 
l.E Overall aims of this study: 56 
CHAPTER 2: MATERIALS AND METHODS: 57 
2.A Reagents 57 
2.A.1 Antibodies used for flow cytometric analysis and coating: 57 
2.A.2 Antibodies used for Western blots: 58 
2.A3 Cytokines used for cell culture: 59 
2.A.4 Synthetic oligonucleotides: 59 
2.A.5. Primers and PCRs used for gentoyping: 59 
2.B Molecular Biology Methods: 61 
2.B.l Bacterial transformation: 61 
2.B.2 Purification of D N A : 61 
2.B.3 Restriction enzyme analysis: 61 
2.B.4 D N A sequencing: 61 
iv 
2.B.5. Generation of Itch expression vectors: 61 
2.B.6 Amplification and purification of probes used for Southern blot analysis: 62 
2.B.7 Radioactive labeling of probes: 62 
2.B.8 Southern blot analysis: 62 
2.B.9 Polymerase chain reactions (PCRs): 63 
2.B.10 Semiquantitative RT-PCR: 63 
2.B.l I Isolation of genomic D N A : 64 
2.B.l 2 Preparation of cell lysates: 64 
2.B.13 Western blots: 65 
l.C Cellular Methods: 65 
2.C.1 Preparation of murine lymphocyte suspensions: 65 
2.C.2 T cell purification from spleen and lymph node: 66 
2.C.3 T cell purification from thymus: 67 
2.C.4 T cell culture: 67 
2.C.5 Coating of plates for stimulation of purified T cells: 67 
2.C.6 Standard flow cytometric analysis: 67 
2.C.7 Intracellular stainings for flow cytometric analysis: 68 
2.C.8 Assessment of cell proliferation by [3 H]-thymidine incorporation: 68 
2.C.9 ThlITh2 differentiation of C D 4 + T cells in vitro 68 
2.CIO TGF-B sensitivity assay: 69 
2.C.I I C F S E proliferation analysis: 69 
2.C.12 Proliferation ofCD8+ memory cells: 70 
2.C.13 In vitro regulatory T cell suppressor assay: 70 
2.C.14 In vitro deletion of Itch using TAT-Cre: 71 
2.D In vivo assays: 71 
l.D.I Mice: 71 
1.D.2 Adoptive transfer ofCD8 SP thymocytes: 72 
2.D.3 Adoptive transfer of peripheral T cells: 72 
l.D.4 In vivo BrdU labeling: 72 
2.D.S Oral tolerization: 73 
2.D.6 Histology: 73 
CHAPTER 3: THE ROLE OF ITCH IN PERIPHERAL TOLERANCE 74 
3.A Introduction: 74 
3.A.1 Tolerance: 74 
3.A.2 E3 ligases in T cell anergy: 74 
3.A.3 The E3 ligase Cbl-b and suppressor cell function: 76 
3.A.4 E3 ligases and TGF-B signaling: 76 
3.A.S Aims of this study: 78 
3.B Results: 79 
3.B.l C57BL/6 Itchfllfl C D 4 Cre mice develop a spontaneous inflammatory disease 79 
3.B.2 Itchfllfl C D 4 Cre accumulate effector I memory C D 4 + cells and B cells in the spleen and lymph 
node 81 
3.B.3 The inflammation in Itchfllfl C D 4 Cre mice does not require B cells 83 
3.B.4 Transfer of C D 4 + T cells transfers the Itch pathology 86 
3.B.5 The activation of Itchfllfl C D 4 Cre T cells is not spontaneous 88 
3.B.6 Itchfllfl C D 4 Cre mice develop and maintain C D 4 + C D 2 5 + suppressor cells 90 
3.B.7 C D 4 + C D 2 5 + suppressor cells from Itchfllfl C D 4 Cre mice are functionally anergic and 
suppressive: 91 
3.B.8 C D 4 + C D 2 5 - effector cells from Itchfllfl C D 4 Cre mice are capable of being suppressed by 
C D 4 + C D 2 5 + regulatory T cells: 92 
3.B.9 C D 4 + T cells from Itchfllfl C D 4 Cre mice are insensitive to TGF-B mediated suppression of 
proliferation: 94 
3.B.10 Naive CD44lo C D 4 + T cells from Itchfllfl C D 4 Cre mice are sensitive to TGF-B mediated 
suppression of proliferation 96 
3.B.11 Itchfllfl C D 4 Cre mice do not develop oral tolerance: 96 
3.C Discussion: 99 
3.C.1 C57BLI6 Itchfllfl C D 4 Cre mice develop a spontaneous inflammatory disease 99 
3.C.2 The Itch inflammatory phenotype is due to Itch deficient C D 4 + T cells: 100 
3.C.3 The activation of Itchfllfl C D 4 Cre T cells is not cell autonomous 101 
3.C.4 C D 4 + C D 1 5 + in vitro suppressor function is intact in Itchfllfl C D 4 Cre mice: 103 
3.C.5 TGF-B sensitivity may be affected in Itch deficient C D 4 + T cells: 105 
3.C.6 The role of Itch in T cell anergy: 106 
3.D Summary: 108 
CHAPTER 4: THE ROLE OF TH2 CELLS IN THE PATHOLOGY OF ITCH MICE 109 
4. A Introduction: 109 
4.A.1 Thl versus Thl immune responses: 109 
4.A.1 Evidence for a role of Itch in regulating Thl differentiation: 109 
4.A.3 Aims of this study: 110 
4.B Results: Ill 
4.B.l Increased Thl differentiation of Itch deficient naive C D 4 + T cells: Ill 
4.B.l Itch deletion does not effect Thl differentiation: Ill 
4.B.3 Itch deletion in vitro leads to a bias towards Thl differentiation: 112 
4.B.4 Itch modulation of Thl differentiation is Stat 6 dependent: Ill 
4.B.5 Itch pathology in vivo is Stat6 dependent 114 
4.B.6 Increased antigen sensivily in Itch deficient C D 4 + T cells: 117 
4.C Discussion: 119 
4.C.1 Itch regulates Thl differentiation in C D 4 + T cells: 119 
4.C.1 Itch modulation of Thl differentiation is along the IL-4-Stat6 pathway: 119 
4.C.3 Stat6 dependence of inflammatory pathology seen in Itch deficient mice: 720 
4.C.4 Itch deficient C D 4 + cells display increased antigen sensitivity: Ill 
4.D Summary: 122 
CHAPTER 5: THE ROLE OF ITCH IN CD8+ MEMORY CELL GENERATION 124 
5.A Introduction: 124 
5.A.1 C D 8 + memory cells: 114 
5.A.I. Factors regulating C D 8 + memory cell generation 114 
5.A.3 Aims of this study: 115 
5.B. Results: 125 
5.B.l Accumulation of memory-like C D 8 cells in secondary lymphoid organs of 8-week old Itchfllfl 
C D 4 Cre mice 115 
5.B.l Increased frequency ofCD44hi C D 8 SP cells in the thymi of Itchfllfl C D 4 Cre mice 117 
5.B.3 The increased frequency of memory like C D 8 + cells is independent of the inflammatory 
pathology in Itchfllfl C D 4 Cre mice 729 
5.B.4 Itch deficient memory-like cells CD8+ cells function like memory cells in response to IL-15 
stimulation in vitro 131 
5.B.5 Itch deficient memory-like C D 8 + cells have the same basal homeostatic proliferation rate as 
wild-type cells 133 
5.B.7 Itch does not regulate antigen sensitivity in C D 8 + cells 135 
5.C Discussion: 137 
S.C.I Accumulation of memory-like C D 8 + cells in the secondary lymphoid organs of Itchfllfl C D 4 
Cre mice: 137 
5.C.1 Itch deficiency leads to upregulation ofCD44 on C D 8 SP cells in the thymus: 138 
5.C.3 Accumulation of Itch deficient memory-like C D 8 + cells is independent of the inflammatory 
pathology in Itchfllfl C D 4 Cre mice: 139 
5.C.4 Itch deficient memory-like C D 8 + cells behave like memory C D 8 + cells 140 
5.C.5 C D 8 + memory cell homeostatic proliferation is unaffected in Itchfllfl C D 4 Cre mice: 740 
5.C.6 Antigen sensitivity is unaffected by Itch deficiency in C D 8 + cells: 747 
5.D Summary: 142 
vi 
CHAPTER 6: DISCUSSION 142 
6. A Itch fl/fl CD4 Cre mice develop a spontaneous inflammatory disorder: 142 
6.B Dysregulated Th2 immune response in Itch fl/fl CD4 Cre mice: 143 
6.C The role of Itch in CD8+memory cell generation: 145 
REFERENCES: 147 
Vll 
List of Figures: 
Figure 1-1. Regulatory T cell subtypes 7 
Figure 1-2. The lineage and functional relationships of regulatory T cells 12 
Figure 1-3. Instructive versus selective models of T helper differentiation 18 
Figure 1-4. Transcriptional regulation of Th2 differentiation 21 
Figure 1-5. Progressive and linear models of memory CD8+ cell generation 34 
Figure 1-6. The ubiquitination pathway 49 
Figure 1-7. The structural domains of HECT, RING, Ubox, and SOCS E3 ligases 51 
Figure 1-8. Generation of conditional Itch deficient mice 55 
Figure 3-1. Inflammatory lesions along mucosal linings in Itch fl/fl CD4 Cre mice 80 
Figure 3-2. Accumulation of B cells and activated T cells in secondary lymphoid 82 
organs of 8-week old Itch fl/fl CD4 Cre mice 
Figure 3-3. B cells accumulation is not essential for the Itch inflammatory 85 
pathology 
Figure 3-4. Itch deficient CD4+ T cells are directly responsible for the Itch 87 
pathology 
Figure 3-5. Itch deficiency does not lead to spontaneous activation of CD4+ T cells 89 
Figure 3-6. CD4+ CD25+ regulatory T cell function is intact in Itch fl/fl C D 4 Cre 93 
Mice 
Figure 3-7. Itch regulates TGF-(3 sensitivity 95 
Figure 3-8. Itch deficient cells are not anergized upon oral tolerization 98 
Figure 4-1. Itch regulates Thl/Th2 differentiation 113 
Figure 4-2. Stat6 is required for Itch dependent Th2 differentiation in vitro 115 
Figure 4-3. Stat6 is required for the pathology seen in Itch fl/fl CD4 Cre mice 116 
Figure 4-4. Itch deficiency leads to an increased proliferative responses in response 118 
to antigenic stimulation in vitro 
Figure 5-1. Expansion of CD8+ memory cell population in 8-week old 126 
Itch fl/fl CD4 Cre mice 
Figure 5-2. Normal T cell development but early CD8+ cell activation in 128 
Itch fl/fl CD4 Cre mice 
Figure 5-3. CD8+ memory-like cell accumulation in Itch deficient mice is 130 
independent of the Itch inflammatory pathology 
Figure 5-4. The memory-like CD8+ cells accumulating in Itch fl/fl C D 4 Cre 132 
mice have functional properties of memory CD8 cells 
Figure 5-5. The rate of homeostatic proliferation of memory CD8+ cells is 134 
unaffected in Itch fl/fl CD4 Cre mice 
Figure 5-6. Proliferative capacity in response to antigenic stimulation is 136 
unaffected in Itch deficient CD8+ cells 
v m 
List of Tables: 
Table 2.1 Primers 59 
Table 2.2 PCR program cycles 60 




Cloning of the inversion breakpoints in the agouti mutant strain a has 
implicated the E3 ligase Itch in the spontaneous inflammation that occurs in these mice. 
1 RH 
Anaylsis of a mice suggests that the inflammatory disease is due to a dysregulated T 
helper type-2 immune response. In order to verify the importance of Itch inactivation in 
the spontaneous inflammation of a mice and to determine which cell type is 
responsible for the pathology, the Itch gene has been targeted for conditional deletion in 
mice using the Cre-loxP system. 
The results presented in this thesis provide the first direct evidence that Itch 
deficient CD4+ T cells are sufficient to cause spontaneous inflammation. The function of 
CD4+CD25+ regulatory T cells was found to be intact in vitro. Instead, sensitivity to the 
immunomodulatory cytokine TGF-(3 was reduced in Itch deficient CD4+ T cells. 
Inadequacies in peripheral tolerance mechanisms were observed based on oral tolerance 
studies. 
Itch deficiency was found to directly contribute to the CD4+ bias towards T 
helper type-2 (Th2) differentiation observed in a mice. Itch modulation of Th2 
differentiation occurs in a Stat6 dependent pathway. Itch fl/fl CD4 Cre Stat 6 -/- CD4+ T 
cells were found to be incapable of differentiating into Th2 cells in vitro. Itch fl/fl CD4 
Cre Stat 6 -/- did not develop spontaneous inflammation disease, underscoring the 
1 ST-T 
importance of Th2 differentiation in the pathology of a mice. 
Itch fl/fl CD4 Cre mice were found to accumulate memory phenotype CD8+ cells 
in their secondary lymphoid organs. The inflammatory pathology of Itch fl/fl CD4 Cre 
1 
mice was not required for accumulation of Itch deficient memory-like C D 8 + cells. The 
cause for this accumulation remains unclear, although an increase in homeostatic 
proliferation of the memory-like cells is considered unlikely. 
The findings of this thesis provide definitive support for several speculations 
regarding the function of Itch. In addition, they provide novel venues of study for the 
role of Itch in the immune system. Collectively, they argue that further study of this E3 
ligase will be a fruitful endeavor for immunologists. 
C h a p t e r 1: Introduction 
1.A Tolerance in the immune system: 
In a well-regulated immune system, immune reactions occur in response to 
pathogenic antigens but not in response to self or harmless foreign antigens. This 
acceptance of both self-antigens and antigens to which the immune system is constantly 
exposed (through inhalation or ingestion) is defined as tolerance. The study of tolerance 
mechanisms is an integral field of immunology, and the manipulation of tolerance has 
extensive clinical applications. Problems with tolerance are linked to a wide spectrum of 
clinical pathologies, including allergies and autoimmune diseases. Furthermore, the 
ability to tolerize or break tolerance to specific antigens has ramifications in both tumor 
immunology and transplantation. 
1.A.1 Deletion: 
One of the key mechanisms for maintaining tolerance against self-antigens is 
clonal deletion of self-reactive T cells, either in the thymus or in the periphery (Miller 
and Basten 1996). The importance of thymic deletion has been underscored by the 
recent description of AIRE deficient mice (Anderson, Venanzi et al. 2002), which 
develop a multi-organ autoimmune disease due to an inability to delete self-reactive T 
cells in the thymus. The existence of autoreactive T cells in the periphery of healthy 
individuals, however, indicates that clonal deletion does not completely account for 
tolerance (Fowell and Mason 1993). 
1.A.2 Ignorance: 
Another straightforward mechanism for tolerance is immunological ignorance. In 
this situation, immune cells cannot localize to the environment in which their antigen is 
found (Zinkernagel, Ehl et al. 1997). The blood-brain barrier is a classic example of this 
type of tolerance, as lymphocytes are not found in the central nervous system of 
otherwise healthy individuals. Signaling pathways involved in T cell mobility may play a 
key role in this mode of tolerance. 
1.A.3 T cell anergy: 
Sometimes T cells do encounter their cognate antigen but do not elicit an immune 
response through proliferation or cytokine release (Schwartz 1996). This cell-
autonomous state of unresponsiveness is defined as anergy and can be induced when a T 
cell is stimulated by antigen in the absence of co-stimulation (Jenkins, Chen et al. 1990) 
or in a specific immunomodulatory cytokine milieu (Groux, Bigler et al. 1996). The 
molecular basis of anergy remains poorly defined, but heterkaryon studies involving 
fusion of anergic and nonanergic T cells have made it clear that the anergic state is 
maintained by the dominant action of one or more regulatory molecules, rather than the 
simple absence of signaling components (Telander, Malvey et al. 1999). 
l.A.3.1 Clonal anergy: 
Anergy can be further subdivided into two potentially distinct experimental 
groups: clonal anergy and in vivo anergy (Schwartz 2003). Clonal anergy arises in 
antigen-experienced cells and occurs in response to partial stimulation without 
appropriate co-stimulatory signals. It should be noted that clonal anergy can only be 
induced in previously stimulated cells, with most studies of clonal anergy involving T 
cell lines. It has not been successfully described for naive T cells, making this form of 
anergy a purely in vitro model system for tolerance (Davis and Lipsky 1993; Schwartz 
2003). Once cells become clonally anergic, they do not proliferate in response to 
subsequent antigenic stimulation; however, their effector functions are not affected. This 
form of anergy can be reversed by the addition of exogenous interleukin 2 (IL-2) (Essery, 
Feldmann et al. 1988; Powell, Bruniquel et al. 2001). 
The biochemical pathways involved in regulating clonal anergy have been worked 
out in some detail. Treatment of T helper type 1 (Thl) cell lines with cyclosporine A 
inhibits clonal anergy, implying that the calcium/calmodulin/calcineurin pathway is 
critical for anergy induction (Jenkins, Chen et al. 1990). Further proof that this pathway 
is important comes from studies in which treatment of T cells with the calcium ionophore 
ionomycin mimics clonal anergy (Jenkins, Pardoll et al. 1987). Critical differences 
between clonal anergy and ionomycin-induced anergy exist, however, as the latter takes a 
longer time to induce, abolishes all cytokine production, and is stable for only four days. 
Biochemically, the selective activation of NFAT without AP-1 is critical for anergy 
induction, as it leads to reduced IL-2 production as well as activation of a specific set of 
"anergy genes" (Macian, Garcia-Cozar et al. 2002). In addition, there is a loss of 
mitogen activated protein kinase (MAPK) signal transduction in anergized cells 
((DeSilva, Feeser et al. 1996; Fields, Gajewski et al. 1996; Li, Whaley et al. 1996). 
l.A.3.2 In vivo anergy: 
In contrast to the induction of clonal anergy in antigen experienced cells, in vivo 
anergy is seen when naive T cells are stimulated with antigen in the absence of co-
stimulatory molecules or in the presence of high levels of co-inhibitory molecules. Cells 
undergoing in vivo anergy proliferate and differentiate to varying degrees but then fail to 
proliferate upon second exposure to the antigen. Historically, in vivo anergy was first 
noted in 1989 with the injection of Mls-la splenic cells into Mls-lb mice (Rammensee, 
Kroschewski et al. 1989). Most T cells proliferated and died, but a small proportion 
survived and did not proliferate in response to further stimulation with Msl-lb cells. The 
potential caveat in this model and subsequent superantigen model systems was that the 
surviving, non-proliferating cells may never have recognized the antigen. Jenkins and 
colleagues addressed this issue by devising a model of anergy involving adoptive transfer 
of transgenic T cells into nonirradiated syngenic mice followed by intraperitoneal 
injection of antigen (Pape, Merica et al. 1998). Cells that survived the initial proliferation 
and collapse were viable for several months and remained unresponsive to further antigen 
stimulation for several weeks. This tolerance was not due to bystander suppressor effects 
or a suppressor cytokine milieu, as mixed transgenic TCR transfers revealed that anergy 
was antigen specific (Pape, Merica et al. 1998). 
Considering the different natures of clonal anergy and in vivo anergy, it is not 
surprising that the biochemical events regulating these two types of anergy seem to be 
very different. Whereas clonally anergic cells show a block at the level of MAPK 
signaling, changes in proximal tyrosine phosphorylation events and calcium mobilization 
upon antigen engagement have been described for in vivo anergy (Bhandoola, Cho et al. 
1993; Migita, Eguchi et al. 1995; Tanchot, Guillaume et al. 1998; Utting, Teh et al. 
2000). 
1.A.4 Regulatory T cells: 
Activation and proliferation of T cells can be actively suppressed by a dominantly 
acting subset of T cells known as regulatory T cells (Sakaguchi 2000; Shevach 2000; 
Shevach 2002). These cells have generated considerable excitement because of their 
dominant role in modulating immune responses, which has led to intriguing speculations 
for their potential roles in au t o i m m u n e diseases, transplants, cancer, and infectious 
diseases. There are currently at least three classes of T cells for which regulatory or 
immunomodulatory functions have been described in detail, and the relationship between 
these three remains unclear (Figure 1-1). 
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Figure 1-1. Regulatory T cell subtypes. Both naturally occurring (nTreg) and peripherally 
induced (pTreg) have been implicated in downregulating immune responses (yellow box). The 
lineage relationship between nTregs and pTregs is presently unclear. Figure taken from Piccirillo 
et al., Trends in Immunology, 2004. 
A.4.1 C D 4 + C D 2 5 + Regulatory T cells: 
CD4+CD25+ regulatory T cells, which make up 5-10% of peripheral T cells, are a 
naturally occurring immunosuppressive T cell subpopulation (Sakaguchi, Sakaguchi et al. 
1995). CD4+CD25+ cells behave like partially anergic cells in vitro, proliferating poorly 
in response to TCR stimulation unless provided with exogenous IL-2 (Papiernik, de 
Moraes et al. 1998; Takahashi, Kuniyasu et al. 1998). Depletion of these cells in vivo 
leads to multi-organ autoimmune disease characterized predominantly by gastritis, 
thyroiditis, and oopheritis (Takahashi, Kuniyasu et al. 1998). It is of note that though 
more than one organ may be affected in a given mouse, this disease is always restricted to 
organs, with no evidence for the development of systemic autoimmune disease or anti-
nuclear antibody formation (Takahashi, Kuniyasu et al. 1998; Shevach 2000). In addition 
to their role in maintaining immune homeostasis, CD4+CD25+ cells have also been 
implicated in acquired tolerance such as oral tolerance (Thorstenson and Khoruts 2001; 
Zhang, Izikson et al. 2001; Hauet-Broere, Unger et al. 2003). In addition CD4+CD25+ 
regulatory T cells can inhibit T helper type 2 (Th2) mediated airway eosinophilia in mice 
(Suto, Nakajima et al. 2001). 
Characterization of CD4+CD25+ regulatory T cell is still in its infancy. Although 
markers other than IL-2 receptor alpha chain (CD25) have been identified for regulatory 
T cells (CD103, galectin 1, Ly6, OX-40, CTLA-4 (CD158), 4-1BB, glucocorticoid 
induced tumor necrosis factor receptor (GITR), TNFR2, TGF-(3 1, programmed cell death 
1 (PDI), and neutropilin-1) , they are also expressed on activated CD4+ cells (Gavin, 
Clarke et al. 2002; McHugh, Whitters et al. 2002; Bruder, Probst-Kepper et al. 2004). A 
functional role for CTLA-4 in regulatory T cell function has been described (Read, 
Malmstrom et al. 2000), but the role of CTLA-4 in suppressor function remains 
controversial. Classification of CD45RBlo cells as another, potentially overlapping, 
group of naturally occurring regulatory T cells causes further confusion in the literature, 
although it has recently been shown that only the CD4+CD25+ fraction of CD45RBlo 
have functional suppressive properties in vivo (Mottet, Uhlig et al. 2003). A critical 
discovery was the recent finding that regulatory T cell development is controlled by the 
transcription factor Foxp3. Foxp3 is selectively expressed in CD4+CD25+ cells 
(Fontenot, Gavin et al. 2003; Hori, Nomura et al. 2003) and over expression of Foxp3 in 
non-suppressor cells leads to a suppressor phenotype both in vitro and in vivo (Hori, 
Nomura et al. 2003). 
The mechanisms by which CD4+CD25+ cells suppress immune responses are 
still a subject of debate. Upon TCR mediated activation, CD4+CD25+ are capable of 
suppressing proliferation of other T cells by inhibiting in vitro IL-2 production in an 
antigen non-specific manner, but require direct cell-cell contact with T cells to do so 
(Thornton and Shevach 1998; Thornton and Shevach 2000). Interluekin 4 (IL-4), 
Interleukin 10 (IL-10), and Transforming Growth Factor |3 (TGF-(3) are not required for 
this in vitro suppression (Takahashi, Kuniyasu et al. 1998; Thornton and Shevach 1998; 
Piccirillo, Letterio et al. 2002). In vivo, the mechanism by which CD4+CD25+ 
regulatory T cells exert their effect is less clear. It seems unlikely that the direct cell-
contact mediated suppression seen in vitro is the sole mechanism by which such a 
relatively small percentage of CD4+CD25+ suppressor T cells can systemically regulate 
the effects of all T cells, but data supporting other mechanisms are still contradictory and 
unclear. 
l.A.4.2 Trl Regulatory T cells: 
A potentially distinct group of regulatory T cells,Trl cells, secrete IL-10 and 
TGF-(3 and dampen immune responses via these immunomodulatory cytokines 
(Roncarolo, Bacchetta et al. 2001). In contrast to CD4+CD25+ cells, which are naturally 
generated in the thymus, Trl cells are induced upon exposure to foreign or tissue specific 
antigen in the periphery (Bluestone and Abbas 2003). Similar to CD4+CD25+ 
suppressor cells, Trl cells are capable of suppressing T cell proliferation in vitro in an 
antigen non-specific manner; however, their effects are mediated primarily by IL-10 and 
TGF-(3. Both IL-10 and TGF-|3 are particularly important for regulating immune 
responses to mucosal antigens (Jutel, Akdis et al. 2003). 
The role of IL-10 in modulating immune responses is well established. IL-10 
deficient mice develop chronic cholitis due to dysregulation of Thl mediated immune 
responses (Kuhn, Lohler et al. 1993). Conversely, IL-10 transgenic mice fail to mount 
proper Thl and Th2 responses (Rouleau, Cottrez et al. 1999). IL-10 dampens immune 
responses via multiple mechanisms, including inhibition of antigen presentation by 
antigen presenting cells (APCs) (Enk, Angeloni et al. 1993; Steinbrink, Wolfl et al. 1997; 
Moore, de Waal Malefyt et al. 2001) and induction of T cell anergy (Groux, Bigler et al. 
1996; Zeller, Panoskaltsis-Mortari et al. 1999). 
A specific role for IL-10 in the function of regulatory T cells comes from several 
lines of experimental evidence. The existence of IL-10 secreting T cells has been 
associated with tolerance in SCID patients transplanted with HLA mis-matched 
hematopoetic stem cells (Roncarolo, Yssel et al. 1988; Bacchetta, Bigler et al. 1994). 
Induction of anergy to phopholipase A2, the major allergen of bee venom, in either 
patients undergoing immunotherapy or in naturally tolerant beekeepers, correlates with 
an increase in IL-10 producing T cells (Akdis, Blesken et al. 1998). In addition, antigen 
stimulation of T cells in the presence of IL-10 leads to the generation of poorly 
proliferating T cell clones that secrete high levels of IL-10, moderate levels of TGF-(3, 
interferon gamma (IFN-y) and Interleukin 5 (IL-5), and no IL-2 or IL-4 (Groux, O'Garra 
et al. 1997). These regulatory T cells, defined as Tr-1 cells, are capable of suppression in 
vitro. Suppression is predominantly mediated by IL-10 and TGF-(3 in an antigen non-
specific manner. 
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In addition to their suppressive capabilities in vitro, Trl cells are capable of 
modulating immune responses in vivo. Trl cells can inhibit Inflammatory Bowel Disease 
(IBD) in severe combined immunodeficiency (SCID) mice (Groux, O'Garra et al. 1997). 
In contrast to the preventative role of CD25+ or CD45RBlo regulatory T cells, Trl cells 
are capable of suppressing IBD associated inflammation even after the inflammatory 
process has begun (Foussat, Cottrez et al. 2003). Trl cells have also been shown to 
inhibit airway hyperreactivity (Stock, Akbari et al. 2004) as well as Th2 mediated 
inflammation in an IL-10 dependent manner (Cottrez, Hurst et al. 2000). Taken together, 
these data suggest a role for IL-10 secreting Trl regulatory T cells in modulating immune 
responses. 
The connection between suppression by CD4+CD25+ regulatory T cells and Trl 
T cells is still unclear. Since CD4+CD25+ regulatory T cells have been shown to lead to 
the differentiation of T cells into Trl cells in vitro (Dieckmann, Bruett et al. 2002), it is 
possible that the function of regulatory T cells in vivo is mediated by their ability to 
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Figure 1-2. The lineage and functional 
relationships between CD4+CD25+ 
naturally occurring regulatory T cells 
and induced Tr-1 and Th3 regulatory T 
cells. Induced regulatory T cells 
(striped cells) can develop either from 
CD4+CD25+ cells (blue stripes) or 
CD4+CD25- cells (red stripes). 
CD4+CD25+ cells function to suppress 
either by direct cell contact mediated 
inhibition, or through the suppressive 
cytokines secreted by induced 
regulatory T cells. Figure taken from 
Bluestone et al., Nature Reviews 
Immunology, 2003. 
T 




l.A.4.3 T h 3 regulatory T cells: 
Another subset of induced suppressor cells is T helper type-3 (Th3) cells, which 
secrete TGF-p, IL-10, and IL-4. Th3 cells can be induced by stimulation of T cells in 
the presence of TGF-P in vitro (Zheng and McKeown-Longo 2002). Th3 cells are also 
induced in gut associated lymphoid tissue (GALT) in models of oral and mucosal 
tolerance (Chen, Kuchroo et al. 1994; Friedman and Weiner 1994; Neurath, Fuss et al. 
1996; Weiner 1997; Weiner 2001). Th3 cells are capable of inhibiting Th2 immune 
responses (Garside, Steel et al. 1995; Russo, Jancar et al. 1998) and have also been 
shown to be important in models of colitis (Neurath, Fuss et al. 1996; Powrie, Carlino et 
al. 1996) and tracheal eosinophilia (Haneda, Sano et al. 1997; Russo, Jancar et al. 1998). 
TGF-p secretion was critical for the suppressive function of Th3 regulatory T cells in the 
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colitis model, as blocking TGF-i3with antibodies blocked the regulatory cells' 
suppressive capacity (Powrie, Carlino et al. 1996). 
The TGF-(3 family is one of the most pleiotropic cytokine families known, with 
members playing a role in development, epithelial cell growth and differentiation, and 
carcinogenesis (Letterio and Roberts 1998). The three isoforms of TGF-(3 (TGF-(3 1, 
TGF-(3 2, TGF-(3 3) are highly homologous and use the same serine-threonine kinase type 
I and type II receptors to signal (Massague 1990). TGF-(3 1 is the predominant TGF-(3 
isoform expressed in lymphoid organs, whereas TGF-(3 2 and TGF-(3 3 are highly 
expressed in mesyncymal tissues and bone (Millan, Denhez et al. 1991). Early 
embryonic lethality of TGF-(3 2 and TGF-(3 3 deficient mice has made studying their role 
in immune cell function difficult (Kaartinen, Voncken et al. 1995; Proetzel, Pawlowski et 
al. 1995). About 60% of TGF-(3 1 deficient mice die in utero, but the remainder develop 
a severe autoimmune phenotype that leads to their death by 4 weeks of age due to 
cardiopulmonary infiltrations (Shull, Ormsby et al. 1992; Kulkarni, Ward et al. 1995; 
Yaswen, Kulkarni et al. 1996). 
TGF-|3 plays a critical role in T cell function during an immune response. TGF-(3 
deficient mice progressively develop a multi-organ autoimmune disease (Shull, Ormsby 
et al. 1992; Kulkarni, Huh et al. 1993), and a similar disease phenotype is seen in mice 
expressing a dominant negative TGF-(3 receptor II subunit in T cells (Gorelik and Flavell 
2000). TGF-(3 inhibits proliferation, cytokine production, and cytotoxicity in T cells 
(Letterio and Roberts 1998). In addition, TGF-(3 secreting regulatory T cells are capable 
of regulating both Thl and Th2 mediated immune responses (Bridoux, Badou et al. 
1997). Retroviral transduction of T cells with TGF-(3 induces IL-10 production, 
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suggesting that part of TGF-p's role in modulating the immune response may be through 
IL-10 (Kitani, Fuss et al. 2003). 
l.A.4.4 TGF-P, IL-10, and CD4+CD25+ regulatory T cells: 
The role of IL-10 or TGF-(3 in the suppressor function of CD4+CD25+ regulatory 
T cells is still unclear and is one reason for the distinction between regulatory subtypes. 
Assays using cells deficient in TGF-(3 and IL-10 signaling have shown that TGF-(3 and 
IL-10 are not necessary for the suppressive effects of CD4+CD25+ regulatory T cells in 
vitro (Piccirillo, Letterio et al. 2002). These results have been used to suggest that 
CD4+CD25+ regulatory T cells do not exert their effect through either of these cytokines; 
however, it remains unclear if the mechanisms used by CD4+CD25+ cells to suppress T 
cell proliferation in vitro are the same as those used in vivo. 
The role of IL-10 in mediating CD4+CD25+ suppression in vivo may depend on 
the context of the immune response. IL-10 deficient CD25+ cells are capable 
suppressing the autoimmune disease that occurs in post-natal day 3-thymectomized mice 
(Thornton and Shevach 1998). In contrast, CD25+ regulatory T cells prevent 
inflammatory bowel disease in the SCID colitis model in an IL-10 dependent manner 
(Asseman, Mauze et al. 1999). IL- 10-/- CD4+CD25+ T cells can suppress autoimmune 
gastritis but not bacterial driven inflammatory bowel disease, suggesting that the type of 
inflammatory response may also influence the role of IL-10 in the suppressive effects of 
CD4+CD25+ regulatory T cells (Suri-Payer and Cantor 2001). 
The role of TGF-,3 in CD4+CD25+ regulatory T cell function in vivo is equally 
unclear. Studies using identical regiments of anti-TGF-(3 antibodies have provided 
contradictory results in different in vivo models of suppressor function (Powrie, Carlino 
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et al. 1996; Read, Malmstrom et al. 2000; Piccirillo, Letterio et al. 2002; Nakamura, 
Kitani et al. 2004). TGF-f3 is not required for suppression of autoimmune gastritis by 
CD4+CD25+ regulatory T cells (Piccirillo, Letterio et al. 2002). In contrast, TGF-(3 is 
required for CD4+CD45RBlo regulatory T cell suppression in the SCID model of colitis 
(Powrie, Carlino et al. 1996). CD4+CD45RBlo cells do not represent a different 
regulatory T cell subpopulation, as TGF-(3 is also required when CD4+CD45RBlo cells 
are further purified into CD4+CD25+CD45RBlo cells (Read, Malmstrom et al. 2000). 
CD4+ CD25+ regulatory T cell suppression of trinitrobenzene acid (TNBS) induced 
colitis in SJL/J mice (Fuss, Boirivant et al. 2002) is also TGF-(3 dependent. Finally, 
TGF-(3 has been implicated in CD4+CD25+ suppression of CD8+ cytotoxic T cells in a 
model of type-1 diabetes (Green, Gorelik et al. 2003). Thus, most existing data suggest 
that CD4+CD25+ suppress via a TGF-(3 dependent mechanism in vivo, but 
counterexamples exist which may imply a context dependent role for TGF-(3 as well. 
The mechanism by which TGF-(3 exerts an effect on regulatory T cell functions is 
even less clear. Surface bound TGF-(3 is upregulated in CD4+CD25+ suppressor cells 
upon antigen stimulation (Nakamura, Kitani et al. 2001). The coordinate expression of 
TGF-p and TGF-PRII on suppressor cells may explain their anergic phenotype, as TGF-J3 
negatively regulates IL-2 mediated proliferation (Kehrl, Wakefield et al. 1986). TGF-P 
has also been shown to play a role in the generation (Park, Paik et al. 2004) and 
expansion (Yamagiwa, Gray et al. 2001) of regulatory T cells. TGF-(3 may work in part 
by inducing Foxp3 expression and regulatory T cell function of naive T cells (Chen and 
Wahl 2003; Fantini, Becker et al. 2004) (Figure 1-2). In addition, TGF-(3 plays a critical 
role in the suppressive capabilities of T helper cells that have been anergized and 
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converted to suppressor cells by CD25+ regulatory T cells (Jonuleit, Schmitt et al. 2002). 
This mechanism may provide a means by which local suppression can be spread to a 
more systemic level of tolerance. In summary, it is clear that the exact relationship 
between TGF-(3 and CD4+CD25+ suppressor cells requires further experiments. 
1.B Atopic Diseases: 
Mucosal immune responses are tightly regulated to allow activation of effector 
mechanisms against pathogens but prevent cell mediated inflammatory responses to non-
pathogenic external antigens. Misregulation of these immune responses may lead to 
atopic diseases. Atopic diseases, including asthma and atopic dermatitis, are 
multifactorial and complex pathologies that effect approximately 20% of the world's 
population, according to the World Health Organization. These diseases share in 
common high IgE levels (referred to as atopy) as well as infiltration of effector cells at 
the site of the allergic response. The types of effector cells present can be diverse, 
ranging from T lymphocytes to eosinophils, monocytes/macrophages, and mast cells. 
Both genetic predisposition and environmental factors influence the type and extent of 
the pathology (Cookson 1999). 
1.B.1 The role of Th2 immune responses in atopic diseases: 
CD4+ helper T cells can differentiate into two well defined subsets called T 
helper type 1 (Thl) cells and T helper type 2 (Th2) cells. Thl cells preferentially express 
the chemokine receptors CCR5, CXCR3, and CCR1 and produce inflammatory cytokines 
such as interferon gamma (IFNy) and lymphotoxin alpha (LTa). Thl cells generally 
mediate cellular immunity. Th2 cells express the chemokine receptors CCR3 and CCR4 
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and produce cytokines such as interleukins 4,5,9,10, and 13 (IL-4,IL-5,IL-9,IL-10,IL-13). 
These cytokines in turn regulate B cell proliferation and isotype switching (Rossi and 
Zlotnik 2000; Dong and Flavell 2001). Th2 immune responses are critical for humoral 
responses and for immune responses against extracellular parasites such as helminthes 
(Heinzel, Sadick et al. 1989; Finkelman, Pearce et al. 1991). The distinction between 
Thl and Th2 immune responses is not only significant during an immune response 
against a pathogen, but is also important in immune system mediated pathologies. The 
dominance of either helper cell type shapes the outcome of immunologically mediated 
disease conditions, including autoimmune diseases and allergic responses (Abbas, 
Murphy etal. 1996). 
There exists a strong correlation between atopic diseases and Th2 differentiation 
of T cells. The Th2 cytokine cluster is a susceptibility locus for atopic diseases (1997; 
Kawashima, Noguchi et al. 1998; Forrest, Dunn et al. 1999). Coordination of the effector 
cells in atopic diseases is controlled primarily by the cytokines secreted by Th2 T cells 
(Abbas, Murphy et al. 1996; O'Garra 1998). Furthermore, over expression of Th2 
cytokines by even threefold upon antigen encounter leads to spontaneous atopic 
dermatitis and lung infiltrations similar to those seen in asthmatic patients (Lee and 
Flavell 2004). 
1.B.2 The Generation of Th2 effector T cells: 
The signals that determine T helper cell differentiation and function are not yet 
completely understood. It is currently thought that several potentially unrelated factors 
contribute to a cell's lineage commitment choice. Experimental evidence suggests that 
Thl/Th2 differentiation is influenced by factors such as the strength of the TCR signal, 
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the-costimulatory ligand engaged, the cytokine environment, and cell cycle progression. 
It is important to note that the phenotype of helper cells becomes increasingly stable over 
time and independent of extrinsic factors such as cytokines (Huang, Hu-Li et al. 1997). 
1.B.3 Instructive versus Selective signals for T helper differentiation: 
There are currently two models for h o w cyotkines m a y affect T helper 
differentiation (Figure 1-3). The Instructive model states that cytokines directly lead to 
epigenetic modifications of T helper specific loci, increasing the expression of either Thl 
or Th2 specific genes. In contrast, the Selective model argues that Thl or Th2 skewing 
cytokines favor the growth of T helper cells that stochastically express the respective 
mRNA. In the case of Th2 differentiation, data exist to support both models (Farrar, 
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Figure 1-3. Instructive versus selective models of T helper differentiation, a. Instructive model. 
Cytokines provide instructive signals to naive cells to differentiate along given pathways, b. 
Selective model. Cytokines support the outgrowth of T helper cells that stochastically 
differentiate along a given pathway. Figure taken from Murphy et al. Nature Reviews 
Immunology 2002. 
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1.B.4 T h e role of Cytokines in T helper differentiation: 
It is well established that cytokines play a dominant role in Thl versus Th2 
differentiation under most experimental conditions. The importance of IL-12 and IL-4 in 
the development of Thl and Th2 helper cells, respectively, has been established for over 
a decade (reviwed in (Abbas, Murphy et al. 1996)). The importance of cytokines has 
been demonstrated in several ways. Addition of exogenous IFN-y and IL-12 leads to Thl 
differentiation (Gajewski and Fitch 1988; Manetti, Parronchi et al. 1993), whereas 
exogenous IL-4 leads to Th2 differentiation. Conversly, mice deficient in IL-4 or IL-4 
Ra have markedly diminished Th2 responses (Kopf, Le Gros et al. 1993; Noben-Trauth, 
Shultz et al. 1997). The critical role of IL-2 in Th2 differentiation has been demonstrated 
in similar studies (Ben-Sasson, Le Gros et al. 1990; Le Gros, Ben-Sasson et al. 1990). 
The role of cytokines in T helper differentiation has also been supported by studies of 
cytokine signaling pathways. For example, SOCS5, which binds the IL-4R and inhibits it 
function, leads to Thl skewing (Seki, Hayashi et al. 2002). 
1.B.5 Transcriptional regulation of Th1 versus Th2 differentiation: 
T helper differentiation is influenced by cytokines through both autocrine and 
paracrine mechanisms. The autocrine feedback loop is considered critical for T helper 
differentiation. As a consequence, the transcriptional regulation of signature cytokines 
within a differentiating cell plays an important role in determining its eventual fate. 
Recent work has shown that chromatin remodeling is necessary during the differentiation 
of both Thl and Th2 cells (Agarwal and Rao 1998). In addition, specific transcription 
factors have been shown to support either Thl or Th2 differentiation. Although Thl 
differentiation is mediated primarily by the master regulator T-bet (Szabo, Sullivan et al. 
2002), multiple transcription factors are involved in Th2 differentiation (Figure 1-4). 
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l.B.5.1 N F A T : 
The N F A T (nuclear factor of activated T cells) family of transcription factors is 
involved in regulting T helper differentiation. NFATc and NFATp can both bind to the 
IL-4 promoter NFAT sites (Timmerman, Healy et al. 1997). It is thought that the two 
NFAT factors antagonize each other, as NFATp deficient mice have a dysregulated Th2 
immune response whereas NFATc deficient mice have a dysregulated Thl immune 
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F i g u r e 1-4. Transcriptional regulation of T h 2 differentiation, a. P a t h w a y s for the induction of IL-4 
expression. Signals through the T Cell Receptor (TCR) and through the IL-4 receptor are important 
for the initial induction of GATA-3 and remodeling of the IL-4 locus. NFAT, AP1, and c-Maf are 
critical for initial IL-4 transcription, b. Pathways for the induction of Th2 cytokines. Signals from the 
TCR, co-stimulatory ligands, and additional ligands synergistically increase GATA-3 expression. 
Figure taken from Murphy et al., Nature Reviews Immunology, 2002. 
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l.B.5.2 J u n B and c-Maf: 
Two other transcription factors that influence Th2 differentiation include Jun B 
and c-Maf. JunB positively regulates IL-4 gene expression by binding specifically to the 
AP-1 site in the promoter of IL-4 (Li, Tournier et al. 1999). It does this in combination 
with c-Maf, a basic region/leucine zipper transcription factor that is specifically 
upregulated in Th2 cells and also binds to a site in the proximal IL-4 promoter (Ho, 
Hodge et al. 1996). In transgenic mice overexpressing c-Maf, there is an increased bias 
towards Th2 differentiation(Ho, Lo et al. 1998). Analysis of c-Maf deficient mice has 
demonstrated that c-Maf is critical for IL-4 production, as c-Maf deficient T cells are 
markedly deficient in IL-4 production (Kim, Ho et al. 1999). Similarly, overexpression 
of JunB in transgenic mice leads to Th2 differentiation of T cells even under Thl 
polarizing conditions (Li, Tournier et al. 1999). 
l.B.5.3 Stat6: 
The transcription factor Stat6 is necessary and sufficient for IL-4's role in Th2 
differentiation (Zhu, Guo et al. 2001). Stat6 is phosphorylated and activated in response 
to IL-4 and IL-13 (Kohler, Alliger et al. 1994), two major cytokines involved in Th2 
differentiation. Although IL-4 transcription can occur in the absence of Stat6, IL-4 
mediated signaling is completely abrogated (Kaplan, Wurster et al. 1999). As a result, T 
cells from Stat 6 deficient mice are defective in differentiating into Th2 cells in vitro 
(Kaplan, Schindler et al. 1996). Stat6 deficient mice produce very reduced levels of Th2 
cytokines in response to infection with the nematode Nippostrongylus brazilinesis and the 
parasite worm Schistosoma mansonii (Takeda, Tanaka et al. 1996; Kaplan, Whitfield et 
al. 1998). In addition, Stat6 deficient mice show a complete abrogation of antigen 
induced airway hyperresponsiveness, which is driven by a Th2 T cell response (Akimoto, 
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Numata et al. 1998; Kuperman, Schofield et al. 1998). Conversely, ectopic expression of 
Stat6 in cells undergoing TH1 differentiation leads to the development of Th2 cells and 
the upregulation of GATA-3 and c-Maf, demonstrating that Stat6 regulates Th2 
differentiation upstream of these two transcription factors (Kurata, Lee et al. 1999). It 
should be noted that in some model systems, Th2 differentiation can be induced in the 
absence of Stat 6 (Ouyang, Lohning et al. 2000) and Th2 driven immune responses are 
not significantly affected (Finkelman, Morris et al. 2000; Jankovic, Kullberg et al. 2000). 
These results suggest that Stat6 independent pathways for Th2 differentiation may also 
exist, though analysis of in vivo data is complicated by the fact that IL-4 production from 
NK and NKT cells is Stat6 independent (Kaplan, Wurster et al. 1999; Stetson, Mohrs et 
al. 2003). 
l.B.5.4 GATA-3: 
Of the transcription factors that influence Th2 differentiation, GATA-3 is perhaps 
the most powerful. GATA-3 is rapidly induced in Th2 differentiating cells in a partially 
IL-4 and Stat6 dependent manner (Ouyang, Ranganath et al. 1998; Ouyang, Lohning et 
al. 2000), and it remains expressed in effector Th2 cells (Zheng and Flavell 1997). 
Transgenic mice in which GATA-3 is overexpressed produce Th2 cytokines (IL-4, IL-5, 
IL-6, IL-10) even under Thl polarizing conditions where no exogenous IL-4 is present 
(Zhang, Cohn et al. 1997; Zheng and Flavell 1997). Antisense mediated reduction of 
GATA-3 blocks Th2 cytokine production in Th2 clones and allergic airway inflammation 
in vivo (Zheng and Flavell 1997; Finotto, De Sanctis et al. 2001). Expression of a 
dominant negative GATA-3 also decreases Th2 mediated pulmonary allergic responses in 
mice (Zhang, Yang et al. 1999). Furthermore, conditional deletion of GATA-3 leads to 
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impaired Th2 differentiation in vitro, even in the presence of exogenous IL-4. In 
addition, it abolishes Th2 immune responses in vivo (Zhu, Mm et al. 2004). Deletion of 
GATA-3 in fully differentiated Th2 cells abolishes IL-5 and IL-13 production, although 
IL-4 production is only diminished (Zhu, Min et al. 2004). 
Although GATA-3 is critically important for Th2 differentiation, it alone cannot 
account for all aspects of Th2 differentiation. GATA-3 expressing T cells polarized 
under Thl differentiation conditions, though they generate Th2 cytokines, do not expand 
as well as conventional Th2 cells. This growth defect can be rescued by the expression 
of the Stat6-inducible gene growth factor inhibitor 1 (Gfi-1) (Zhu, Guo et al. 2002). 
l.B.5.5 Stat5: 
The Stat5 transcription factors regulate Th2 differentiation in a GATA-3 
independent fashion. Four isoforms of Stat5 exist, encoded by two genes (Stat5a and 
Stat5b) that each give rise to two isoforms based upon post-translational modifications 
(Azam, Erdjument-Bromage et al. 1995; Azam, Lee et al. 1997). Stat5 proteins are 
activated downstream of the IL-2R, IL-7R, IL-9R, and IL-15R and have been implicated 
in IL-2 induced cell cycle progression (Hoey and Grusby 1999; Moriggl, Topham et al. 
1999). Stat5a-deficient mice or cells in which Stat5 activity is blocked by treatment with 
cell permeable phospho-Stat5 peptide are defective in Th2 differentiation (Yamashita, 
Katsumata et al. 2000; Kagami, Nakajima et al. 2001). Furthermore, expression of a 
constitutively active Stat5a protein removes the requirement for IL-2, IL-4, and Stat6 in 
Th2 differentiation (Zhu, Cote-Sierra et al. 2003). The constitutively active Stat5a 
protein does not lead to enhanced GATA-3 expression. Rather, Stat5a and GATA-3 
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collaborate in Th2 differentiation by "opening" the IL-4 gene locus at different regions 
(Zhu, Cote-Sierra et al. 2003). 
1.B.6 Cell cycle progression and T helper differentiation: 
Cell cycle progression is critical for both Thl and Th2 differentiation. 
Instructional signals for promoting Thl or Th2 differentiation can neither induce effector 
cytokine expression in the absence of cell cycle progression nor alter the pattern of 
division-dependent expression of effector cytokines, suggesting that epigenetic 
modifications are critical for T helper differentiation. More cell divisions are required for 
Th2 differentiation than Thl differentiation (Bird, Brown et al. 1998). 
1.B.7 Co-stimulatory ligands and Th1 versus Th2 differentiation: 
The role of antigen presenting cells (APCs) in directing Thl versus Th2 
differentiation is substantiated by numerous studies (reviewed by (Eisenbarth, Piggott et 
al. 2003; Kapsenberg 2003). APCs influence T helper differentiation through both 
cytokines and cell surface expressed ligands. Though not all modes of influence are as 
yet determined, the role of co-stimulatory ligands is clear. 
CD28 co-stimulation is particularly important for Th2 differentiation (Seder, 
Germain et al. 1994; Schweitzer and Sharpe 1998). Stimulation of CD4+ T cells with 
APCs in the presence of blocking antibodies against CD28 or stimulation with fibroblasts 
lacking CD28 leads to IFNy producing Thl cells but not IL-4 producing Th2 cells. 
CTLA-4, a member of the CD28 family that acts as a negative regulator of T cell 
activation, negatively regulates Th2 differentiation. As a consequence, CTLA-4 deficient 
DO 11.10 transgenic mice show increased Th2 differentiation upon stimulation 
(Oosterwegel, Mandelbrot et al. 1999). Furthermore, Th2 differentiation in the absence 
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of CTLA-4 occurs in the absence of Stat6 signaling (Bour-Jordan, Grogan et al. 2003). 
Stimulation with B7.1 or B7.2 leads to increased Thl or Th2 differentiation, respectively. 
The differential roles of B7.1 and B7.2 in modulating T helper differentiation may be 
explained by their selective recruitment of either CTLA-4 or CD28 to the immune 
synapse (Kuchroo, Das et al. 1995; Pentcheva-Hoang, Egen et al. 2004). Another 
member of the CD28 family, ICOS (Inducible CO-Stimulator) is highly expressed on 
Th2 cells and seems to specifically regulate Th2 effector function. In contrast, ICOS 
inhibits differentiation of naive cells into either Thl or Th2 effector cells (Coyle, Lehar et 
al. 2000). Another co-stimulatory ligand, OX40, participates in Thl cell differentiation. 
Mice deficient in OX40 have reduced numbers of CD4+ IFN-yproducing T cell in 
response to viral infection (Kopf, Ruedl et al. 1999). DR6, a member of the TNF family 
of receptors, also modulates T helper differentiation, as DR6 deficient CD4+ T cells 
show increased Th2 cytokine production (Liu, Na et al. 2001). 
Co-stimulatory ligands can also indirectly affect a T cell's differentiation fate. 
For example, expression of CD40L on a T cell leads to increased IL-12 expression in the 
APC to which it binds (Grewal and Flavell 1998). TRANCE/TRANCE-R ligation on 
dendritic cells also leads to IL-12 expression in vitro and enhanced Thl mediated 
IFNyresponses in vivo (Bachmann, Wong et al. 1999; Green and Flavell 1999). 
Although not technically co-stimulatory signals, the LFA (leukocyte function-associated 
antigen 1)-ICAM (intercellular adhesion molecule 1) binding biases T helper 
differentiation in favor of Thl (Salomon and Bluestone 1998; Luksch, Winqvist et al. 
1999; Camacho, Heath et al. 2001; Smits, de Jong et al. 2002). 
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Recently, the Notch pathway has been implicated in regulating T helper 
differentiation. In vitro stimulation with Delta ligand leads to increased Thl 
differentiation (Maekawa, Tsukumo et al. 2003). Furthermore, dendritic cells that are 
primed to stimulate Thl immune responses express the Delta ligand, whereas dendritic 
cells, which are primed for Th2 immune responses, express Jagged (Amsen, Blander et 
al. 2004). Finally, expression of the constitutively active intracellular domain of Notchl 
leads to increased Th2 differentiation, even in the absence of Stat6 (Amsen, Blander et al. 
2004). These data suggest that the Notch pathway can regulate T helper differentiation 
independently of cytokines. 
1.B.8 TCR signaling and Th1 versus Th2 differentiation: 
T cell activation is strictly controlled by signals emanating from the T Cell 
Receptor (TCR) and co-stimulatory ligands. The biochemical pathways coupling TCR 
engagement with downstream signaling events include a tyrosine kinase cascade, serine 
threonine kinases, G proteins, and Ca2+ mobilization. In addition, actin polymerization 
and receptor turnover critically regulate the duration of an antigenic stimulus by affecting 
the stability of the immune synapse. 
The strength of the stimulation through the TCR has also been shown to modulate 
the differentiation decision of helper T cells. T cells need prolonged stimulation (> 72 
hours) in order to differentiate into either Thl or Th2 cells in the absence of exogenous 
cytokines (Iezzi, Scotet et al. 1999). Th2 differentiation seems to be favored at the 
extremes of antigenic stimulation, with both low dose and low affinity ligand stimulation 
(Constant, Pfeiffer et al. 1995; Pfeiffer, Stein et al. 1995) as well as high antigenic dose 
stimulation (Hosken, Shibuya et al. 1995) favoring Th2 differentiation. In addition T cells 
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require simultaneous stimulation through the T C R and cytokine receptor in order to 
differentiate into Th2 cells, although Thl differentiation can occur if both signals are 
provided separately (Iezzi, Scotet et al. 1999). 
Differences in signaling downstream of the TCR have been described for Thl 
and Th2 cells, but these initial differences were noted between differentiated effector Thl 
and Th2 cells (Fitch, McKisic et al. 1993; Fallon, Smith et al. 1998; Balamuth, 
Leitenberg et al. 2001). The pathways downstream of the TCR that are involved in T 
helper cell differentiation are currently being elucidated. These pathways can either be 
involved in directly promoting T helper differentiation along a given pathway, or can 
influence differentiation by inhibiting differentiation along the alternate pathway. An 
example of the second, indirect mode of action is the Tek family member Itk, which 
promotes Th2 differentiation by negatively regulating T-bet (Miller, Wilcox et al. 2004). 
One of the most proximal events after TCR engagement that has been linked to 
the differentiation process is ZAP-70 signaling. Inhibition of ZAP-70 signaling leads to a 
bias towards Th2 differentiation (Tanaka, Bi et al. 2003). In Th2 differentiating T cells, 
this inhibition is mediated by the SWAP-70 like adaptor of T cells (SLAT) (Tanaka, Bi et 
al. 2003). Recently, a role for SAP (SLAM associated protein) in Th2 differentiation has 
been described. Stimulation of SAP deficient CD4+ T cells in vitro reveals reduced Th2 
cytokine production (Czar, Kersh et al. 2001; Wu, Nguyen et al. 2001). SAP functions as 
an adaptor protein that recruits FynT to SLAM family receptors. The critical role of Fyn 
phosphorylation of SLAM in Th2 differentiation has been established using Fyn-binding 
deficient SAP knock-in mice (Davidson, Shi et al. 2004). Furthermore, the downstream 
pathways affected by SAP deficiency, including PKC-6 recruitment, Bel-10 
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phosphorylation, IxB-a degradation, and nuclear accumulation of NF-kB 1 (Cannons, Yu 
et al. 2004), may also be involved with Th2 differentiation. Consistent with this idea is 
the finding that mice containing a point mutation in the Carma protein, which acts 
downstream of SAP and Fyn, also show a skewed Th2 bias (Jun, Wilson et al. 2003). 
Further downstream of the TCR, JNK signaling has been linked to T helper 
differentiation. Mice deficient for JNK1, JNK1 and JNK2, or the JNK activating kinase 
MKK7 have exaggerated Th2 responses, although these T cells are capable of undergoing 
Thl differentiation under Thl polarizing conditions (Dong, Yang et al. 1998; Dong, 
Yang et al. 2000). Conversely, mice deficient in JNK2 show deficient Thl immune 
responses (Yang, Conze et al. 1998). Moderate increases in the levels of nuclear Jun B 
and significant increases in nuclear NFATc were seen in anti-CD3 and anti-CD28 
activated T cells from JNK1 deficient mice. The accumulation of NFATc is presumably 
due to the absence of JNK1 mediated phosphorylation of NFATc, which is involved in 
inhibiting calcineurin binding and hence NFATc translocation to the nucleus (Chow, 
Dong et al. 2000). 
1.C. CD8+ Memory T cells Maintenance and Generation: 
During a primary infection, one critical aspect of the adaptive immune system is 
the generation of immunological memory against the invading pathogen. The basis of 
immunological memory lies in a specialized subgroup of cells called memory cells, 
which have a number of characteristics that distinguish them from naive cells (Ahmed 
and Gray 1996; Gray 2000). Memory cells survive longer compared to naive cells and 
respond more rapidly to antigen in terms of entry into cell cycle and conversion into 
cytokine secreting effector cells (Pihlgren, Dubois et al. 1996; Rogers, Dubey et al. 
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2000). Because of the cytotoxic abilities of CD8+ effector cells, memory CD8+ cells are 
critical mediators of immunity against a broad range of bacterial, viral, and protozoal 
intracellular pathogens during secondary infections. Understanding the generation and 
maintenance of CD8+ memory cells is thus critical for further improvements in 
vaccination against infectious agents. 
Although small and quiescent like naive cells, CD8+ memory cells differ from 
their naive CD8+ counterparts in several aspects. CD8+ memory cells constitutively 
express genes that are involved in the effector functions of CD8+ cells, such as IFNy, 
perforin, and granzyme B. Though the proteins are synthesized only upon antigen 
encounter, the elevated mRNA levels of these genes allows for the synthesis of increased 
amounts of proteins in a shorter amount of time (Bachmann, Barner et al. 1999; Veiga-
Fernandes, Walter et al. 2000; Swanson, Murakami et al. 2002). Memory CD8+ cells 
also express different surface proteins involved in cell adhesion and chemo taxis. These 
molecules allow memory cells to extravasate into non-lymphoid tissue and mucosal sites. 
Finally, as secondary infections can occur years after the initial infection, memory CD8+ 
cells maintain themselves over an extended period of time through slow, homeostatic 
proliferation (Homann, Teyton et al. 2001). Because of these fundamental differences, 
differentiation of naive CD8+ cells into effector and/or memory cells involves structural 
reorganization of the membrane and cytoskeleton, chromatin remodeling, expression of 
new genes, and induction of cell division (Kaech, Hemby et al. 2002). 
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1.C.1 Central versus Effector M e m o r y C D 8 + T cells: 
l.C.1.1 Phenotypic characterization: 
All CD8+ memory cells can be distinguished by their surface expression of 
canonical memory cell markers such as CD44, CD122, Ly6C, CDlla, and CD132. In 
addition, CD8+ memory cells do not express the activation markers CD25 and CD69 
(Wherry, Teichgraber et al. 2003). Analysis of these cell surface markers allows for the 
identification of potential memory CD8+ cells in polyclonal populations in vivo, where 
the specific antigen to which a memory CD8+ cell was formed is unknown. 
CD8+ memory cells can be further subdivided into central and effector memory 
cells based on location and expression of specific cell surface markers (Sallusto, Lenig et 
al. 1999). CD62Lhi CCR7+ cells are deemed central memory cells, as expression of 
these ligands allows for their efficient homing to lymph nodes via interactions with the 
chemokines CCL19 and CCL21 (Forster, Schubel et al. 1999; Mori, Nakano et al. 2001). 
Upon restimulation, these cells can proliferate and differentiate into effector cells 
(Zinkernagel, Bachmann et al. 1996). Conversely, long-lived CD62Llo CCR7- cells 
cannot home to lymph nodes but exist in the periphery and are termed effector memory 
cells. Effector memory cells have been found in the bone marrow in response to LCMV 
(Slifka, Whitmire et al. 1997), in the lung in response to intranasal influenza (Flynn, Belz 
et al. 1998), respiratory viruses (Hogan, Usherwood et al. 2001) or Sendai virus 
(Usherwood, Hogan et al. 1999), in the liver in response to oral Listeria monocytogenes 
infection (Pope, Kim et al. 2001), in gut mucosal tissue in response to vesicular stomatis 
virus, vaccinia virus, and Listeria (Masopust, Jiang et al. 2001) and in the brain in 
response to dengue virus (van der Most, Murali-Krishna et al. 2003). Both central and 
effector memory populations are found in the blood and spleen. 
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l.C.1.2 Functional characterization: 
The distinct roles central and effector memory subsets in providing protective 
immunity for the host are presently unclear (Masopust and Lefrancois 2003; Masopust, 
Kaech et al. 2004). Contradictory data exist regarding the speed with which effector 
memory and central memory cells acquire effector functions such as cytokine secretion 
and cytotoxic activity. Experiments involving polyclonal stimulation of effector and 
central memory cells have shown that effector memory responses are faster (Sallusto, 
Lenig et al. 1999; Tussey, Speller et al. 2000; Masopust, Vezys et al. 2001); however, 
experiments involving stimulation with cognate antigen have demonstrated equivalent 
responses between the two subpopulations (Unsoeld, Krautwald et al. 2002; Wherry, 
Teichgraber et al. 2003). In addition, central memory cells have a proliferative advantage 
over effector memory cells in response to antigenic stimulation, suggesting that central 
memory cells may provide better immunological protection over time (Wherry, 
Teichgraber et al. 2003) 
l.C.1.3 Generation of CD8+ Central and Effector Memory Cells: 
The lineage relationship between central and effector memory is also presently 
unclear. Two opposing models exist for the relationship between these two subtypes, 
with experimental data existing to support both. In one model, central memory and 
effector memory cells are two independent potential pathways for CD8+ memory cell 
differentiation (Sallusto and Lanzavecchia 2001). Data consistent with this theory comes 
from in vitro studies showing that the cytokine environment can influence the phenotypic 
generation of central or effector memory cells (Manjunath, Shankar et al. 2001). 
Furthermore, the TCR repertoire in human central and effector memory cells is distinct, 
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supporting the argument that these two subpopulations are distinct (Baron, Bouneaud et 
al. 2003). 
In sharp contrast, in vivo data from mice using both a viral and bacterial model of 
infection suggest that there is a linear progression from effector memory cells to central 
memory cells (Wherry, Teichgraber et al. 2003). Furthermore, the conversion rate of 
effector memory cells to central memory is linked to the initial antigenic challenge and 
programmed during the initial antigen encounter. Low dose antigen exposure leads to 
faster conversion rates from effector memory to central memory cells, whereas high dose 
antigen exposure leads to slower rates. Collectively, these findings provide a model for 
linear CD 8+ memory T cell differentiation from effector memory to central memory in 
the case of acute infections. 
The relationship between central and effector memory cells in the case of chronic 
infections is also unclear. Recent experimental data has shown that persistent viral 
antigen leads to the accumulation of distinct populations of memory cells or different 
stages of memory cells, depending on the viral infection (Champagne, Ogg et al. 2001; 
Appay, Dunbar et al. 2002). The lineage relationship between these different populations 
has been difficult to ascertain in vivo. 
1.C.2 Progressive versus Linear models for CD8+ Memory Cell 
Generation: 
The generation of memory cells from naive cells is a poorly understood process. 
There are currently two models for how this differentiation occurs (Figure 1-5). The 
progressive model of differentiation argues that a naive cell commits to either memory 
cell formation or effector cell generation based on the strength of the TCR signal during 
priming, with stronger signals leading to effector cells and weaker signals leading to the 
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generation of memory cells (Sallusto and Lanzavecchia 2001). In contrast, the linear 
differentiation model argues that memory cell precursors are a subset of effector cells that 
survive the contraction phase of the memory cell response. There is data to support both 
these viewpoints. 
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Figure 1-5. Progressive and linear models for m e m o r y C D 8 + cell generation, a. 
Progressive model. C D 8 + T cells can bypass the effector stage and directly 
b e c o m e m e m o r y cells, b. Linear model. M e m o r y C D 8 + cells are direct 
descendents of effector C D 8 + cells. Figure taken from Kaech et al., Nature 
Reviews Immunology, 2002. 
T h e data in favor of the linear progression m o d e l is three fold. Experiments 
utilizing Cre-mediated genetic marking of activated CD8+ cells have shown that memory 
cells can arise from activated CD8+ cells (Jacob and Baltimore 1999; Opferman, Ober et 
al. 1999). In addition, the signals that mediate naive CD8+ cell differentiation into 
effector cells are also sufficient for CD8+ memory cell formation. Cells stimulated with 
antigen for a brief period not only undergo programmed division and gain effector 
function but also generate long-lived memory cells (Mercado, Vijh et al. 2000; Kaech 
and Ahmed 2001). Finally, identification of CD8+ memory cell precursors during an 
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immune response has shown that precursors upregulate expression of genes required for 
effector functions (Kaech, Tan et al. 2003). 
Data also exist that are more consistent with the progressive model of 
differentiation, which states that CD8+ memory cell formation and CD8+ effector cell 
generation are two independent pathways. It has been shown both in vitro and in vivo 
that it is not necessary for CD8+ cells to pass through an effector phase for memory cell 
generation (Lauvau, Vijh et al. 2001; Manjunath, Shankar et al. 2001). Furthermore, 
CD8+ cell proliferation, which is critical for memory cell generation, can be uncoupled 
from gain of effector function (Hernandez, Aung et al. 2002). The discrepancies between 
this data and the data in support of the linear differentiation model may be resolved once 
central and effector memory cell generation are considered separately. 
1.C.3 The impact of Proliferation on CD8+ Memory Cell Development: 
Upon antigen encounter in lymphoid tissues, CD8+ T cells undergo a 
programmed proliferative response. This proliferation leads to a 10,000-100,000 -fold 
increase in the number of antigen specific cells (Murali-Krishna, Altman et al. 1998; 
Blattman, Antia et al. 2002). The extent of proliferation is important because the size of 
the memory pool is directly correlated with the size of the effector-cell population (Hou, 
Hyland et al. 1994; Busch, Pilip et al. 1998). Memory cell numbers after antigen 
encounter are always roughly 10% of cell numbers seen at the peak of the effector 
response, regardless of whether the number of antigen specific cells recruited initially is 
only 1-2% of total CD8+ cells, as in the case for Listeria, or is over 50%, as is the case 
for LCMV (Busch, Pilip et al. 1998; Butz and Bevan 1998). Thus mechanisms that 
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modify CD8+ effector cell generation will invariably effect CD8+ memory cell 
generation as well. 
1.C.4 The effect of Antigen Dose on CD8+ Memory cell Generation: 
Both in vitro and in vivo data demonstrate that only a brief antigenic exposure (2-
24 hours) is required for commitment to 7-10 rounds of programmed division (Mercado, 
Vijh et al. 2000; Kaech and Ahmed 2001; van Stipdonk, Lemmens et al. 2001; Wong and 
Pamer 2001; van Stipdonk, Hardenberg et al. 2003). The daughter cells derived during 
this proliferation need no further antigenic stimulation for proliferation to proceed. 
Furthermore, weak signaling through the peptide-MHC complex, which does not induce 
calcium fluxes or phosphorylation of MAPK, can none-the-less lead to proliferation 
(Rosette, Werlen et al. 2001). 
Although a proliferative response can occur in response to minimal antigen 
exposure, the amount of antigen available plays a critical role in the extent of 
proliferation in vivo. Infection of mice with recombinant vaccinia strains expressing 
different levels of an ovalbumin epitope demonstrate that the magnitude of the CD8+ T 
cell response varies with the levels of epitope presented (Wherry, Puorro et al. 1999). 
Similar results have been obtained by titrating peptide and peptide loaded dendritic cells 
(Ludewig, Ehl et al. 1998; Kedl, Rees et al. 2000; Kaech and Ahmed 2001). These data 
show that upon minimal antigen exposure, CD8+ cells proliferate 7-10 times, but that 
both the recruitment of naive precursors and the rate of expansion of the recruited cells 
can be increased by further antigen exposure, leading to an increase of the magnitude of 
the expansion (Badovinac, Porter et al. 2002). In this way, the strength of antigenic 
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stimulation plays a role in the development of effector and memory CD8+ cells upon 
acute antigen exposure. 
The role of antigen in CD8+ memory cell formation is more complicated in 
persistent infections. Antigen dependent proliferation does not continue indefinitely, and 
expansion ceases in the case of chronic persisting antigen (Badovinac, Porter et al. 2002). 
Furthermore, persisting antigen can compromise CD8+ memory cell development 
(Wherry, Teichgraber et al. 2003). 
1.C.5 The role of co-stimulatory ligands in CD8+ memory cell 
generation: 
There are two ways in which co-stimulatory ligands can effect CD8+ memory cell 
generation. The first is by modulating the strength of the proliferative response. The 
second is by providing signals necessary for CD8+ memory cell generation. Data exist to 
support a role for both of these pathways. 
The strength of the T cell receptor (TCR) signal is determined not only by the 
presence of antigen but also by the co-stimulatory signals present. Studying the role of 
co-stimulatory ligands in CD8+ effector cell generation can be confounded by the fact 
that CD4+ cells are at times necessary for CD8+ effector cell generation (Kaech, Wherry 
et al. 2002). Fortunately, some viral infections in mice induce CD8+ effector cells in the 
absence of CD4+ T cells. Studies performed with these viral infections in mice deficient 
in specific co-stimulatory ligands has shed light on which ligands are important for a 
robust CD8+ effector cell response. The co-stimulatory ligands CD40L and OX40 are 
not critical for CD8+ effector cell function. (Kopf, Ruedl et al. 1999; Whitmire and 
Ahmed 2000). The role of the co-stimulatory ligand CD28 seems to be virus dependent, 
as generation of CD8+ effector cells in response to LCMV is not affected (Shahinian, 
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Pfeffer et al. 1993) but responses to V S V (McAdam, Farkash et al. 2000), vaccinia 
(Sigal, Reiser et al. 1998), and influenza (Wu and Liu 1994) are reduced. 4-1BBL is 
critical for CD8+ effector function. (DeBenedette, Wen et al. 1999; Tan, Whitmire et al. 
1999; Tan, Whitmire et al. 2000). Negative regulators, such as CTLA-4, BTLA, and PD-
1 also play a role in attenuating clonal expansion (Greenwald, Latchman et al. 2002; 
Watanabe, Gavrieli et al. 2003). Thus, modulation of co-stimulatory pathway can effect 
CD8+ memory cell generation indirectly via expansion of CD8+ effector cells. 
A role for co-stimulatory ligands in regulating memory CD8+ cell generation also 
has experimental support. Although CD4+ cells can be dispensable for CD8+ effector 
cell generation, recent data suggest that CD4+ cells are crucial for CD8+ memory cell 
formation. The first evidence of this phenomenon came from analysis of female HY 
TCR transgenic mice exposed to male HY antigen. Although CD8+ effector generation 
and expansion in response to HY occurred normally, CD8+ cells showed poor 
proliferative capacity and effector function upon restimulation in vitro (Bourgeois, Rocha 
et al. 2002). Upregulation of CD40 on CD8+ cells during activation led to the hypothesis 
that CD40-CD40L interactions between CD4+ and CD8+ cells is critical for memory cell 
formation. Additional support for a role for CD4+ cells in CD8+ memory cell generation 
came from a model involving cross-priming-induced CD8+ T cell activation. Depletion 
of CD4+ cells as short as 3 days after the infection revealed that CD4+ cell help was 
required only during the initial antigen exposure (Janssen, Lemmens et al. 2003). 
Finally, the importance of CD4+ cells in CD8+ memory cell generation has been 
extended to include CD8+ memory cell generation after acute infections (Shedlock and 
Shen 2003; Sun and Bevan 2003). Collectively, these data support the uncoupling of 
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CD8+ memory cell formation from CD8+ effector generation in the absence of CD4+ 
cells. Furthermore, robust secondary responses even in the absence of CD4+ helper cells 
suggest that an instructive signal for CD8+ memory cell generation is provided by CD4+ 
cells during the initial CD8+ cell priming (Masopust, Kaech et al. 2004). 
1 .C.6 Proliferation per se and CD8+ memory cell generation: 
The process of proliferation is critical for memory cell development. Experiments 
addressing the role of cell division in CD8+ memory cell generation used in vitro 
proliferation of CD8+ cells labeled with CFSE (carboxyfluoroscein diacetate 
succinimidyl ester) to allow for the isolation of activated CD8+ cells having undergone a 
specific number of divisions. Seventy days after transfer, cytotoxic T lymphocyte (CTL) 
precursor frequencies from mice adoptively transferred with activated CD8+ cells that 
had undergone less than five cell divisions were similar to those of mice transferred with 
naive cells. In contrast, transfer of activated CD8+ cells that had undergone more than 
nine divisions lead to a significant increase in CTL precursor frequency in the transferred 
mice, suggesting that memory cells had been transferred (Opferman, Ober et al. 1999). 
Proliferation is more important than even cognate antigen stimulation, as 
memory-like cells also develop after homeostatic proliferation in a lymphopenic 
environment (Cho, Rao et al. 2000; Goldrath, Bogatzki et al. 2000; Murali-Krishna and 
Ahmed 2000; Goldrath, Sivakumar et al. 2002). Homeostatically proliferating cells not 
only express memory cell-surface markers but also have cytolytic activity and secrete 
IFNy faster in response to antigen (Cho, Rao et al. 2000; Goldrath, Bogatzki et al. 2000). 
These memory-like cells do not behave exactly as memory cells, however. In contrast to 
true memory cells, memory-like cells revert to a naive phenotype upon removal from a 
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lymphopenic environment (Cho, Rao et al. 2000). Furthermore naive CD8+ cells 
undergoing homeostatic expansion do not survive in MHC I deficient hosts (Murali-
Krishna Jl 2000), in direct contrast to memory CD8+ cells (Murali-Krishna, Lau et al. 
1999). 
1.C.7 Cell Survival Factors and CD8+ Memory Cell Development: 
After antigen encounter, the proliferative phase of the immune response is 
followed by a contraction phase, where 90-95% of the CD8+ effector cells undergo 
programmed cell death (Ahmed and Gray 1996). This contraction phase is programmed 
during the initial antigen encounter. Treatment of mice infected with Listeria 
monocytogenes with antibiotics 24 hours after infection reduces the magnitude of 
expansion and the course of infection, but has no effects on the kinetics and extent of 
contraction (Badovinac, Porter et al. 2002). Conversely, treatment with a higher dose of 
Listeria prolongs the infection but does not change the magnitude or kinetics of the 
contraction phase, even when there is a persistent infection at the beginning of the 
contraction phase (Badovinac, Porter et al. 2002). This contraction in the face of 
persisting antigen may be important for preventing lethal autoimmune pathologies. 
The factors that determine the kinetics of the contraction phase as well as which 
cells will survive to become memory cells are currently being elucidated. IFNy has been 
implicated in the timing of the contraction phase, as the delayed kinetics of contraction 
seen in a secondary immune response are also seen in the primary immune response of 
IFNy deficient mice (Badovinac, Tvinnereim et al. 2000). Furthermore, inhibiting 
inflammation and IFNy production by giving antibiotics prior to an infection limits the 
extent of contraction but does not effect memory cell formation (Badovinac, Porter et al. 
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2004). These data suggest that memory cells do not form by a default pathway after 
surviving the contraction phase. 
l.C.7.1 IL-7: 
Memory cell precursors exist in the effector cell population at the peak of the 
immune response, but at this time they do not show the functional hallmarks of memory 
T cells (Kaech, Hemby et al. 2002; Wherry, Teichgraber et al. 2003). These properties 
are gained over the course of several weeks, but the signals that drive this differentiation 
are unknown. What is clear is that survival is a prerequisite for memory cell generation, 
but the mechanisms that lead to the selective survival of precursor memory cells are still 
under investigation. 
The clearest case for a survival factor being involved in memory cell generation is 
IL-7. IL-7 is required for the survival of naive T cells (Tan, Dudl et al. 2001). In 
addition, it is required for naive CD8+ cell proliferation in a lymphopenic environment 
(Goldrath, Sivakumar et al. 2002). Recently, it has been shown that CD8+ memory cell 
precursors can be identified by their expression of IL-7Ra (CD127) during the peak 
effector response after antigen encounter (Kaech, Tan et al. 2003). IL-7Rahi cells are 
identified as memory cell precursors by several lines of evidence. Experiments involving 
transfer of IL-7Rahi or IL-7Ralo cells into naive mice and challenge three weeks later 
show that IL-7Rahi cells but not IL-7Ralo provided immunological protection. 
Although IL-7Rahi memory precursor cells express granzyme B like other effector cells, 
they differ in their expression of tumor necrosis factor receptor superfamily member 7 
(CD27) and killer cell-lectin like receptor Gl (KLRG-1), which have been linked to 
senescent effector cells (Hamann, Baars et al. 1997; Voehringer, Blaser et al. 2001). 
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Furthermore, IL-7Rahi cells undergo homeostatic proliferation in vivo, an important 
characteristic for potential memory cells. 
Since IL-7 is a survival factor for T cells, it is thought that expression of IL-7Ra 
leads to the selective survival of the 10-15% of effector cells that express it. Indeed, 
memory precursor survival depends on the presence of IL-7. How IL-7 increases 
survival is presently unclear. Signals that modify a cells ability to survive do not 
necessarily effect CD8+ memory cell formation. For example, p53 deficiency does not 
lead to an increase in the generation of memory cells (Grayson, Lanier et al. 2001). 
Although Bcl-2 is upregulated in response to IL-7 signaling and in memory cells, 
transgenic Bcl-2 and Bcl-XL mice also show no decrease in the contraction phase or 
increase the size of the memory cell pool after infection (Razvi and Welsh 1993; 
Petschner, Zimmerman et al. 1998). Thus the mechanisms that allow a minority of cells 
expressing IL-7Ra to survive and become long-lived memory cells remain to be 
elucidated. 
Recently, a role for CD8aa expression in defining memory precursor cells and 
causing IL-7Ra upregulation has been demonstrated (Madakamutil, Christen et al. 2004). 
CD8aa binds the nonclassical MHC I molecule Thymus Leukemia antigen (TL) and is 
thought to modulate TCR signaling (Leishman, Naidenko et al. 2001). Expression of 
CD8aa has been linked to thymocyte survival (Barnden, Heath et al. 1997; Chidgey and 
Boyd 1997). Why CD8aa is upregulated on a subset of effector cells, or how its 
upregulation regulates IL7Ra upregulation and survival remain unclear. 
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l.C.7.2 Bcl-6: 
Data exist that implicate the survival factor Bcl-6 in CD8+ memory cell 
generation. Bcl-6 deficient and Bcl-6 transgenic mice have a decrease and an increase in 
memory phenotype CD8+ cells, respectively (Ichii, Sakamoto et al. 2002). Surprisingly, 
there is no change in the rate of apoptosis of CD8+ cells in Bel 6-1- mice; rather, Bel 6 
seems to be involved in maintaining cells in a CD44hi Ly6C+ state and in generating 
central memory cells (Ichii, Sakamoto et al. 2004). Bcl6 may play a similar role in CD8+ 
T cells as it does in B cells, where it is involved in inhibiting terminal differentiation and 
maintaining stem-cell like proliferative qualities (Fearon, Manders et al. 2001). 
1.C.8 Homeostatic proliferation of memory CD8+ cells: 
One of the hallmarks of memory CD8+ cells is their ability to undergo slow 
homeostatic proliferation (Tough and Sprent 1994; Sprent 2003). The rate of 
homeostatic proliferation can vary between CD8+ memory cells, as 40-50% of memory 
cells remain in interphase and do not incorporate BrdU even after five weeks of labeling 
(Tough and Sprent 1994). Survival and homeostatic proliferation are both independent of 
TCR signaling, as memory-phenotype cells persist and proliferate in MHC I deficient 
hosts (Murali-Krishna, Lau et al. 1999). Instead, cyotokines play a key role in 
homeostatic maintenance. 
l.C.8.1 The role of IL-15 in CD8+ memory cell homeostasis: 
Interleukin 15 (IL-15) is synthesized by a wide variety of cells, especially 
macrophages, but not by T cells (Kennedy and Park 1996). Memory CD8+ cells are 
uniquely sensitive to IL-15, as demonstrated by several lines of evidence. Treatment of 
CD44hi CD8+ memory-like cells with low levels of IL-15 in vitro leads to their 
proliferation, in direct contrast to CD441o naive CD8+ cells or CD44hi CD4+ cells 
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(Zhang, Sun et al. 1998). Injection of IL-15 in vivo also causes a proliferative increase in 
the CD44hi CD8+ population (Zhang, Sun et al. 1998). IL-15 transgenic mice have a 
selective accumulation of memory phenotype CD8+ cells (Marks-Konczalik, Dubois et 
al. 2000; Yajima, Nishimura et al. 2001). Conversely, studies in vivo using blocking 
antibodies have revealed that CD8+ memory cell division requires IL-15 but is inhibited 
by IL-2 (Dai, Konieczny et al. 2000; Ku, Murakami et al. 2000). Further evidence for the 
critical role of IL-15 in vivo comes from the selective decrease in CD8+ memory cells in 
IL-15 deficient mice (Lodolce, Boone et al. 1998; Kennedy, Glaccum et al. 2000). 
Transfer of memory CD8+ cells into IL-15 deficient hosts leads to the loss of memory 
cells over time due to a lack of homeostatic proliferation (Goldrath, Sivakumar et al. 
2002). Surprisingly, transfer of IL-15Ra deficient CD8+ cells into normal hosts 
followed by immunization revealed that IL-15Ra expression by CD8+ cells is not 
required for memory cell generation (Burkett, Koka et al. 2003). This finding was 
reconciled with existing data by showing that IL-15Ra can bind and present IL-15 in 
trans to the common (3y chains. Finally, a role for IL-15 in the homeostatic proliferation 
of antigen induced bona-fide memory cells has also been demonstrated (Wherry, Becker 
et al. 2002). The sensitivity of memory CD8+ cells to IL-15 may be due to the selective 
upregulation of the shared IL-2 and IL-15R(3 chain (Giri, Ahdieh et al. 1994) on memory-
like CD8+ cells. 
l.C.8.2 The role of IL-7 in CD8+ memory cell homeostasis: 
The role of IL-7 in homeostatic maintenance of memory CD8+ cells is less clear, 
presumably because of the partially overlapping functions of IL-15 and IL-7. Transfer 
of CD8+ memory cells into hosts given IL-7Ra blocking antibody decreases the extent of 
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homeostatic proliferation but does not completely block it (Goldrath, Sivakumar et al. 
2002). Further evidence for the functional redundancy between IL-15 and IL-7 comes 
from transfer experiments into lymphopenic hosts. Unlike CD8+ memory cells 
transferred into complete hosts, which are completely dependent on IL-15 for their basal 
homeostatic proliferation, CD8+ memory cells transferred into either IL-15 or IL-7 
deficient lymphopenic hosts have only a slight impairment in acute homeostatic 
proliferation. Acute homeostatic proliferation is blocked only in the absence of both of 
these cytokines (Schluns, Kieper et al. 2000; Goldrath, Sivakumar et al. 2002). Finally, 
overexpression of IL-7 in IL-7 transgenic animals leads to IL-15 independent 
maintenance of memory CD8+ cells (Kieper, Tan et al. 2002). These data taken together 
suggest that both IL-7 and IL-15 are involved in regulating homeostatic proliferation of 
CD8+ memory cells, but that in a normal host, competition for IL-7 with other cell types 
makes the role of IL-15 more critical in CD8+ memory cell maintenance. 
1.C.9 Biochemical pathways involved in CD8+ memory cell 
generation and maintenance: 
Although the requirements for CD8+ memory cell generation and maintenance 
have been defined at the cellular and even cytokine level, the biochemical pathways 
governing a cell's decision to commit to the effector and memory lineage remain to be 
determined. Insight into the potentially important signaling molecules has been provided 
by analysis of expression levels of genes in naive, memory, and activated CD8+ cells 
(Kaech, Wherry et al. 2002), but the definitive importance of these candidates awaits 
confirmation from in vivo analysis. 
Genetic proof exists for the role of SOCS1 in CD8+ memory cell generation. 
SOCS1 fl/fl Lck-Cre mice, which under go SOCS1 deletion specifically in the thymus 
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and T cell compartments, shows an increase in the memory-like compartment of CD8+ 
cells in the periphery (Chong, Cornish et al. 2003). Thymocytes from these mice are 
hypersensitive to IL-7 induced Stat5 phosphorylation. SOCS1-/- IFNy-/- mice, which do 
not die from the lethal IFNy induced inflammation seen in SOCS1 -/- mice, also 
accumulate memory phenotype CD8+ cells because of an increased sensitivity to IL-15 
induced Stat5 phosphorylation (Ilangumaran, Ramanathan et al. 2003). 
Stat5 has independently been linked to memory CD8+ cell generation and 
maintenance. Stat5a-/- and Stat5b-/- mice have decreased CD8+ memory cells, whereas 
Stat5 transgenic mice have markedly increased CD8+ memory cell numbers (Kelly, 
Spolski et al. 2003). Stat5 overexpression also rescues the CD8+ memory cell deficiency 
seen in common gamma chain deficient mice (Kelly, Spolski et al. 2003). The precise 
role that Stat5 plays either in the generation or maintenance of memory CD8+ cells 
remains unclear at this time. 
1.D. Ubiquitination: 
Ubiquitination of a protein refers to the covalent attachment of the 76 amino acid, 
ubiquitously expressed globular protein ubiquitin by the stepwise action of three 
enzymes. It is a commonly occurring phenomenon in eukaryotes, second only to 
phosphorylation as a means of post-translational modification. The universality of this 
form of regulation is highlighted by the fact that there is only a three amino acid 
difference in the ubiquitin sequence between yeast and humans (Weissman 2001). 
46 
1.D.1 T y p e s of ubiquitination: 
The ubiquitination of proteins is not a homogenous modification. Proteins can be 
ubiquitinated on either internal lysine residues or on the ct-NH2 at their N-termini 
(Breitschopf, Bengal et al. 1998). Some proteins are ubiquitinated on only specific lysine 
(K) residues (Chau, Tobias et al. 1989; Baldi, Brown et al. 1996), while other proteins 
show little specificity regarding which lysine residue is ubquitinated (Hou, Cenciarelli et 
al. 1994; Treier, Staszewski et al. 1994). The importance of which residues are 
ubiquitinated is unclear at present. 
In addition to the location of the ubiquitin moiety, the length of the ubiquitin 
chain can also vary. Proteins can be mono- or poly- ubquitinated on a given lysine 
residue, and different lysine residues within the same protein may be targeted for mono-
or poly- ubiquitination. Mono-ubiquitination serves as a signal for chromatin 
modification and regulates various trafficking events (Hochstrasser 2004). 
Polyubiquitination is important for regulating a protein's abundance, as a chain of four or 
more ubiquitin tags is required to target a protein for proteosomal degradation (Thrower, 
Hoffman et al. 2000). 
The branching of the ubiquitin chain is also important. Ubiquitin contains seven 
conserved lysine residues, all of which could potentially be used for iso-peptide linkage. 
Thus far, chain linkage sites at ubiquitin KI 1, K29, K48, and K63 have been described in 
vivo. K48 linked polyubiquitin chains historically have been defined as signals for 
proteosomal degradation (Chau, Tobias et al. 1989; Thrower, Hoffman et al. 2000); 
however, emerging data suggests that they may also inhibit a protein's activity without 
leading to its degradation (Elsasser, Gali et al. 2002; Bai, Yang et al. 2004; Flick, Ouni et 
al. 2004). In contrast, polyubquitin chains formed by attachment at K63 have been linked 
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to protein activation (Deng, Wang et al. 2000) and endocytosis (Bonifacino and 
Weissman 1998). 
1.D.2 The roles of ubiquitination: 
Ubiquitination has been linked to myriads of cellular processes, including bulk-
protein degradation, cell-cycle control, DNA repair, stress response, vesicular trafficking 
transcriptional regulation, as well as signal transduction (Hershko and Ciechanover 
1998). Protein ubiquitination regulates the participation of a protein in a particular 
biological process by changing its abundance, activity, or subcellular localization 
(Mueller 2004). The way in which a ubiquitin moiety can regulate a protein's activity in 
so many diverse ways is only beginning to be understood, and there remain many 
unanswered questions. 
1.D.3 The enzymatic reactions of ubiquitination: 
Ubiquitination consists of three steps (Figure 1-6). First, the ubiquitin-activating 
enzyme El activates ubiquitin by forming a thioester bond between the c-terminus 
glycine residue of ubiquitin and the active cysteine residue in El. The universality of this 
step is underscored by the fact that there is a single El gene in humans that gives rise to 
two isoforms of El (Grenfell, Trausch-Azar et al. 1994). The activated ubiquitin is then 
transferred via trans-acylation to the active cysteine residue of one of at least 25 human 
ubiquitin conjugating enzymes (E2). Ubiquitin is then transferred to target proteins with 
the help of E3 ligases, which confer substrate specificity of ubiquitination. There are 
four families of E3 ligases, namely U box (Ufd2 related), RING (Really Interesting New 
Gene), SOCS (suppressor of cytokine signaling), and HECT (homologous to E6-AP C-
terminus) ligases. The distinction between these families is based on structural as well as 
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functional features (Davis and Ben-Neriah 2004). Finally, an additional factor (E4) can 
be necessary for some ubiquitin chain-assembly reactions (Koegl, Hoppe et al. 1999) 
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F i g u r e 1-6. T h e ubiquitination pathway. T h e C-terminus of ubiquitin is linked by a thiol-
ester bond to E1 in an A T P dependent reaction. Ubiquitin is transferred to E2s. E 2s 
associate with E3s. In the case of H E C T E 3 ligases, ubiquitin is transferred to the active 
cysteine of the H E C T domain. Figure taken from Weissman, Nature Reviews Molecular Cell 
Biology, 2001. 
1.D.4 U box E 3 ligases: 
The U box domain was initially identified in the yeast protein Ufd2, which 
possesses E4 activity. Homologs of this protein contain U box domains and comprise the 
U box family of E3 ligases (Figure 1-7). These proteins function as E3 ligases in an E2 
dependent fashion, because they cannot directly ubiquitinate target proteins. None of the 
murine or human family members has been shown to have E4 activity (Hatakeyama and 
Nakayama 2003). 
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1.D.5 R I N G finger E 3 ligases: 
The RING finger domain contains an octet of cysteine and histidine residues that 
constitute a zinc-binding domain (Fig 1-7). Most RING-finger domain proteins function 
as E3 ligases by binding both target substrates and E2 ligases. RING-finger E3 ligases do 
not directly ubiquitinate target proteins but rather function to specify the targets of E2 
ligases. Members of the RING-finger E3 ligase family are further divided into four 
subfamilies based on structural and functional differences. These subgroups are the 
multi-protein subunit families SCF(SKPl,Cull, F-Box), CBC (Cul 2-Elongin, B Elongin, 
C), APC/C (Anaphase Promoting Complex/cyclosome), and the single polypeptide 
RING-finger E3 ligase subfamily. 
1.D.6 SOCS E3 ligases: 
The eight SOCS proteins contain a central src-homology 2 (SH2) domain and a 
C-terminal 40 amino acid SOCS box domain (Figure 1-7). SOCS proteins are negative 
regulators of cytokine signaling cascades, but they use a variety of mechanisms to 
achieve this end. One mechanism is through protein ubiquitination, in which the SOCS-
box domain binds elongins B and C and forms part of an E3 ligase ubiquitin complex 
(Alexander 2002). 
1.D.7 The HECT family of E3 ligases: 
The H E C T (homology to E6-AP C terminus) family members are defined by their 
conserved catalytic C-terminal domain, first identified in the E6- associated protein (E6-
AP) (Figure 1-7). This protein, together with the papillomavirus oncoprotein E6, leads 
to the ubiquitination and degradation of p53 (Scheffner, Huibregtse et al. 1993). The 
conserved C-terminal in the HECT E3 ligases forms a covalent bond with ubiquitin, 
allowing these E3 ligases to directly ubiquitinate substrates. This is contrast to other E3 
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ligases, which bind both E 2 ligases and target substrates, bringing the E 2 ligase in close 
enough proximity to ubiquitinate the substrate. The N-termini of HECT E3 ligases are 
less conserved and contain protein-protein interaction domains or intracellular 
localization domains. Several HECT E3 ligases contain WW domains in groups of two 
or four in the N-termini. These WW domains form hydrophobic pockets for binding 
proline rich sequences. Most HECT E3 ligases that contain WW domains also contain a 
C2 domain that mediates translocation to the membrane in response to increases in 
intracellular calcium. 
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Figure 1-7. The structural 
domains of HECT, RING, Ubox 
and S O C S family E3 ligases. 
Figures taken from 
Hatakeyama et al., Biochem 
Biophys Res Com, 2003 and 
Alexander, Nature Reviews 
Immunology 2002. 
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l.D.7.1 T h e H E C T E 3 ligase Itch 
Itch belongs to the H E C T class of E3 ligases. It contains an N-terminal C2 
domain, 4 WW protein interaction domains, and a C-terminal HECT ubiquitin ligase 
domain. It is a highly conserved protein, with homologs in yeast (Rsp5p) (Hicke and 
Dunn 2003), C. elegans (CelWWPl) (Courbard, Fiore et al. 2002), and Drosophila 
(Su(dx)) (Cornell, Evans et al. 1999). Biochemically, several substrates have been 
identified for Itch. Studies exist implicating Itch in ubiquitinating Notch (Qiu, Joazeiro et 
al. 2000), Bel-10 (Scharschmidt, Wegener et al. 2004), CXCR4 (Marchese, Raiborg et al. 
2003), human enhancer of filamintin (Feng, Guedes et al. 2004), endophilin (Angers, 
Ramjaun et al. 2004), Smad 2 (Bai, Yang et al. 2004), Cbl (Magnifico, Ettenberg et al. 
2003), LMP2A (Ikeda, Caldwell et al. 2003), occludin (Traweger, Fang et al. 2002), NF-
E2 (Chen, Frank et al. 2001), phospholipase C gamma (PLOy) (Heissmeyer, Macian et al. 
2004), and Jun-B (Fang, Elly et al. 2002). The physiological relevance of these findings, 
especially with regard to the immune system, is still unclear in many cases. 
1.D.8 Roles for Ubiquitin in the Immune System: 
Since ubquitination is such a universal and fundamental cellular process, it is not 
surprising that cells of the immune system utilize it as well; however, understanding of 
ubiquitination-regulated processes in the immune system is still in its infancy. One of the 
best-described examples is the activation of NF-kB. NF-kB translocation to the nucleus 
requires the IKK-regulated, ubiquitin-mediated degradation of IkB (Karin and Ben-
Neriah 2000). The RING domain containing multimeric structure SCFp"TrCP is 
responsible for this ubiquitination. 
The Cbl-RTNG and SOCS family E3 ligases are implicated in the termination of 
activation signals. c-Cbl downregulates receptor tyrosine kinases via targeting to the 
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endocytic pathway (Levkowitz, Waterman et al. 1998; Joazeiro, Wing et al. 1999; Thien 
and Langdon 2001). In T cells, c-Cbl ubiquitinates the TCR^ chain in a Zap-70 
dependent fashion, leading to TCR downmodulation upon antigen stimulation (Wang, 
Altman et al. 2001; Naramura, Jang et al. 2002). Ubiquitin also regulates immune cell 
signaling cascades in a degradation-independent manner. For example,TRAF6 
uibiquitination in response to IL-1(3 leads to its activation (Deng, Wang et al. 2000; 
Wang, Deng et al. 2001). In addition, Cbl-b ubiquitinates the phosphotidyl inositol 3 
kinase (PI3K) subunit p85, preventing its association with CD28 and TCR^ (Fang, Wang 
et al. 2001). This ubiquitination is critical for inhibiting a cell's response in the absence 
of co-stimulation. The importance of Cbl-b mediated regulation is underscored by the 
occurrence of spontaneous autoimmune disease in Cbl-b deficient mice and the inability 
of Cbl-b deficient T cells to be anergized (Bachmair, Finley et al. 1986; Jeon, Atfield et 
al. 2004). 
1.D.9 The role of Itch in the immune system: 
The relevance of Itch to the immune system was initially discovered with the 
1 PiH 
cloning o f the inversion breakpoints in the m u r i n e agouti m u t a n t strain a , w h i c h along 
with a darker coat color displayed an inflammatory disease consisting of interstitial 
inflammation of the lungs, splenomegaly, lymphadenopathy, and dermatitis in the mice. 
The inversion resulted not only in a break in the agouti locus, but also disrupted the gene 
for the E3 ligase Itch (Perry, Hustad et al. 1998). Subsequent analysis of the naturally 
occurring Itch deficient mice revealed increased serum IgGl and IgE titres, prompting an 
analysis of Th differentiation in Itch deficient mice (Fang, Elly et al. 2002). It was found 
that CD4+ T cells from Itch deficient mice display a bias towards Th2 differentitation in 
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vitro, and further biochemical analysis demonstrated that this bias was due to increased 
JunB levels (Fang, Elly et al. 2002). 
Although the inversion clearly affected the Itch protein, it was possible that the 
regulation of other genes within the inverted region was affected. Furthermore, although 
the inflammatory disease in Itch deficient mice was consistent with a bias in Th2 
differentiation, the experiments performed could not address whether the changes in 
CD4+ T cell differentiation were secondary to the inflammatory pathology in these mice 
or a cause for it. Since all cells were deficient for Itch, it was difficult to ascertain which 
lymphocyte subpopulation was responsible for initiating the disease. 
1.D.10 Generation of mice with cell specific inactivation of Itch: 
The limitations inherent in the analysis of Itch deficient mice led Kristina Jonsson 
to generate mice in which it would be possible to inactivate Itch in a cell specific manner 
(Jonsson 2002) (Figure 1-8). These mice were generated by flanking the last exon of 
Itch containing the catalytic cysteine of the HECT domain with loxP sites (Itch fl/fl 
mice). Breeding of Itch fl/fl mice to transgenic mice expressing Cre in specific cell types 
allowed for the analysis of Itch inactivation in a cell specific manner. Because Cre 
mediated deletion leads to the loss of only the last 32 amino acids of the 864 amino acid 
protein, a truncated Itch protein may still be present in cells in which Cre is expressed. 
The E3 ligase activity of this protein is abolished, however, because of the absence of the 
catalytic cysteine in the mutant protein. Itch fl/fl Deleter Cre mice, in which Itch is 
deleted in all cells, have the same inflammatory disease as the Itch deficient mice 
resulting from an inversion in the 
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Figure 1-8. Generation of conditional Itch deficient mice: a. Strategy for Itch gene targeting. 
Domain structure of the Itch protein, partial structure of the Itch genomic locus, m a p s of the 
targeting vector and the targeted Itch locus before and after Cre mediated recombinations are 
delineated. Filled rectangles represent exons. Triangles represent loxP sites. The partially filled 
rectangles represents the selection marker genes. Restriction sites are E: Eco R V . Probes d and 
e used in Southern blots are depicted by filled rectangles in the m a p and the length of respective 
restriction fragments detected by these probes is depicted numerically above dashed lines 
representing the restriction fragments, b. Deletion efficiency in Itch fl/fl C D 4 Cre mice. Southern 
blot analysis of genomic D N A from splenocytes or thymocytes digested with E c o R V and 
visualized with probe d. T cells were purified by depletion and the bound fraction consisting of 
non-T cells w a s used to determine C D 4 Cre specificity. Genomic D N A w a s digested using 
E c o R V and a Southern blot w a s performed with probe d. T h e size of wt, deleted, and floxed 
restriction fragments are indicated, c. Western blot anlaysis of the wild-type Itch protein in C D 4 + 
cells purified from the spleen and lymph nodes of Itch fl/fl C D 4 Cre mice and littermate controls. 
Expression of tubulin w a s measured to control for the accuracy of protein loading. 
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agouti locus. This data supports the role of Itch in the pathology described in the a18H 
inversion mutant. 
1.E Overall aims of this study: 
The experiments described in this thesis present an attempt to define which Itch 
deficient lymphocyte population is sufficient for generating the previously described Itch 
pathology, which regulatory networks of the immune system are disrupted as a 
consequence of Itch deficiency, and which signaling pathways are affected due to Itch 
deficiency. The findings are discussed in three chapters, based on the immune responses 
analyzed. 
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C h a p t e r 2: Materials a n d m e t h o d s : 
2.A Reagents 
2.A.1 Antibodies used for flow cytometric analysis and coating: 
All antibodies were purchased from BD Pharmingen unless otherwise noted. 
anti-mouse CDllb (clone M/170) biotin 1:100 
anti-mouse CD 122 (clone TM-B1) biotin 1:100 
anti-mouse CD127 (clone SB/199) PE 1:50 
anti-mouse CD 19 (clone ID3) biotin 1:100 
anti-mouse CD 19 (clone 1D3) biotin 1:100 
anti-mouse CD24 (clone Ml/69) biotin 1:400 
anti-mouse CD25 (clone 7D4) PE 1:100 (Southern biotech) 
anti-mouse CD25 (clone 7D4) biotin 1:100 
anti-mouse CD28 (clone 37.51) purified 1:100 
anti-mouse CD3e (clone 145-2C11) purified 1:400 
anti-mouse CD4 (clone GK1.5) PE 1:200 
anti-mouse CD4 APC 1:100 
anti-mouse CD44 (clone IM7) FITC, PE, and biotin 1:100 
anti-mouse CD45R/B220 (clone RA3-6B2) cychrome 1:75 
anti-mouse CD5 (clone 53-7.3) biotin 1:100 
anti-mouse CD62L (clone MEL-14) 1:100 
anti-mouse CD69 (clone H1.2F3) 1:100 
anti-mouse CD86(B7.2) (clone GL1) biotin 1:100 
anti-mouse CD8 (clone 53-6.7) FITC 1:100 
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anti-mouse CD90.2 (clone 53-2.1) PE 1:400 
anti-mouse gamma delta TCR (clone GL3) biotin 1:100 
anti-mouse LY-6G (GR-1) (clone RB6-8C5) FITC and biotin 1:100 
anti mouse CD49b (clone DX5) biotin 1:100 
anti-mouse TCR beta chain (H57-597) biotin 1:100 
anti-mouse TER-119 biotin 1:100 
anti-mouse NK1.1 (clone PK136) biotin and PE 1:100 
streptavidin-cy7 PE 1:100 
anti-mouse IFNy (clone XMG1.2) FITC 1:100 
anti-mouse IL-4 (clone 11B11) PE 1: 75 
anti-mouse TCRVa 11.1 biotin 1:100 
anti-mouse TCRVpll biotin 1:100 
anti-mouse TCRV(38 (clone F23.1) bitoin 1:100 
anti-mouse TCRV(33 (clone KJ25) biotin and PE 1:100 
anti-BrdU FITC 1:50 
2.A.2 Antibodies used for Western blots: 
Rabbit cc-Itch (1383, recognizing the C-terminus of Itch) 1:1000 
Rabbit a -JunB (SantaCruz) 1:500 
Mouse a -tubulin (Sigma) 1:1000 
Mouse a -actin (Santa Cruz) 1:20,000 
a -mouse IgGHRP (Amersham) 1:10,000 
a -rabbit IgG HRP (Amersham) 1:10,000 
a -mouse IgM HRP (Amersham) 1:20,000 
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2.A.3 Cytokines used for cell culture: 
IL-2 (laboratory made; supernatant of X63-Ag8-653 plasmacytoma cell lines transfected 
with IL-2 expression vector. 1:1000 dilution equivalent to 50 U/ml recombinant IL-2 
based on ELISA) 
IL-4 (R&D) 
IL-12(R&D) 
IL-15 (recombinant human IL-15, RDI) 
2.A.4 Synthetic oligonucleotides: 
Oligonucleotides for PCR and sequencing were purchased lyophilized from 
Fisher and Invitrogen and reconstituted at a concentration of 200uM in water. 
2.A.5. Primers and PCRs used for gentoyping: 












5'-TCT ggA CgA A g A gCA T C A ggg-3' 
5'-TAT CAg T C T CAg Tgg ggg Tg-3' 
5'-CTg AgC T C T gTT TTC gTC Tg-3' 
5'-AC A AgA ggTAgg AgA CAA gCA TT-3' 
5'-TgC AgC TTA TTT ATC ATT CCT TA-3' 
5'-Tgg TTA CTT TAT TTg gCT TTg ACA A-3' 
5'-gAC TTg gAg ATT gCC AAC CCA TAT CTA 
AgT-3' 
5'-TgA gC gAA ggT gTA gTC ggA gTT TgC 
ATT 
5'- CAg gAg ggA TCC AgT gCC AgC-3' 
5'- Tgg CTC TAC AgT gAg TTT ggT-3' 
5'-CTg gAC CTC ACC AAA CgC-3' 
5'- CCC ggA TgA CgT gTG C-3' 
5'-CTg AAT gAA CTg CAg gAC gA-3' 
5'-ATA CTT TCT Cgg CAg gAg CA-3* 
5'- AgA CAC ACC ggC TTg CAA CAC Ag -3' 
5'- TgC CgA gAA AgT CCT TCT gCC Ag-3' 
5'- gTg gAA TgA gTg CgA ggC CAg A-3' 
5'-TAA TCg CCA TCT TCC AgC Ag-3' 
5'-CAA TTT ACT gAC CgT ACA C-3' 





























Wt 237 bp 
Fl 270 bp 
Del 497 bp 
400bp 
300bp 
+/+ 275 bp 
+/- 275 bp 
172 bp 
-/- 172 bp 
W T 450 bp 































5'-CgC ATA ACC AgT gAA ACA gCA T-3* 
5'-gAA gAC ACC ggg ACC gAT CCA g-3' 
5'-CgC ATA ACC AgT gAA ACA gCA T-3' 
5'- CAg TgA ATgACA gAT ggA CCT CC-3' 
5'-gCA gAA gCC ACA ACC ATA CAT TC-3* 
5'-CAC AgT A A C TCg TTC TTC TCT gC-3' 
5' CTC CTT CAT CCA CCA AgA CTA ACA 
CA-3' 
5'- CAT ggC ACA ACT CAg gCA ACT AgA-3' 
5'- ggT ACC TgC AgT TCg CCT ATg A-3' 
5'-Tgg ggC AAC CAg gCT Agt gTA TA-3' 
5'- AgC ACT gTG gTT CCT TC-3' 
5'- Agg TCC CCA TTA gAg AA-3' 
5'-CAG CTG CCT ACA GTG CCC CTA G-3' 
5'-CAT TTG CCA GCA GTG GGT AG-3' 
5'-ATC CTA CCC ACT GCT GGC AAA TGG 
AGT C-3' 
5'-GCT GGT GAA AAG GAC CTC T-3' 
5'-CAC AGG ACT AGA ACA CCT GC-3' 





















WT 400 bp 
JHT 650 bp 
b 640 bp 










Table 2.2 P C R program cycles 











































l.B Molecular Biology Methods: 
2.B.1 Bacterial transformation: 
Heat shock competent E. coli DH5ct were used for transformation. Bacteria were 
thawed and incubated with plasmid DNA for 20 minutes on ice, heat-shocked at 42°C for 
45 seconds, and kept on ice for 2 minutes. Bacterial cells were incubated in 1 ml LB 
medium at 37°C for 30 minutes prior to plating on LB agar plates containing appropriate 
selection antibiotics. Colonies were picked 12-16 hours after incubation at 37°C. 
2.B.2 Purification of DNA: 
Plasmid D N A was isolated by mini, midi, and maxi-prep kits from Qiagen 
according to the manufacturer's protocol. DNA fragments were excised from agarose 
gels using a scalpel and purified using Qiaquick gel extraction kit (Qiagen) according to 
the manufacturer's protocol 
2.B.3 Restriction enzyme analysis: 
Restriction enzymes (Boeringer, Gibco, Takara, New England Biolabs) were used 
according the manufacturer's instructions. 
2.B.4 DNA sequencing: 
D N A sequencing was performed by the D N A sequencing core facility at the 
Rockefeller University. 
2.B.5. Generation of Itch expression vectors: 
The murine Itch gene was PCR amplified from genomic D N A and subcloned into 
the Bluescript plasmid. Itch was further subcloned into the EGFP_C1 expression vector. 
The Itch gene with the N terminus C2 region deleted was also PCR amplified from 
genomic DNA and cloned into the EGFP_C1 expression vector. In the Itch-EGFP_C1 
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expression vector, the c-terminus cysteine required for the catalytic function of the HECT 
domain of Itch was mutated to an alanine using the ExSite PCR based site directed 
mutagenesis kit (Stratagene) according to the manufacturer's protocol. 
2.B.6 Amplification and purification of probes used for Southern blot 
analysis: 
The probe d and probe e were amplified from genomic D N A by PCR using 
primers d2 forward and d2 reverse and e2 forward and e2 reverse, respectively. The 
probes d and e fragments were subcloned into Bluescript BSKS II (+). Probes were 
amplified from the subcloned DNA for Southern blot analysis. 
2.B.7 Radioactive labeling of probes: 
Probes were labled with radioactive dCTP ("ready to go D N A Labelling beads, 
Amersham Pharmacia) according to the manufacturer's protocol. 
2.B.8 Southern blot analysis: 
Southern blot analysis was performed by standard procedures. Briefly, genomic 
fragments or PCR products were resolved on 0.8% or 1.2% agarose gels, respectively. 
Gels were stained in ethhidium bromide-containing running buffer (lx TAE) and 
photographed with ultraviolet light to control for resolution of marker fragments. After 
equilibrating the gel in transfer buffer (0.4M NaOH, 0.6M NaCl) for 20 minutes, DNA 
was transferred onto a nitrocellulose membrane (Hybond N+, Amersham Biosciences) by 
capillary blotting. Following overnight transfer, the membrane was rinsed in 
neutralization solution (0.5 M Tris-HCl pH 7.0, IM NaCl) and DNA was permanently 
fixed to the membrane by UV cross-linking in a photo-crosslinker (UV Stratalinker, 
Stratagene). The membrane was blocked overnight at 65 C in hybridization buffer 
(50mM Tris-HCl pH7.5, IM NaCl, 1% SDS, 10% dextran sulfate, 300 ng/ml sonicated 
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salmon sperm D N A ) . The labeled probe was added to the hybridization buffer and 
incubated at 65°C overnight. Finally, the membrane was washed with 0.5-2x SSC 
(150mM NaCl, 15mM tri-sodium citrate) and 0.1-1% SDS, and exposed for 
autoradiography. 
2.B.9 Polymerase chain reactions (PCRs): 
Unless otherwise noted, PCRs were performed using Klentherm buffer (67 m M 
Tris HCI, pH 9.2, 16mM (NH3)2S04, 0.15 mg/ml BSA, and 3.5 mM MgCl2), 25uM 
dNTPs, and 4pmol primers, and 1 ul Taq polymerase (Invitrogen) in a 20-25 u,l reaction 
volume. 
2.B.10 Semiquantitative RT-PCR: 
Semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) was 
performed to assess mRNA levels of target genes. Total RNA was isolated from 5xl05-
1x10 cells using Trizol (GibcoBRL) and the concentration was measured by 
spectophotometry. Equal concentrations of RNA were reverse transcribed into cDNA 
using oligo(dT) primers and the Superscript reverse transcription kit (Invitrogen) 
according to the manufacturer's protocol. A control reaction was performed without the 
addition of reverse transcriptase to control for DNA contamination. Three fold serial 
dilutions of cDNA were used for PCR reactions. Foxp3 PCR reactions were performed 
with 1.5 mM MgCl2.The PCR reactions were visualized by Southern blotting with HPRT 
and Foxp3 specific probes. 
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2.B.11 Isolation of genomic D N A : 
Genomic D N A was isolated from 1/4 inch mouse tail clips following a standard 
protocol (Laird, Zijderveld et al. 1991) Briefly, tails were digested in 500 uJ tail lysis 
buffer (10 mM Tris-HCl pH8.5, 5mM EDTA, 0.2% sodium dodecyl sulfate (SDS), 200 
mM NaCl, 100 u.g/ml proteinase K) at 55°C over night. Cell debris was pelleted at 
15000 x g for 8 minutes and the supernatant was transferred to a fresh epindorf tube. 
DNA was precipitated with the addition of 1 ml 100% ethanol and vigorous shaking. The 
precipitate was pelleted at 15000 x g for 2 minutes, washed in 70% ethanol, air dried for 
5 minutes, and resuspended in 200-400 ul TE (10 mM Tris-HCl pH 8.0, ImM EDTA). 
DNA was resolved at 55°C for 30 minutes. 1 ul of the resolved DNA solution was used 
per PCR reaction. 
2.B.12 Preparation of cell lysates: 
Cells were washed one time in plain RPMI medium prior to lysis. If the cell 
number was less than 5xl06 cells, the tubes into which the cells were placed were 
precoated with fetal calf serum for 5 minutes at room temperature. Cells were lysed in n-
octylglucoside (ODG) lysis buffer (50 mM Tris, pH 7.4, 150 mM NaCl, 20 mM NaF, 
ImM EDTA, ImM EGTA, 2% ODG, 10% Glycerol) with fresh protease inhibitors 
(Sigma) and 2mM Na orthovanadate added prior to lysing. Cells were lysed on ice for 30 
minutes and nuclei were pelleted by centrifugation at 15000 x g for 10 minutes at 4°C. If 
not used immediately, the supernatants containing cellular protein extracts were frozen at 
-80°C. 
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2.B.13 Western blots: 
The total protein concentration of lysates was determined by a B C A assay 
(Pierce) against a bovine serum albumin standard according to the manufacturers 
protocol. Lysates were resolved by 8%-15% SDS polyacrilamide gel electropheresis 
(SDS-PAGE) and transferred to polyvinylidenediflouride (PVDF) membrane (Immobilon 
P, Millipore) by semi-dry blotting according to the manufacturer's protocol. Unspecific 
binding to membranes was blocked by one hour incubation with 5%BSA TBST (100 mM 
Tris-HCl pH 7.6, 140 mM NaCl, 0.2% Tween). Primary antibodies were incubated 
overnight in TBST at dilutions indicated elsewhere. Membranes were washed 5 times for 
5 minutes in TBST and incubated with secondary HRP-coupled anti-species antibodies 
(Amersham) for 30-60 minutes at room temperature. Membranes were washed again five 
times for five minutes and proteins were detected by chemiluminescence (ECL, 
Amersham) according to the manufacturer's protocol. 
l.C Cellular Methods: 
2.C.1 Preparation of murine lymphocyte suspensions: 
Mice were killed using dry ice (CO2) and blood was removed from the heart by a 
1 ml syringe with a 26 gauge needle. Thymus, spleen, and lymph nodes (superficial 
cervical, mandibular, axillary, lateral axillary, pancreatic, superficial inguinal, iliac, 
hypogastric, and mesenteric) were isolated and placed in 5 ml ice cold Hanks Balanced 
Salt Solution (BSS). Single cell suspensions were obtained by either gentle shearing of 
organs placed in meshes using a blunt forcep or by incubation or organs in a collagenase 
enzyme mixture (Blendzyme II, Roche). For preparation of single cell suspension using 
Blendzyme, a PBS solution containing 130 fxg/ml blendzyme and 100 \ig/ml DNAase 
was prepared fresh. A spleen (cut into four pieces) or pooled lymph nodes from one 
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mouse were placed into one well of a 48 well plate containing 350 ul of solution 
Blendzyme solution. Cells were incubated at 37 C for 15 minutes and single cell 
suspensions were made by gentle mechanical disruption using a 1 ml syringe (with no 
needle). Cells were placed in 5 ml BSS to dilute the suspension, and the cell suspension 
was filtered through an 0.7 u.m mesh and washed one time in BSS. Splenic erythrocytes 
were lysed by incubating cells for 1 minute at room temperature in 1 ml ACK buffer 
(0.15M NH4C1, 10 mM KHC03, 0.1 mM EDTA). The reaction was stopped by adding 9 
ml BSS. Cells were washed once with BSS and the single cell suspension was filtered 
through an 0.7 um mesh. Cells were counted using a hemacytometer. Dead cells were 
excluded by staining with trypan blue (Gibco) prior to counting. 
2.C.2 T cell purification from spleen and lymph node: 
Unless otherwise mentioned, T cells were purified by depletion using M A C S LS 
columns. For purification of CD4+ T cells, cells were incubated at 2xl08 cells/ml in 
Hanks Balanced Salt Solution (BSS) with a mixture of biotinylated antibodies against 
CD8, CD 19, CD24, CD lib, GR-1, CD49b, NK1.1, TCR-yS, and TER-119 followed by 
incubation with Streptavidin beads. Naive CD44 low cells were further purified from 
purified T cells by incubation in BSS at a concentration of lxlO7 cells/ml with a mixture 
biotinylated and FITC coupled CD44 antibodies at 1: 300 dilution. The FITC coupled 
CD44 antibodies were added for flow cytometric analysis of the purification procedure. 
CD8 T cells were purified by the same protocol, except that CD4 antibodies were added 
rather than CD8 antibodies and GR-l(Ly-6C) antibodies were omitted from the depletion 
antibody cocktail. Cell purity after purification was consistently > 95% as assessed by 
flow cytometry. 
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2.C.3 T cell purification from thymus: 
Cells were purified by depletion using M A C S LS columns. Cells were incubated 
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at 4x10 cells/ml in BSS with a mixture of biotinylated antibodies against CD19, CD1 lb, 
GR-1, CD49b, NK1.1, TCR-y6, TER-119. For CD4 single positive cell purification, 
CD8 antibodies were added at 1:50 dilution. For CD8 single positive cell purification, 
CD4 antibodies were added at 1:50 dilution. After washing, cells were incubated with 
strepavidin beads prior to running on an LS column. Purified cells consisted of double 
negative (DN) thymocytes and the single positive thymocytes that were purified. 
2.C.4 T cell culture: 
Unless otherwise noted, T cells were cultured in T cell medium that consisted of 
RPMI (Gibco), 10% fetal calf serum, 2mM Glutamine (Gibco), lOOU/ml 
penicillin/streptomycin (Gibco), and 55uM 2-mercaptoethanol (Gibco). 
2.C.5 Coating of plates for stimulation of purified T cells: 
96 well round bottom plates were coated with indicated concentrations of 
antibodies in 30 \xl volume for 1-2 hours at 37°C. 24 well plates were incubated with 200 
\xl of antibody solution. a-CD3e (clone 145-2C-11) used for coating was made in the 
laboratory and a-CD28 (clone 37.51) was bought from Pharmingen. After the incubation 
time period, the antibody mixture was aspirated, and the wells were washed one time 
with PBS prior to addition of cells. 
2.C.6 Standard flow cytometric analysis: 
2xl05-lxl06 cells were placed per well of a 96 well round bottom plate and 
washed in PBS/l%BSA/0.01%azide (PBA). Cells were incubated with indicated 
dilutions of antibody (listed elsewhere) in 15 ul PBA for 10 minute at 4°C, washed in 100 
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\xl PBA, and, if necessary, incubated with secondary antibodies in 15 u.1. After a 
secondary wash, cells were resuspended in 50-100 ul PBA containing 2nM TO-PRO-3 
(Molecular Probes) to exclude dead cells. 
2.C.7 Intracellular stainings for flow cytometric analysis: 
Brefeldin A was added at a concentration of 10 iug/ml four-six hour prior to cell 
staining. Intracellular stainings were performed using the BD Pharmingen 
Cytofix/Cytoperm kit according to the manufacturer's protocol, with the following 
variations. Cells were fixed for 20 minutes at RT in 30 \xl Cytofix, cytoperm solution. 
Antibody stainings were performed in 15 ul volume for 15 minutes at room temperature. 
Antibody dilutions are listed elsewhere. 
2.C.8 Assessment of cell proliferation by [3H]-thymidine 
incorporation: 
Eight hours prior to harvest, 1 uCi [3H]-thymidine was added in 50 u.1 volume to 
each triplicate well of a 96 well plate. For analysis of [3H]-thymidine incorporation, cells 
were harvested onto glass fibre filter paper (Printed Filtermat A, Wallac) using a cell 
harvester. The filter paper was dried using a microwave prior to being immersed in (3-
scintillation fluid. Scintillation counts were measured by a (3-counter. 
2.C.9 Th1/Th2 differentiation of CD4+ T cells in vitro. 
lxlO6 purified naive CD441o C D 4 cells were incubated in a 24 well plate with 
plate bound 10 u.g/ml cc-CD3 and 5 ng/ml a-CD28 antibodies in T cell medium. Thl or 
Th2 differentiation of cells was stimulated using a mix of cytokines and antibodies. For 
Thl differentiation, cells were placed in T cell medium containing 2 u.g/ml anti-IL4 
antibody, 3.5 ng/ml IL-12 and 25 U/ml IL-2. For Th2 differentiation, cells were 
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maintained in medium containing 2 [xg/ml anti-IFNy antibody, lOOOU/ml IL-4 and 25 
U/ml IL-2. Cells maintained in non-biased differentiation conditions were maintined in 
25 U/ml IL-2. In some experiments laboratory made IL-2 supernatant was added at 
equivalent concentrations. Cells maintained in blocking conditions were stimulated in the 
presence of 10 u.g/ml a-IFNy and oc-IL-4. Cells were stimulated for 2 days in the 
appropriate differentiation medium in antibody coated wells, split 1:4, and rested for four 
days in differentiation medium in uncoated wells. On the sixth day, cells were washed 
two times in T cell medium to remove antibodies and cytokines, and 2xl05 cells were 
restimulated in 96 well round bottom plates with plate-bound a-CD3 and a-CD28 
antibodies. Brefeldin A was added at a concentration of 10 u,g/ml 1 hour afterwards, and 
four hours later cells were stained for intracellular IL-4 and IFNy production using a 
standard intracellular staining protocol. Flow cytometric analysis of intracellular 
stainings was performed thereafter. 
2.C.10 TGF-p sensitivity assay: 
lxlO5 purified CD4+ or CD441o CD4+ T cells were cultured per triplicate well in 
96 well round bottom plates coated with 10 u.g/ml cc-CD3e and 5 ji,g/ml a-CD28 
antibodies. Cells were cultured in medium alone or in medium containing 1, 2.5, 5, 10, 
or 25 ng/ml recombinant human TGF(3 (R&D). Cells were cultured for 72 hours at 37C, 
and lu.Ci/well of [3H] thymidine was added for the final 8 hours of culture. Incorporated 
[3H] thymidine levels were measured using a scintillation counter. 
2.C.11 CFSE proliferation analysis: 
Purified cells were washed in RPMI and then lx 107 cells/ml were incubated with 
2.5u.M carboxyfluoroscein diacetate succinimidyl ester (CFSE; Molecular Probes) in 
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RPMI at 37 C for 10 minutes. One volume primary T cell medium was added to stop the 
labeling reaction. After the indicated days in culture, flow cytometric analysis of 
proliferation as measured by CFSE dilution was performed. Cells were surface stained 
for CD4 or CD8 prior to flow cytometric analysis. For all data plots, only live events are 
displayed. 
2.C.12 Proliferation of CD8+ memory cells: 
lxlO5 purified CD441o and CD44hi CD8+ cells were cultured in the presence of 
different amounts of recombinant human IL-15 for three days. 8 hours prior to harvest 1 
|j,Ci [ H]-thymidine was added to the cultures. Proliferation was measured by [ H]-
thymidine incorporation of flow cytometric analysis of CFSE dilution. 
2.C.13 In vitro regulatory T cell suppressor assay: 
CD4+ T cells were purified by the standard depletion protocol. The cells in the 
bound fraction were retained for use as antigen presenting cells (APCs) in the suppressor 
assay. CD25- vs. CD25+ CD4+ cells were further sorted by incubating 1 x 108 cells/ml 
with a 1:8 dilution of a-CD25 (7D4) PE antibody. Cells were incubated for 15-20 
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minutes at 4C with occasional agitation. Cells were washed, resuspended at 1 x 10 
cells/ml and incubated with anti-PE microbeads at 1:8 dilution for 15-20 minutes at 4°C. 
CD25- responder cells were collected as the flow through fraction from the MACS 
column. CD25 + suppressor cells were collected as the retained fraction after two rounds 
of column purification. Suppressor assays were set up using 5xl04 irradiated (3000rad) 
APCs, 5xl04 CD25- responder cells, 10 u.g/ml soluble anti-CD3 antibody, and titrated 
numbers of suppressor cells (5xl04, 2.5xl04, 1.25xl04, 6xl03, and 3xl03) per triplicate 
well of a 96 well round bottom plate. Control wells included wells with medium alone, 
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wells with APCs and anti-CD3e antibody only, wells with responder/suppressor co-
culture without anti-CD3 antibody, and wells with APCs, anti-CD3 antibody, and CD25+ 
suppressor cells only. Cells were cultured for 72 hours at 37C and liuCi/well of [3H] 
thymidine was added for the final 8 hours of culture. Incorporated 3H thymidine levels 
were measured using a scintillation counter. 
2.C.14 In vitro deletion of Itch using TAT-Cre: 
2x10 purified CD4+ T cells from fl/fl or fl/+ mice were washed four times in 
plain RPMI medium in epindorf tubes. Cells were incubated with 100|xg/ml TAT-Cre 
(made in the lab) at a concentration of 1 x 108 cells/ml for one hour at 37°C in an 
incubator. Cells were washed two times with T cell culture medium and then set up for 
culture. 
l.D In vivo assays: 
2.D.1 Mice: 
C57B1/6 and Balb/c mice were maintained at the Labarotory Animal Research 
Center (LARC) at the Rockefeller University in a pathogen free environment. 
Conditional Itch mice were generated by Kristina Jonsson in the University of Cologne 
and maintained on a pure C57B1/6 background (backcrossed more than 10 generations). 
C57B1/6 JHT (Jackson Laboratory), C57B1/6 (32M -/-(Jackson Laboratory), C57B1/6 
CDld -/- (Nussenzweig laboratory), C57B1/6 MHC II -/- (Taconic Farms), C57B1/6 Rag -
/- (Jackson Laboratory), C57B1/6 AND transgenic (Jackson Laboratory), Balb/c Stat 6 -/-
(Jackson Laboratory), and mixed background DO 11.10 rag -/-mice were crossed to Itch 
fl/fl CD4 Cre mice to obtain genotypes discussed in the results section. Genotypes were 
assessed using PCR as described elsewhere. Unless otherwise noted, littermate controls 
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were used for all experiments. The genotype of these controls was Itch fl/+, Itch fl/+CD4 
Cre, or Itch fl/fl. No phenotypic difference was ever noted between control genotypes. 
Whenever possible, results were confirmed with mice from independent crosses. 
2.D.2 Adoptive transfer of CD8 SP thymocytes: 
1 x 107 thymocytes enriched for CD8 SP and D N cells by M A C S depletion of 
CD4+ cells were CFSE labeled and retroorbitally injected into unirradiated wild-type 
recipients in 200 ul PBS. Two Itch fl/fl CD4 Cre or wild-type littermate controls were 
used per transfer. Recipient mice were sacrificed four weeks later, and lxlO7 
splenocytes or pooled lymph node lymphocytes were stained for CD8 and CD44. Flow 
cytometric analysis of CD44 expression was performed on gated CD8+ CFSE labeled 
cells. 
2.D.3 Adoptive transfer of peripheral T cells: 
1 x 107 purified CD4+, CD8+, or CD3+ T cells were injected retroorbitally into 
6-8 week old Rag deficient mice in 200 ul PBS. Mice were sacrificied and histological 
analysis of organ sections was performed one month after transfer. Successful transfer of 
lymphocytes was confirmed by staining of peripheral blood for transferred lymphocytes 
at the time of killing. 
2.D.4 In vivo BrdU labeling: 
6-8 week old mice given tap water containing 0.8 mg/ ml Bromodeoxyuridine 
(Sigma) and 1% sucrose. A stock of 500 ml of BrdU containing water was made and 
kept at 4C, and the drinking water of mice was changed every two days. After ten days, 
mice were sacrificed and flow cytometric analysis of BrdU incorporation was performed. 
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Intracellular staining for BrdU was performed using the instructions provided by the 
manufacturer (BD Pharmingen). 
2.D.5 Oral tolerization: 
C57B1/6 x Balb/c mixed genetic background DO 11.10 dxd or Itch fl/fl CD4 Cre 
D011.10 dxd mice were given drinking water containing 20 mg/ml Ovalbumin (Sigma) 
for five days. Mice were then sacrificed and CD4+ T cells were purified separately from 
spleen and mesenteric lymph nodes. 5 x IO4 CD4+ cells were cultured with 5 x 105 
irradiated syngeneic APCs and either 0, 15nM, 150 nM, or 1.5mM ovalbumin peptide per 
triplicate well in a 96 well round bottom plate. Cells were cultured for 72 hours at 37C, 
and luCi/well of [ H] thymidine was added for the final 8 hours of culture. Incorporated 
[ H] thymidine was measured using a scintillation counter. 
2.D.6 Histology: 
Haematoxilin and eosin stainings of organ sections were performed by the 
Genetically Engineered Mouse Phenotype Core at the Rockefeller University. Dr. Krista 
La Perle provided descriptions of the pathology with representative pictures. 
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C h a p t e r 3: T h e role of Itch in peripheral tolerance 
3.A Introduction: 
3.A.1 Tolerance: 
Tolerance refers to the ability of the immune system to recognize and accept both 
self-antigens and nonpathogenic foreign antigens to which it is exposed. Problems with 
tolerance can lead to a wide spectrum of pathologies, ranging from allergies to 
autoimmune diseases. Key mechanisms in maintaining tolerance include T cell anergy, 
regulatory T cells, and immunomodulatory cytokines such as IL-10 and TGF-(3. 
3.A.2 E3 ligases in T cell anergy: 
Recently, experimental data from several groups has suggested a critical role for 
E3 ligases in both clonal and in vivo anergy. Several lines of evidence support a role for 
the RING finger E3 ligase Cbl-b in T cell anergy. Cbl-b deficient mice spontaneously 
develop systemic autoimmunity (Bachmaier, Krawczyk et al. 2000). This spontaneous 
autoimmune disease was initially linked to the ability of Cbl-b deficient T cells to bypass 
the requirement for CD28 co-stimulatory signals for their activation (Chiang, Kole et al. 
2000). The function of Cbl-b was defined as abrogating signals from the TCR, such that 
only stimulation with co-stimulatory ligands allows for full signal strength and activation. 
Since anergy has been linked to stimulation in the absence of co-stimulatory signals, Cbl-
b became a natural target to consider in anergy induction. Further support for a role for 
Cbl-b in the anergy phenotype came from studies demonstrating that Cbl-b mRNA and 
protein levels were upregulated in T cells upon anergy induction (Heissmeyer and Rao 
2004). The most convincing data has come from recent experiments using Cbl-b 
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deficient mice, which demonstrate that Cbl-b deficient T cells are incapable of being 
anergized both in vitro and in vivo (Jeon, Atfield et al. 2004). 
Another E3 ligase which is selectively upregulated in anergic cells and thus may 
regulate T cell anergy is GRAIL (Gene Related to Anergy in Lymphocytes) 
(Anandasabapathy, Ford et al. 2003; Seroogy, Soares et al. 2004). T hybridoma cells 
overexpressing GRAIL show a defect in both IL-2 and IL-4 production, similar to anergic 
cells (Anandasabapathy, Ford et al. 2003). Furthermore downregulation of GRAIL in 
primary T cells transduced with ouabain 1 (a GRAIL-binding protein that increases its 
rate of turnover) demonstrate enhanced IL-2 production, while T cells transduced with 
otubain 1 ARF-1 (an isoform that inhibits GRAIL degradation) show reduced IL-2 
inducibility (Soares, Seroogy et al. 2004). While these data are suggestive for a role of 
GRAIL in anergy, definitive proof awaits the analysis of GRAIL deficient mice. 
Several indirect lines of evidence also implicate Itch in anergy induction. 
Induction of clonal anergy in vitro using ionomycin leads to an upregulation of Itch 
mRNA and protein levels (Heissmeyer, Macian et al. 2004). Furthermore, stimulation of 
anergic but not activated T cells causes Itch to translocate to the detergent insoluble 
fraction of the plasma membrane (rafts) (Heissmeyer, Macian et al. 2004). The reported 
higher levels of Jun B in the nucleus of Itch deficient T cells (Fang, Elly et al. 2002) may 
also effect anergy induction. In addition to its role in Th2 differentiation, JunB is also 
responsible for AP-1 dependent IL-2 production, and JunB levels are specifically reduced 
after clonal anergy induction (Mondino, Whaley et al. 1996). The increased levels of 
JunB in Itch deficient T cells could therefore affect anergy induction as well. 
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The most direct evidence for the involvement of Itch in the anergic state is that 
Itch deficient T cells fail to become anergic after treatment with ionomycin (Heissmeyer, 
Macian et al. 2004). The caveat in this experimental protocol is that ionomycin induction 
of anergy requires stimulation of T cells under Thl polarizing conditions. Since Itch 
deficient T cells display a bias towards Th2 differentiation, it is possible that the observed 
differences in anergy reflect the Th differentiation bias more than a problem with anergy 
induction per se. 
3.A.3 The E3 ligase Cbl-b and suppressor cell function: 
The molecular mechanisms by which CD4+CD25+ regulatory T cells exert their 
suppressive effects on CD4+CD25- effector cells remains unclear. Proteins that 
negatively regulate signaling in effector cells are excellent candidates to consider as 
targets that are required for suppressor cells to function. Recently, it has been shown that 
CD4+CD25- effector T cells deficient in the RING-finger E3 ligase Cbl-b have an 
impaired ability to be suppressed by CD4+CD25+ regulatory T cells. Thus, although 
Cbl-b deficient mice have functional suppressor cells, suppression fails due to the 
inability of effector cells to be suppressed (Wohlfert, Callahan et al. 2004). 
3.A.4 E3 ligases and TGF-J3 signaling: 
Upon ligation of TGF-(3RII with TGF-|3, TGF-p RLI heterodimenzes with TGF-|3 
RI and phosphorylates it. Smad 2 and Smad 3 are recruited to this activated receptor 
complex and are in turn phosphorylated by TGF-(3 RI. Phosphorylated Smad2 and 
Smad3 then heterodimerize with Smad4 and translocate to the nucleus. Phosphorylation 
of Smad proteins is critical for their nuclear import. In addition ubiquitin mediated 
degradation of a repressor protein bound to Smads (SnON) is required for TGF-|3 
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signaling. Once in the nucleus Smad proteins activate transcriptional complexes through 
cis-regulatory Smad binding sequences (Bottner, Krieglstein et al. 2000; Wahl, Swisher 
et al. 2004). TGF-(3 signaling is silenced by dephosphorylation and ubiquitin mediated 
degradation of Smad proteins by Smad ubiquitin regulatory factors (Smurfs) (Zhu, 
Kavsak et al. 1999; Lin, Liang et al. 2000). 
T cells from mice deficient in the RING finger ligase Cbl-b show defects in 
TGF-(3 mediated suppression of proliferation (Wohlfert, Callahan et al. 2004). The 
biochemical pathway that leads to this insensitivity is presently unclear. The authors 
analyzed both TGF-(3 receptor expression and proximal downstream signaling events 
such as Smad phosphorylation, but found no difference between Cbl-b deficient and 
wild-type T cells (Wohlfert, Callahan et al. 2004). 
Recently, the murine E3 ligase Itch and its human homologue Atrophin-1 
Interacting Protein 4 (AIP-4) have been implicated in regulating TGF-(3 signaling. In a 
Smad 3 dependent fashion, AIP-4 was found to bind and ubiquitinate human enhancer of 
filamentation (HEF-1), a member of the multiple domain docking protein Cas family, 
leading to its proteosome mediated degradation in vivo (Feng, Guedes et al. 2004). Since 
HEF-1 degradation has been observed in response to TGF-(3 signling in both fibroblasts 
and a T cell line (Liu, Elia et al. 2000), this data suggests that AIP-4 may be responsible 
for TGF-(3 mediated HEF-1 degradation. Though this data is intriguing, it should be 
considered with the caveat that no genetic proof was provided for the role of AIP-4 in 
regulating HEF-1. 
In a separate study, Itch was shown to directly regulate TGF-(3 signaling by 
modulating Smad2 activation (Liu, Elia et al. 2000). Itch deficient mouse embryonic 
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fibroblasts were found to have reduced susceptibility to TGF-(3 induced cell growth and 
arrest. Interestingly, Itch ubiquitin-mediated modulation of signaling was in a 
proteolysis-independent manner. Instead, TGF-.6 insensitivity was found to correlate 
with decreased Smad 2 phosphorylation and association with the TGF-(3R. Further proof 
that the activity of Smad2 was changed was provided by analysis of SnON levels. Upon 
Smad2 phosphorylation and nuclear accumulation, SnON is degraded by Smurf2 
mediated ubiquitination. SnON levels remained high in Itch deficient fibrolasts, 
providing further evidence that Samd2 phosphorylation was decreased. Transfection 
experiments revealed that Itch was capable of ubiquitinating Smad2 and that Smad2, Itch, 
and TGF-f3R form a complex in TGF-|3 stimulated fibroblasts. Surprisingly, the poly-
ubiquitination of Smad2 occurred on K48. Although K48 polyubiquitination is generally 
associated with proteasomal degradation, Smad2 ubiquitination did not lead to its 
degradation. Rather, Smad2 ubiquitination affected its ability to bind to the TGF-(3 
receptor and consequently Smad2 phosphorylation. Whether this change in binding is 
due to a conformational change due to ubiquitination or due to Itch localizing Smad2 to 
the membrane via its C2 domain remains to be determined. 
3.A.5 Aims of this study: 
The inflammatory phenotype seen in the a18H naturally occurring Itch deficient 
mice suggests that there is at some level inappropriate regulation of the immune response. 
To establish the role of T cells in the inflammatory pathology seen in naturally Itch 
deficient mice, conditionally Itch deficient mice were generated. The aim of the 
experiments described in this section of the thesis was to provide evidence for the 
importance of CD4+ T cells in the inflammatory phenotype and to provide insight into 
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which tolerance mechanisms may be affected in Itch fl/fl C D 4 Cre mice. In particular, 
the role of CD4+CD25+ suppressor cells and the cytokine TGF-(3 in modulating Itch 
deficient T cells was addressed. In addition, the ability of Itch deficient T cells to be 
anergized by oral tolerance was assessed. 
3.B Results: 
3.B.1 C57BL/6 Itch fl/fl CD4 Cre mice develop a spontaneous 
inflammatory disease 
As reported previously for the naturally occurring Itch mutant mouse strain a18H 
(Perry, Hustad et al. 1998), Itch fl/fl CD4 Cre mice developed a visible dermatitis by 20 
weeks of age. In order to ascertain the type and extent of the inflammatory pathology, 
organ sections from two, five, and seven month old mice were stained with hematoxylin 
and eosin (Figure 3-1). Analysis of sections from two-month old mice revealed 
inflammatory lesions surrounding the epithelial lining of the respiratory tract, including 
the nasopharynx and alveoloi, the gastrointestinal tract, including the eosophagus and 
stomach, and the urinary tract, including the ureters. The inflammatory lesions were 
marked by hyalinosis of the epithelial lining. Neutrophil infiltrates and plasma cells were 
present in the lesions, along with eosinophilc crystalline granules. The lungs revealed the 
most severe accumulation of eosinophilic granules as well as infiltrating macrophages, 
neutrophils, and plasma cells. No lesions were present in other internal organs, including 
the brain, heart, thyroid gland, parathyroid gland, pancreas, liver, small intestine, large 
intestine, adrenal gland and kidneys. The kidneys did show signs of hydronephrosis, but 
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Figure 3-1. Inflammatory lesions along mucosal linings in Itch fl/fl C D 4 Cre mice. Left panel. Heaematoxilin 
and eosin stainings of organ sections from 2 month old Itch fl/fl C D 4 Cre mice and littermate controls. 
Analysis of lung sections reveals perivascular infiltrates and acidophilic macrophage pneumonia. Analysis 
of sections of nasopharynx, esophagus, nonglandular sections of the stomach, and ureters reveals 
acidophilic neutrophilic infiltrates, plasma cell infiltrates, and hyalanosis. Kidney sections revealed 
hydronephrosis but no signs of inflammation. Right panel. Six month old mice develop further infiltrates 
in the p a n c r e a s , skin, a n d t h y m u s . Dermatitis b e c o m e s grossly visible at this time. 
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were present in the kidneys themselves. 
By 5 months of age, neutrophil, macrophage, and plasma cell infiltrates were 
additionally seen in the pancreas, thymus, and skin (Figure 3-1). Dermatitis was grossly 
visible at this time. In addition, the corticomedullary boundary of the thymus was 
obliterated. 
Since Itch fl/fl CD4 Cre mice were housed in a pathogen free environment, and 
since CD4 Cre leads to the deletion of Itch in only T cells and CD4+ NKT cells, it can be 
concluded that the inflammatory phenotype is due to either a cell autonomous, 
spontaneous activation of T cells or the inappropriate activation of T cells by self or non-
pathogenic environmental antigens. 
3.B.2 Itch fl/fl CD4 Cre accumulate effector/memory CD4+ cells and B 
cells in the spleen and lymph node 
By eight weeks of age, Itch fl/fl C D 4 Cre mice had developed splenomegaly and 
lymphadenopathy. In particular, the mandibular lymph nodes tended to be prominently 
enlarged as compared to wild type mice upon gross inspection. Flow cytometric analysis 
of lymphocyte populations revealed that there was an increase in the percentage as well 
as absolute number of B cells in both the spleen and lymph node (Figures 3-2a and 3-
3a). In contrast there was a decrease in the percentage of CD4+ T cells in the spleen and 
lymph nodes, although the absolute numbers were similar or greater (Figure 3-2c). In 
the spleen, and to a lesser extent in the lymph nodes, a greater percentage of CD4+ T 
cells showed an effector/memory phenotype, as ascertained by CD44 and CD62L surface 
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CD44hiCD62UoCD4+ 
total mem/act naive 
• WT Ditch fl/fl CD4 Cre 
Figure 3-2. Accumulation of B cells and activated T cells in secondary lymphoid organs of 8 w e e k 
old Itch fl/fl C D 4 Cre mice. First panel. Spleen S e c o n d panel. L y m p h nodes a. Flow cytometric 
analysis of lymphocyte populations. N u m b e r s indicate the percentage of cells in the gated 
subpopulation. b. Cell surface expression of activation markers of C D 4 + cells, c. Increased 
numbers of effector/memory C D 4 + cells in Itch fl/fl C D 4 Cre mice. Increase in absolute numbers 
of total C D 4 + , and effector m e m o r y C D 4 + (CD44hiCD62Llo) cells. Absolute C D 4 + cell numbers 
w e r e calculated using absolute splenic and lymphnode n u m b e r s and percentages of gated 
subpopulations. Each data point represents the average of two Itch fl/fl C D 4 Cre and two littermate 
controls analyzed on the s a m e day. d. Increased percentage of actively dividng effector/memory 
C D 4 + cells in Itch fl/fl C D 4 Cre mice. Proliferation rate of peripheral C D 4 + T cells in W T (open bars) 
and Itch fl/fl C D 4 Cre (grey bars) mice in vivo. BrdU incorporation a m o n g total, effector/memory 
(CD44hiCD62Llo), and naive (CD44loCD62Lhi) C D 4 + cells after mice were given drinking water 
containing 0.8 mg/ml BrdU for 10 days is shown. *The proliferation rate of splenic total C D 4 + and 
effector/memory C D 4 + cells as measured by BrdU incorporation is significantly higher in Itch fl/fl 
C D 4 Cre mice (p<0.001 by student's t-test). Four mice were used per experimental group. Flow 
cytometric data is representative of three independent experiments. 
groups of two Itch fl/fl C D 4 Cre mice and two littermate controls revealed a statistically 
significant increase in the percentage of CD44hi CD62L low effector/memory cells in the 
spleens of Itch fl/fl CD4 Cre mice (p<0.01 by student's t-test). In addition, an increased 
percentage of splenic CD4+ cells showed recent activation markers such as CD25 and 
CD69 (Figure 3-2c). No statistical difference was seen in the percentage of activated 
CD4 cells in the lymph nodes. 
Further confirmation that total CD4+ cells in the spleens of Itch fl/fl CD4 Cre 
mice contained more activated CD4+ cells came from in vivo studies in which mice were 
given drinking-water containing 0.8 mg/ml of the DNA analog bromodeoxyuridine 
(BrdU) for ten days. On the tenth day, mice were sacrificed and flow cytometric 
analysis of the percentage of BrdU positive cells in naive and effector/memory 
subpopulations of CD4+ cells was performed. Itch fl/fl CD4 Cre mice contained 1.5 fold 
more proliferating CD4+ cells in the effector/memory compartment in the spleen 
compared to littermate controls (Figure 3-2d). No difference in BrdU uptake was found 
in the lymph nodes. These data are consistent with the hypothesis that there are more 
activated CD4+ T cells in the spleens of Itch fl/fl CD4 Cre mice. 
3.B.3 T h e inflammation in Itch fl/fl C D 4 Cre mice does not require B 
cells 
Although conditional deletion of Itch using C D 4 Cre insures that the disease 
pathology is not initated by Itch deficiency in B cells, it remained possible that B cells 
were critical for driving its progression. This hypothesis was consistent with data 
showing increasing accumulation of B cells in the spleen and lymph nodes of Itch fl/fl 
CD4 Cre mice with increasing age and pathology (Figure 3-2, data not shown). To 
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address the role of B cells in the Itch pathology, Itch fl/fl C D 4 Cre mice were crossed to 
C57BL/6 JhT mice. JhT mice lack functional B cells due to a targeted disruption of the 
heavy-chain joining region, which leads to developmental arrest of B cells at the pro-B 
cell stage (Gu, Zou et al. 1993). Itch fl/fl CD4 Cre JhT mice developed dermatitis and 
acidophilic macrophage pneumonia with similar severity and kinetics as Itch fl/fl CD4 
Cre mice (Figure 3-3). Haematoxilin and eosin stainings of organ sections revealed 
similar levels of neutrophil infiltrates in the mucosal linings of the respiratory and Gl 
tract. There was a large decrease in the number of lymphocytes cuffing blood vessels in 
effected areas of the lung, consistent with previous data showing that the majority of 
lymphocytes in inflamed areas were CD 19+ B cells (Jonsson 2002). These data support 
the view that the activation of B cells and the increase in serum IgGl and IgE titres in 
Itch fl/fl CD4 Cre mice are secondary events in the pathology and not essential for the 
inflammatory disease present in these mice. 
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Figure 3-3. B cell accumulation is not essential for the Itch inflammatory pathology, a. Increased 
numbers of B cells in spleen and lymph nodes of Itch fl/fl C D 4 Cre mice. Each point represents an 
independent experiment of cell counts from the average of two wild-type and two Itch fl/fl C D 4 Cre 
mice. Absolute B cell numbers were calculated from absolute splenic and lymph node numbers and 
the percentage of CD19+ B cells as assessed by flow cytometric analysis, b. B cell deficient Itch fl/fl 
C D 4 Cre J H T mice develop an inflammatory pathology similar in extent and kinetics to Itch fl/fl C D 4 
Cre mice. Haematoxilin and eosin stainings of lung sections and stomach sections are shown. 
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3.B.4 Transfer of C D 4 + T cells transfers the Itch pathology. 
Although C D 4 Cre is thought to delete specifically in the double positive stage of 
thymocyte development, CD4 is also expressed at low levels in macrophages and 
dendritic cells. In addition, CD4 Cre leads to Itch deletion in CD8+ cells as well as 
CD4+ cells. In order to further substantiate the role of CD4+ cells in the Itch pathology, 
lx IO7 purified T cells or CD4+ T cells were transferred from 8-week old Itch fl/fl CD4 
Cre mice and littermate controls into Rag-/- recipients. Transfer of Itch deficient total T 
cells and CD4+ T cells lead to a recapitulation of the Itch pathology one month after 
transfer into Rag deficient mice (Figure 3-4). Recipients of Itch deficient CD4+ T cells 
were visibly cachectic and had obvious dermatitis, whereas recipients of wild-type CD4+ 
T cells showed no signs of pathology. Haematoxilin and eosin stainings of organ 
sections from Rag deficient mice that received Itch deficient CD4+ T cells revealed 
alveolar macrophages pneumonia in the lungs, as well as esophagitis, gastritis, and 
nasopharyngitis. Notably, transfer of Itch deficient CD4+ T cells into unirradiated wild-
type hosts lead to no visible pathology and no change in the percentage of activated 
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Figure 3-4. Itch deficient C D 4 + T cells are directly responsible for the Itch pathology. Haemotoxilin 
a n d eosin staining of organ sections from R a g deficient m i c e that w e r e retroorbitally injected with 
n o cells, 1 x 10 wild-type C D 4 + T cells, or 1 x 10 Itch deficient C D 4 + T cells . Mice w e r e sacrificied 
o n e m o n t h after transfer. 
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3.B.5 T h e activation of Itch fl/fl C D 4 Cre T cells is not spontaneous 
In order to address the role of antigen in the activation of CD4+ T cells in Itch 
fl/fl CD4 Cre mice, Itch fl/fl CD4 Cre mice were crossed to the AND TCR transgene on a 
C57BL/6 b haplotype background (Kaye, Hsu et al. 1989). The AND transgene encodes 
a T cell receptor made from Va 11.1 alpha chain and V(33 beta chain which recognizes a 
peptide derived from pigeon cytochrome C on k haplotype MHC II molecules. T cells 
expressing this receptor are expected to maintain a naive phenotype, as CD4+ T cells 
have no access to pigeon cytochrome C in an otherwise unmodified mouse. Flow 
cytometric analysis of Itch fl/fl CD4 Cre AND+ mice revealed that there was still an 
accumulation of effector/memory phenotype T cells in Itch fl/fl CD4 Cre AND+ mice in 
comparison to AND+ littermates; however, analysis of Vail.1+, V(33+ CD4+ T cells 
revealed no difference in the percentage of naive cells between wild-type and Itch fl/fl 
CD4 Cre mice (Figure 3-5). Overall, these data support the conclusion that Itch 
deficiency in CD4+ T cells does not lead to spontaneous or antigen independent 
activation, but rather modulates the signal from the TCR upon antigen engagement in a 
manner that leads to an inflammatory disease. 
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Figure 3-5. Itch deficiency does not lead to 
spontaneous activation of C D 4 + T cells. Flow 
cytometric analysis of C D 4 + T cells from A N D 
transgenic Itch fl/fl C D 4 Cre mice and littermate 
controls. Cell surface expression of activation 
markers in total C D 4 + T cells and in C D 4 + T cells 
expressing the V P and V a chains of the A N D 
transgene is shown. Results are representative of 
two independent experiments. 
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3.B.6 Itch fl/fl C D 4 Cre mice develop and maintain C D 4 + C D 2 5 + 
suppressor cells. 
The pathology seen in Itch fl/fl C D 4 Cre mice is clearly due to an unregulated 
inflammatory response. Though this inflammatory response, which is predominantly 
seen at mucosal sites and the skin, does not resemble the multi-organ autoimmune disease 
described in mice deficient in CD4+CD25+ suppressor cells, it never-the-less remained a 
formal possibility that the inflammatory pathology in Itch deficient mice was in some 
way connected to an absence of suppressor T cells. In order to address this possibility, 
splenocytes and lymphocytes were co-stained for CD4 and CD25 cell surface markers 
and the percentage of CD4+CD25+ cells was assessed by flow cytometry. 8-week old 
Itch fl/fl CD4 Cre mice showed an increase in the percentage of CD4+CD25+ cells 
compared to littermate controls (Figure 3-6a). Since CD25 is also upregulated on 
activated CD4+ cells, it remained a possibility that the CD4+CD25+ cells seen in Itch 
fl/fl CD4 Cre mice represented activated rather than suppressor T cells. A more 
selective marker for suppressor T cells is Foxp3. Semi-quantitative RT-PCR from 
purified CD4+ cells from Itch deficient mice and littermate controls revealed no 
difference in the expression levels of Foxp3 (Figure 3-6b). Thus by two independent 
means of assessment, Itch deficient mice contain CD4+CD25+ suppressor T cells. From 
this data, one can conclude that the both the generation and maintenance of CD4+ CD25+ 
suppressor T cells is not affected in Itch deficient mice. 
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3.B.7 C D 4 + C D 2 5 + suppressor cells from Itch fl/fl C D 4 Cre mice are 
functionally anergic and suppressive: 
Although the previous data established that Itch deficient mice phenotypically 
have suppressor T cells, it was possible that these suppressor cells were not functional. 
The ability of Itch deficient CD4+CD25+ cells to suppress effector CD4+ cells was tested 
using an in vitro suppressor assay. This assay is routinely used to measure suppressor 
function, and in the case of Cbl-b deficient cells, provided definitive proof of a failure of 
suppression (Wohlfert, Callahan et al. 2004). To address the ability of Itch deficient 
CD4+CD25+ to suppress, CD4+CD25+ were sorted from Itch fl/fl CD4 Cre mice and 
wild-type littermate controls. The mice used for these experiments were 8-12 weeks old, 
with significant evidence of pathology both grossly and also by accumulation of activated 
T cells and B cells in their secondary lymphoid organs. Older mice were used to 
circumvent the argument that suppressor function ceases to work only later in the life of 
the mice, when disease is visibly present. CD4+CD25+ cells from Itch fl/fl CD4 Cre or 
control mice were co-cultured with wild-type CD4+CD25- responder cells in the 
presence of irradiated wild-type APCs and soluble a-CD3 antibody. To assess the 
anergic phenotype of the suppressor cells, CD4+CD25+ cells were also cultured alone 
with irradiated APCs and soluble a-CD3 antibody. Both wild-type and Itch fl/fl CD4 Cre 
CD4+CD25+ cells failed to proliferate by themselves, providing evidence that Itch 
deficient CD4+CD25+ cells are functionally anergic (Figure 3-6c, left panel). 
Furthermore, co-culture of either wild-type or Itch fl/fl CD4 Cre CD4+CD25+ suppressor 
cells with wild-type CD4+CD25- effector cells lead to a titratable decrease in the 
proliferation of CD4+CD25- effector cells (Figure 3-6c, left panel). Thus, one can 
conclude that Itch deficient CD4+CD25+ cells are indeed functional suppressor cells. 
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3.B.8 C D 4 + C D 2 5 - effector cells from Itch fl/fl C D 4 Cre mice are 
capable of being suppressed by C D 4 + C D 2 5 + regulatory T cells: 
The ability of CD4+CD25+ cells from Itch fl/fl C D 4 Cre mice to suppress did not 
rule out the converse possibility that effector cells from Itch fl/fl CD4 Cre mice were 
incapable of being suppressed. To address this possibility, an in vitro suppressor assay 
was performed with wild-type CD4+CD25+ suppressor cells and CD4+CD25- effector 
cells from either wild-type or Itch fl/fl CD4 Cre mice. Again, older mice with clear signs 
of pathology (8-12 weeks old) were used for these experiments. CD4+CD25- effector 
cells from both wild-type and Itch fl/fl CD4 Cre mice were capable of being suppressed 
to an equal degree (Figure 3-6c, right panel). Finally, to rule out the possibility that 
suppression fails between mutant CD4+CD25+ suppressor and mutant CD4+CD25-
effector cells, the in-vitro suppressor assay was performed with Itch fl/fl CD4 Cre 
CD4+CD25+ suppressor cells and Itch fl/fl CD4 Cre CD4+CD25- effector cells. 
Suppression again was obvious in a titratable fashion (Figure 3-6c, right panel). This 
set of data combined with the previously mentioned data show that regulatory T cell 
suppression as measured by an in vitro suppressor assay is not effected by Itch deletion in 
T cells. 
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Figure 3-6. C D 4 + C D 2 5 + regulatory T cell function is intact in Itch fl/fl C D 4 Cre mice. a. C D 4 + C D 2 5 + 
cells are present in Itch fl/fl C D 4 Cre mice. Flow cytometric analysis of the C D 4 + C D 2 5 + subpopulation 
in the spleen. N u m b e r s indicate the percentage of cells in the gated C D 4 + subpopulation. Similar 
results w e r e obtained for lymph n o d e s (data not s h o w n ) , b. A population of Itch deficient C D 4 + 
cells express F o x p 3 . Semi-quantitative R T - P C R analysis of F o x p 3 expression in purified C D 4 + T 
cells from wild-type a n d Itch deficient mice. Total R N A w a s reverse transcribed using oligo(dT) 
primers a n d threefold serial dilutions of c D N A w e r e used for P C R reactions. T h e P C R products 
w e r e visualized by southern blotting with F o x p 3 a n d H P R T specific probes. R T - P C R analysis of 
H P R T expression w a s used as a loading control, c. Itch deficient C D 4 + cells display suppressor 
cell function in vitro. In vitro suppressor assay. Left panel. Wild-type C D 4 + C D 2 5 - responder cells 
w e r e cultured with A P C s a n d soluble anti-CD3e alone and with wild-type ( W T ) or Itch fl/fl C D 4 Cre 
(MT) C D 4 + C D 2 5 + suppressor cells added at a ratio of 1:8, 1:4, 1:2, or 1:1. Right panel. Itch fl/fl 
C D 4 Cre C D 4 + C D 2 5 - responder cells were cultured with A P C s +soluble anti-CD3e alone and with 
wild-type (WT) or Itch fl/fl C D 4 Cre (MT) C D 4 + C D 2 5 + suppressor cells added at a ratio of 1:8, 1:4, 
1:2,1:1. Anergy of C D 4 + C D 2 5 + suppressor cells was confirmed by co-culturing with A P C s + soluble 
anti-CD3e (a). Culture of A P C s alone (b) and A P C s and responder cells without soluble anti-CD3 
(c) provided negative controls for proliferation. Cells were cultured for 72 hours, and pH] thymidine 
was added 8 hours before cell harvesting. Proliferation was determined by the analysis of the pH] 
thymidine incorporation. 
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3.B.9 C D 4 + T cells from Itch fl/fl C D 4 Cre mice are insensitive to T G F -
c6 mediated suppression of proliferation: 
Peripheral tolerance is maintained by numerous mechanisms, only one of which is 
CD4+CD25+ suppressor T cells. TGF-(3 is an immunomodulatory cytokine that has an 
unclear role in suppressor T cell function in vivo, but has a clear role in regulating T cell 
activation and modulating inflammatory responses (Gorelik and Flavell 2000). The 
recent demonstration that Itch and its human homolog AIP-4 are involved in TGF-(3 
signaling in fibroblasts and cell lines (Bai, Yang et al. 2004; Feng, Guedes et al. 2004) 
suggested that it may also play a role in modulating TGF-(3 signaling in T cells. In order 
to address this possibility, purified CD4+ T cells were isolated from either spleen or 
lymph nodes of wild-type and Itch fl/fl CD4 Cre mice and stimulated in vitro with plate-
bound a-CD3 and a-CD28 antibodies in the presence of increasing concentrations of 
TGF-(3. Wild-type CD4+ T cells showed a titratable decrease in proliferation in response 
to exogenous TGF-(3. In stark contrast, proliferation of CD4+ T cells from Itch fl/fl CD4 
Cre mice was not inhibited by TGF-(3, even at ten fold higher concentrations than those 
necessary to inhibit wild-type CD4+ T cells (Figure 3-7a). These data suggested that 
CD4+ T cells from Itch fl/fl CD4 Cre mice may be insensitive to TGF-|3. 
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Figure 3-7: Itch regulates T G F - P sensitivity, a. Total C D 4 + T cells from Itch fl/fl C D 4 Cre mice 
are insensitive to T G F - P mediated suppression. Purified C D 4 + T cells from wild-type (squares) or 
Itch fl/fl C D 4 C r e (triangles) w e r e cultured with 10 ug/ml oc-CD3 and 5 ng/ml cc-CD28 platebound 
antibodies in the presence or a b s e n c e of indicated concentrations of recombinant h u m a n T G F p . 
Proliferation w a s assessed after 7 2 hours of culture by the incorporation of [3H] thymidine a d d e d 
eight hours prior to cell harvesting. Results are representative of two independent experiments with 
three mice per experimental group. Left panel. Spleen. Right panel, lymph nodes, b. CD44lo 
"naive" CD4+ T cells are sensitive to TGFP mediated suppression. Wild-type (WT) or Itch fl/fl CD4 
Cre (MT) CD44lo CD4+ T cells were purified to >98% purity from pooled spleen and lymph node 
lymphocytes. Cells were cultured with 10 ng/ml anti-CD3 and 5 ng/ml anti-CD28 platebound 
antibodies in the presence (grey bars) or absence (open bars) of 2.5 ng/ml recombinant human 
TGF-p. Proliferation was assessed by pH] thymidine incorporation during the last eight hours of a 
72 hour culture period. Data represent three wild-type and Itch fl/fl CD4 Cre mice. Left panel. 
CD44lo CD4+ T cells. Right panel. Total CD4+ T cells from the same mice. 
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3.B.10 Naive CD44lo C D 4 + T cells from Itch fl/fl C D 4 Cre mice are 
sensitive to TGF-p mediated suppression of proliferation 
Since TGF-p inhibition is dependent on the levels of IL-2 present (Kehrl, 
Wakefield et al. 1986), it remained a possibility that the difference seen in vitro was 
compounded by the increase in IL-2 secreting activated/effector cells in Itch fl/fl CD4 
Cre mice compared to wild type control mice. In order to address this concern, CD441o 
CD4+ cells were purified and stimulated in the presence of TGF-(3. CD441o CD4+ cells 
from Itch fl/fl CD4 Cre mice proliferated five-fold more than their wild-type 
counterparts, although proliferation levels of total CD4+ cells were similar. TGF-P 
mediated suppression was more evident in Itch fl/fl CD4 Cre CD441oCD4+ cells than in 
total CD4+ cells (Figure 3-7b). These data suggest that TGF-P insensitivity seen in Itch 
deficient CD4+ T cells may correlate with their activated phenotype. 
3.B.11 Itch fl/fl CD4 Cre mice do not develop oral tolerance: 
Itch m R N A and protein levels are increased in a model of clonal anergy induced 
by incubation of differentiated Thl T cells with ionomycin (Heissmeyer, Macian et al. 
2004). Although this data suggests that Itch may be upregulated in clonally anergic cells, 
it does not provide any evidence for the role of Itch in anergy induction in vivo. In order 
to directly address the role of Itch in peripheral tolerance in vivo, Itch fl/fl CD4 Cre 
DO 11.10 TCR transgene mice were give soluble ovalbumin for 5 days to induce oral 
tolerance. CD4+ cells from splenocytes were restimulated with ovalbumin peptide 
presented by irradiated syngeneic splenocytes for three days, and proliferation rates were 
determined by [3H] thymidine incorporation. Preliminary results indicate that CD4+ T 
cells from Itch fl/fl CD4 Cre mice fail to tolerize. There was no difference in the extent 
of proliferation of mutant mice whether they were fed Ovalbumin or not (Figure 3-8a). 
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It should be noted; however, that the proliferation rates of mutant cells were considerably 
lower than wild-type cells, in striking contrast to what is seen in nontransgenic mice upon 
antibody stimulation (Figure 3-8b). 
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Figure 3-8. Itch deficient cells are not anergized upon oral tolerization. DO11.10 mice (WT) or 
D011.10 Itch fl/fl CD4 Cre (MT) were given water alone (water) or water containing 20 mg/ml ovalbumin 
(OVA) for five days. Mice were sacrificed on the sixth day and purified CD4+ splenocytes were cultured 
with indicated concentrations of OVA peptide presented by irradiated syngeneic splenocytes. Proliferation 
was measured three days later by addition of pH] thymidine to cultures eight hours prior to harvesting. 
a. Proliferation in response to titrated concentrations of peptide in mice given water (squares) or 
ovalbumin (triangles) in their drinking water. Left panel. DO11.10 mice. Right panel. D011.10 Itch 
fl/fl CD4 Cre mice b. Proliferation rates of DO11.10 mice (WT) and D011.10 Itch fl/fl CD4 Cre mice 
(MT) mice in response to 0 m M (empty bars) or 1.5mM O V A peptide (filled bars). 
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3.C Discussion: 
3.C.1 C57BL/6 Itch fl/fl CD4 Cre mice develop a spontaneous 
inflammatory disease 
Histological analysis of 8-week old Itch fl/fl C D 4 Cre mice revealed an 
inflammatory phenotype identical to that described for the naturally occurring Itch 
1 QTT 
mutant strain a . The inflammation was characterized by infiltrates consisting of 
neutrophils, eosinophils, macrophages, and plasma cells along the respiratory tract, 
gastrointestinal tract and urinary tract. The lungs showed the most striking level of 
inflammation in the alveoli, where infiltrates of eosinophilic macrophages accumulated to 
the point of alveolar acidophilic macrophage pneumonia. The inflammation was far from 
systemic, however, as many internal organs, including the brain, liver, thyroid gland, 
small and large intestine and kidneys, showed no inflammatory infiltrates in the mice 
analyzed. Specifically, it seems that the infiltrates accumulated along mucosal linings 
and eventually along the skin, all areas which are exposed to external antigens. The 
location of these infiltrates is suggestive of a problem in regulating local inflammatory 
responses in areas exposed to external antigens. This concept makes the study of Itch 
deficient mice particularly intriguing from the standpoint of allergies, which are also 
known to involve dysregulated immune responses to external antigens. 
Analysis of lymphocyte populations in secondary organs revealed that while there 
was visible splenomegaly and lymphadenopathy, there was no difference in the absolute 
numbers of CD4+ cells. The percentages and absolute numbers of activated/memory 
phenotype CD4+ T cells were increased in the spleen but not in the lymphnodes. 
Furthermore, analysis of proliferation rates in vivo in Itch fl/fl CD4 Cre mice and 
littermate controls suggests that the CD44hiCD62Llo cells are indeed activated cells 
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undergoing proliferation. W h y then is there no accumulation of CD4+ cells in the 
spleen? One reason is that later timepoints need to be assessed in order to see the 
accumulation. A second potential explanation is that the CD4+ cells emigrate to the 
periphery upon activation. In situ stainings of organ sections for CD4+ cells could 
address this hypothesis. 
3.C.2 The Itch inflammatory phenotype is due to Itch deficient CD4+ 
T cells: 
In addition to the fact that conditionally Itch deficient Itch fl/fl C D 4 Cre mice 
develop an inflammatory phenotype akin to Itch deficient mice, two pieces of data 
described in this thesis provide compelling evidence that the Itch inflammatory 
phenotype is due solely to Itch deficiency in CD4+ T cells. Firstly, although Itch 
deficient mice show an accumulation of plasma cells in inflammatory lesions and 
increased serum IgGl and IgE titres, Itch fl/fl CD4 Cre JHT mice developed an 
inflammatory disease similar in kinetics and severity to that seen in Itch fl/fl CD4 Cre 
miced. Thus, while B cells are activated in Itch mice, their role in the pathology is 
secondary. Secondly, transfer of purified Itch deficient CD4+ T cells into Rag deficient 
mice led to a recapitulation of the inflammatory phenotype within one month of transfer. 
These data not only provide evidence for a role of CD4+ T cells in the Itch pathology, but 
also demonstrate that Itch deficient CD8+ T cells are not required for the pathology. 
Strikingly, the location of inflammatory lesions mirrored that seen in Itch fl/fl CD4 Cre 
mice, suggesting that the location of inflammation is not arbitrary and must provide 
insights into the role of Itch in modulating immune responses. 
Genetic proof that CD4+ cells are required for the Itch pathology can be obtained 
from the analysis of Itch fl/fl CD4 Cre MHC II -/- mice. Breedings to generate these 
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mice are currently underway. In addition, genetic evidence of the role of Itch defcient 
CD8+ T cells in the Itch pathology can be obtained from the analysis of Itch fl/fl CD4 
Cre p2M -/- mice. Breedings of these mice have been hampered by the linkage between 
P2M and Itch, but eventually will yield conclusive results. 
The transfer of CD4+ T cells into unirradiated syngeneic hosts failed to cause any 
visible pathology, in striking contrast to transfer into Rag deficient mice. There are 
several potential explanations for this, none of which are addressed by the experiments 
performed thus far. Firstly, the discrepancy between transfer into Rag deficient mice and 
unirradatiated syngeneic hosts may simply be a matter of the number of CD4+ T cells 
that survived the transfer. It is much easier for lymphocytes to survive in a lymphopenic 
host than to compete with existing lymphocytes for niches. Secondly, transfer of CD4+ 
T cells into lymphopenic hosts leads to their homeostatic expansion. This expansion may 
trigger activation of CD4+ T cells (King, Ilic et al. 2004). Although transfer of CD4+ T 
cells from WT mice caused no obvious pathology in recipient mice, it may be that Itch 
deficiency coupled with further activation of T cells is required for the Itch pathology to 
occur. This scenario seems unlikely, as the transferred Itch deficient CD4+ T cells came 
from mice with visible splenomegaly, lymphadenopathy, and inflammation, which speak 
in favor of the T cells already being sufficiently activated to cause disease. The third and 
most intriguing possibility is that the discrepancy between transfer into Rag deficient 
hosts and unirradiated syngenic hosts is due to an underlying problem with regulatory T 
cell suppressor function in Itch deficient mice. Transfer of mixed wild-type and Itch 
deficient CD4+ T cells into Rag deficient mice should provide a way to tease apart some 
of these potential explanations. If the transfer of mixed wild-type and Itch deficient 
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CD4+ T cell populations leads to disease, then one could argue that the absence of 
disease in unirradiated syngeneic hosts is more likely due to the percentage of cells that 
survived transfer rather than absent suppressor functions in vivo. 
3.C.3 The activation of Itch fl/fl CD4 Cre T cells is not cell 
a u t o n o m o u s 
While transfer of CD4+ T cells from diseased Itch fl/fl C D 4 Cre mice transferred 
the disease, it remained unclear whether the activation of Itch deficient CD4+ T cells 
occurred cell autonomously or in an antigen-dependent manner. Analysis of Itch fl/fl 
CD4 Cre AND transgenic mice revealed that AND TCR expressing CD4+ T cells 
remained naive as judged by surface marker staining. Although AND Itch fl/fl CD4 Cre 
mice became sick and accumulated activated CD4+ T cells, these CD4+ cells did not 
express the AND transgene. These data support the notion that Itch deficiency in CD4+ 
T cells does not lead to spontaneous activation. Instead these data are consistent with the 
hypoethesis that Itch deficiency modulates signaling such that TCR signaling leads to 
inappropriate activation and inflammatory responses in these mice. Itch may regulate 
TCR signaling itself or may regulate co-stimulatory ligand signaling such that upon 
antigen encounter, Itch deficient CD4+ T cells respond inappropriately. It is also 
possible that Itch regulates CD4+ T cell effector function upon T cell activation. 
One potential caveat in this interpretation of the data is that surface markers were 
used to assess the naive phenotype of CD4+ T cells. Although cell surface markers are 
commonly used to identify a cell's activation status, it remains a formal possibility that 
Itch deficient AND transgenic CD4+ T cells, while appearing naive, were none-the-less 
activated and contributing to the disease phenotype. These concerns will be addressed 
with the generation of Itch fl/fl CD4 Cre mice on a Ragl deficient TCR transgenic 
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background. Crosses are already underway for both the A N D and D O 11.10 transgenes. 
If Itch deficient cells truly require cognate antigen stimulation to become inappropriately 
activated, then one would expect Itch fl/fl CD4 Cre Rag-/- AND+ and Itch fl/fl CD4 Cre 
Ragl -/- DO 11.10 mice to remain free of pathology. Conversely, if Itch deficient CD4+ 
cells secrete cytokines even in the absence of antigenic stimulation, then one would 
expect the Rag deficient TCR transgenic mice to also succumb to disease. 
3.C.4 C D 4 + C D 2 5 + in vitro suppressor function is intact in Itch fl/fl 
C D 4 Cre mice: 
The inflammatory pathology seen in Itch fl/fl CD4 Cre mice, which is restricted 
primarily to mucosal areas and does not affect internal organs, is very different from the 
multi-organ pathology described for mice deficient in CD4+CD25+ regulatory T cells. 
None-the-less, it could be formally argued that the dysregulated inflammatory response 
seen in Itch deficient mice was due to either an absence or a problem in the function of 
CD4+CD25+ suppressor T cells. Itch fl/fl CD4 Cre mice contain CD4+CD25+ cells, as 
judged both by surface marker staining and expression of the regulatory T cell specific 
transcription factor Foxp3. In addition, in vitro suppressor assays using wild-type and 
Itch deficient suppressor and responder cells revealed no qualitative difference in the 
ability of Itch deficient suppressor cells to suppress and Itch deficient responsder cells to 
be suppressed. It should be noted that there was a small but consistent difference in the 
suppressor assay curves between wild-type and Itch deficient cells. Assays in which Itch 
deficient cells were added had higher proliferation counts and required higher numbers of 
suppressor cells to bring the counts down. This difference can easily be explained by the 
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contaminating fraction of activated CD25+ cells in the CD4+CD25+ suppressor cell 
population of Itch deficient mice. 
Although Itch deficient CD4+ T cells show no obvious defect in suppressor 
function as assessed by in vitro suppressor assays, it remains quite possible that there is a 
problem with suppressor function in vivo. How CD4+CD25+ regulatory T cells function 
in vivo remains a matter of controversy, but it is unlikely that direct contact-mediated 
suppression is the mechanism by which these cells globally suppress inflammatory 
responses in an organism. Currently, the only in vivo assessment of CD4+CD25+ 
suppressor cell function comes from a SCID colitis model. Transfer of purified 
CD45RBhi CD4+ cells into SCID mice causes colitis, which can be suppressed by co-
transfer of CD45RBlo CD4+CD25+ cells (Mottet, Uhlig et al. 2003). It would be 
interesting to see if transfer of Itch deficient CD45RBhi and either wild-type or Itch 
deficient CD45RBlo CD4+CD25+ cells leads to colitis, as this data would indicate a 
problem with suppression of Itch deficient responder cells in vivo. Conversely transfer of 
wild-type CD45RBhi and either wild-type or Itch deficient CD45RBlo CD4+ CD25+ 
suppressor cells could address the suppressive potential of Itch deficient suppressor cells. 
These experiments will require backcrossing the Itch conditional deletion onto a Balb/c 
background first, but will eventually provide definitive data regarding suppressor T cell 
function in vivo in the absence of Itch. 
It is also increasingly clear that the naturally occurring CD4+CD25+ regulatory T 
cells are not the only T cells with suppressor function in vivo. Tr-1 and Th3 suppressor 
cells, which are both induced upon exposure to antigen under tolerizing conditions, also 
play key roles in modulating immune responses. The suppressive capabilities of these 
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cells may be affected by Itch deficiency. The generation of Tr-1 cells and their IL-10 
dependent suppressive capabilities in vitro have been described for DO 11.10 mice 
(Groux, O'Garra et al. 1997). It would be interesting to repeat these experiments with 
CD4+ T cells from Itch fl/fl CD4 Cre DO 11.10 mice. Problems with either the generation 
of Tr-1 cells or their suppressive functions in vitro could provide an interesting 
explanation for the Itch inflammatory phenotype. 
3.C.5 TGF-p sensitivity m a y be affected in Itch deficient C D 4 + T cells: 
Recently, Itch has been implicated in regulating TGF-P signaling. Analysis of 
purified CD4+ T cells from Itch fl/fl CD4 Cre mice initially seemed to support a role for 
Itch in TGF-P signaling in CD4+ T cells; however, analysis of CD441o CD4+ cells 
provided data inconsistent with the initial findings. Although there was a great deal of 
variation between the purified Itch deficient CD441o CD4+ T cells from different Itch 
fl/fl CD4 Cre mice, they showed a greater sensitivity to TGF-P than total Itch deficient 
CD4+ T cells. These data may be interpreted to suggest that the TGF-P insensitivity seen 
in total CD4+ T cells reflects their activated status more than direct TGF-P insensitivity. 
TGF-P inibits in vitro T cell proliferation in an IL-2 dependent manner (Kehrl, Wakefield 
et al. 1986), and the enhanced proliferation seen in Itch deficient CD4+ T cells suggests 
that there may be an increase in IL-2 production, either due to an intrinsic change in IL-2 
production in response to Itch deficiency, or due to the activated status of CD4+ T cells 
purified from Itch fl/fl CD4 Cre mice. Definitive answers can only be provided by 
purification of naive CD4+ T cells from Itch fl/fl CD4 Cre Rag deficient TCR transgenic 
mice, once it is established that these mice do not develop an inflammatory pathology. 
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One puzzling feature of the comparison of total CD4+ T cells from wild-type and 
Itch deficient mice with regards to sensitivity to TGF-P is that the difference in TGF-P 
sensitivity is far more striking than the difference in activated CD4+ cells as assessed by 
surface marker staining. One explanation, which has already been discussed, is that 
surface marker analysis underestimates the number of activated CD4+ T cells. Another 
possibility is that the cells that are insensitive to TGF-P suppression not only proliferate 
but also cause bystander activation of other CD4+ T cells through their secretion of IL-2. 
It is known that TGF-P mediates its suppression in an IL-2 dependent manner. But why 
don't the activated CD4+ T cells from wild-type mice also cause this bystander activation 
of naive CD4+ T cells? One possible reason is that only Itch deficient activated CD4+ 
cells are insensitive to TGF-P mediated suppression. One possible way to address this 
issue would be to activate CD4+ T cells for 24-48 hours prior to the addition of TGF-p. 
3.C.6 The role of Itch in T cell anergy: 
Recent experimental evidence supports a role for E3 ligases, including Itch in 
regulating T cell anergy (Heissmeyer, Macian et al. 2004). Tolerization of Itch fl/fl CD4 
Cre DO 11.10 transgenic mice supports this hypothesis, as Itch deficient CD4+ T cells 
failed to tolerize. These data are preliminary, however, and much more definitive 
experiments are needed before a compelling case for the role of Itch in anergy induction 
in vivo can be made. Itch deficient CD4+ DO11.10 T cells proliferated to the same 
extent, whether or not the mice were tolerized to OVA using an oral tolerization protocol. 
Although these data are consistent with a role for Itch in anergy induction, it should be 
noted that the proliferation rates of Itch deficient CD4+ T cells were low, whether or not 
the mice from which they were derived were tolerized. These data are in striking contrast 
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to what is seen upon polyclonal stimulation of Itch deficient T cells in vitro. It is 
presently unclear whether this discrepancy is due to the stimulation of Itch deficient T 
cells with more physiologically relevant APCs and peptide or is related to the TCR 
transgene. 
Analysis of Itch fl/fl CD4 Cre DO 11.10 Rag -/- mice should provide a cleaner 
sytem for anlayis, as all CD4+ cells should be OVA sensitive and naive. Comparison of 
proliferation rates between DO 11.10 Rag -/- and Itch fl/fl CD4 Cre DO 11.10 Rag -/- mice 
either upon polyclonal antibody stimulation or APC and peptide stimulation should 
provide important control data regarding the effects of the type of stimulus on 
proliferation rates. Furthermore, analysis of oral tolerance in Rag deficient mice should 
also remove the confounding variable that T cells in Itch fl/fl CD4 Cre mice do not 
anergize because of the inflammatory environment they are in rather than because of 
problems with anergy induction per se in the absence of Itch. 
Experimental evidence also exists for a role of suppressor cells in oral tolerization 
protocols (Thorstenson and Khoruts 2001). Many of the existing oral tolerization 
protocols may lead to tolerance through both suppressor cells as well as anergy. 
Definitive experiments regarding anergy induction will therefore require transfer of 
CD4+ T cells into transgenic mice expressing soluble OVA, where the only mechanism 
for tolerance is anergy (Abul Abbas, personal communication). Unfortunately, these 
transfers require Itch fl/fl CD4 Cre DO 11.10 mice on a Balb/c background. As such, they 
will require 10 generations of backcrossing to DO11.10 Balb/c mice before these assays 
can be performed. 
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3.D S u m m a r y : 
Collectively, the results presented in this chapter of the thesis demonstrate that 
Itch deficient CD4+ cells are sufficient to phenocopy the pathology of Itch deficient 
mice. Activation of Itch deficient CD4+ T cells requires antigen. CD4+CD25+ 
regulatory T cell suppressor function is intact, at least by in vitro assays. TGF-P 
sensitivity may be reduced in Itch deficient CD4+ T cells but this may be secondary to 
the inflammatory pathology. Finally, peripheral tolerance mechanisms may be affected 
in Itch fl/fl CD4 Cre mice in vivo. 
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C h a p t e r 4: T h e role of T h 2 cells in the pathology of Itch 
m i c e 
4.A Introduction: 
4.A.1 Th1 versus Th2 immune responses: 
CD4+ helper T cells can differentiate into two well define subsets called T helper 
type 1 (Thl) and T helper type 2 (Th2) T cells during an immune response. Thl cells 
preferentially produce inflammatory cytokines such as interferon gamma (IFNy) and 
lymphotoxin alpha (LTa) and are generally mediators of cellular immunity. Th2 cells 
produce cytokines such as interleukins 4,5,9,10, and 13 (IL-4,IL-5,IL-9,IL-10,IL-13) and 
are critical for humoral responses as well as immune responses against extracellular 
parasites such as helminthes (Heinzel, Sadick et al. 1989; Finkelman, Pearce et al. 1991). 
During dysregulated immune responses, the dominance of either helper cell type shapes 
the outcome of immunologically mediated disease conditions, including autoimmune 
diseases and allergic responses (Abbas, Murphy et al. 1996). 
4.A.2 Evidence for a role of Itch in regulating Th2 differentiation: 
The inflammatory pathology and increased serum IgGl and IgE titres in Itch 
deficient mice prompted investigators to look at Th2 differentiation in Itch deficient 
CD4+ T cells. Analysis of CD4+ T cells from Itch deficient mice revealed a bias towards 
Th2 differentiation in vitro (Fang, Elly et al. 2002). Biochemical analysis suggested that 
this bias was due to increased JunB levels in Itch deficient CD4+ T cells. Recent 
experimental data has provided further mechanistic details regarding the regulation of 
JunB by Itch. Gao and colleagues have found that Itch is phosphorylated upon TCR 
engagement in a Janusk Kinase (JNK) dependent manner (Gao, Labuda et al. 2004). This 
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phosphorylation leads to increased E3 ligase activity of Itch, leading to increased JunB 
turnover in recently stimulated T cells. The models the authors propose is that in the 
absence of either JNK signaling or Itch, JunB accumulates in activated T cells, favoring 
Th2 differentiation. This model is consistent with the similar Th2 bias and the moderate 
Jun B accumulation seen in both Itch deficient and JNK1 deficient mice (Dong, Yang et 
al. 1998; Fang, Elly et al. 2002). What remains unclear from these findings is how Itch 
autoubiquitination, which is also increased upon JNK mediated phosphorylation of Itch 
and which leads to Itch degradation, relates to the overall Itch activity in stimulated T 
cells. Furthermore, it should be noted that JNK1 deficient cells, while displaying 
moderate accumulation of nuclear JunB, show a far more drastic increase in nuclear 
NFATc. This drastic increase could also increase the Th2 bias observed in JNK1 
deficient mice. Finally, the Th2 bias seen in Itch deficient and JNK deficient mice may 
be secondary to other changes in the mice due to complete ablation of the respective 
genes in all cell types. 
4.A.3 Aims of this study: 
Previous work has shown that Itch deficient CD4+ T cells have an increased 
propensity to differentiate into Th2 cells in vitro. While these data were consistent with 
the increased IgGl and IgE serum titres in older mice, it was unclear whether the bias 
observed was secondary to existing pathology in the mice or the actual cause of the 
pathology. The experiments described in this chapter provided a causal link between Itch 
deficiency in CD4+ T cells and the Th2 bias observed in Itch deficient mice. 
Furthermore, the importance of this Th2 bias in the inflammatory pathology was 
addressed using genetic techniques. Overall the experiments were designed to 
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definitively determine the link between Itch deficiency, dysregulated Th2 immune 
responses, and the pathology seen in Itch deficient mice. 
4.B Results: 
4.B.1 Increased Th2 differentiation of Itch deficient naive CD4+ T 
cells: 
In order to determine whether Itch deficient CD4+ T cells have an inherent bias 
towards Th2 differentiation, CD441o naive CD4+ T cells were purified from wild-type 
and Itch fl/fl CD4 Cre mice at 4 weeks of age. At this age, no dermatitis is visible and 
FACS analysis reveals minimal changes in lymphocyte populations or activation status of 
CD4+ cells as compared to wild type littermate controls. Purified naive CD441o CD4+ T 
cells were stimulated in vitro with plate bound a-CD3e (10 u.g/m.1) and a-CD28 (5 
[xg/ml) antibodies in the presence of 25 U/ml IL-2 for two days, rested for three days, and 
restimulated with plate bound a-CD3e and a-CD28 antibodies in the presence of 
Brefeldin A for four to six hours. Cytokine production by the cells was then assessed by 
intracellular staining. Analysis of these experiments revealed that naive Itch deficient 
CD4+ T cells had the same propensity towards Th2 differentiation as published for total 
CD4+ populations of naive and activated cells (Figure 4-la,b). 
4.B.2 Itch deletion does not effect Th1 differentiation: 
Thl and Th2 differentiation are reciprocally regulated pathways, such that 
differentiation towards Thl inhibits Th2 differentiation, and vice versa. It thus seemed 
possible that the increased Th2 differentiation in Itch deficient CD4+ cells was due to an 
inability to differentiate towards the Thl lineage. In order to address this issue, naive 
wild type and Itch deficient CD4+ cells were stimulated under Thl polarizing conditions. 
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No difference was seen in the ability of Itch deficient cells to become Thl cells (Figure 
4-la). 
4.B.3 Itch deletion in vitro leads to a bias towards Th2 differentiation: 
Although purification of naive cells from Itch fl/fl C D 4 Cre mice suggested that 
Itch deficiency in CD4+ T cells was directly responsible for the Th2 skewing bias 
observed, it remained possible that the naive T cell as judged by surface marker stainings 
had received non-TCR mediated signals in vivo that influenced their differentiation in 
vitro. To further substantiate the claim that Itch can directly modulate CD4+ Thl versus 
Th2 lineage commitment decisions, CD4+ T cells from Itch fl/+ and Itch fl/fl mice were 
treated with cell permeable Cre (TAT-Cre) in vitro. Cells were allowed to proliferate for 
7 days in medium in the presence of anti-IFNy and anti-IL-4 antibodies to inhibit 
differentiation. At this time, cells that had deleted Itch at the genomic level had also 
reduced Itch protein levels as measured by Western (Figure 4-lc). Cells were then 
subjected to a second round of stimulation under Thl, Th2, or unpolarizing conditions. 
Intracellular cytokine analysis for IFNy and IL-4 after a-CD3e and a-CD28 stimulation 
revealed that TAT-Cre treated Itch fl/fl CD4+ cells showed an increased frequency of 
Th2 cells compared to TAT-Cre treated Itch fl/+ CD4+ cells (Figure 4-lc). 
4.B.4 Itch modulation of Th2 differentiation is Stat 6 dependent: 
Stat6 is a transcription factor critical for signaling downstream of the IL-4 
receptor, and its presence is critical for TH2 differentiation of wild-type CD4+ cells. 
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D W T AUch fl/fl CD4 Cre 
F i g u r e 4-1. Itch regulates T h 1 / T h 2 differentiation, a. In vitro differentiation of Itch deficient C D 4 4 l o 
naive C D 4 + T cells leads to a Th2 bias. Purified CD44lo C D 4 + T cells were stimulated with plate 
bound anti-CD3e and anti-CD28 antibodies in medium containing IL-2 alone (nonpolarizing medium), 
IL-2, IFNy, and anti-IL-4 antibodies (Th1 polarizing medium) or IL-2, IL-4, and anti-IFNy antibodies 
(Th2 polarizing medium). Cells were stimulated for 2 days, rested for four days, washed, and 
restimulated for four hours in the presence of Brefeldin A. Cytokine production was assessed by 
intracellular staining for IFNy and IL-4. Numbers indicate the percentage of cells in the gated 
subpopulation. b. Summary of the percentage of IL-4+ cells from purified wild-type (open sqaures) 
and Itch fl/fl CD4Cre (closed tringles) C D 4 + cells cultured under nonpolarizing conditions as described 
in a. Each dot represents an individual mouse. The percentage of IL-4+ cells was significantly 
increased in Itch fl/fl C D 4 Cre mice compared to littermate controls (p=0.001 by student's t-test). 
c. In vitro deletion of Itch leads to Th2 bias in differentiation. Purified C D 4 + cells from fl/+ or fl/fl 
mice were incubated with cell permeable Cre (TAT-Cre) for one hour. Cells were stimulated for 3 
days with plate bound anti-CD3e and anti-CD28 antibodies under T helper differentiation blocking 
conditions (10ng/ml anti-IFNy and anti-IL-4 antibodies). After resting cells for four days, Itch protein 
levels in TAT-Cre treated cells were assessed by Western blot of half the cells (lower panel). 
Numbers indicate relative Itch protein levels normalized to tubulin and quantified using NIH Imager. 
Remaining cells were stimulated and cyotkine production was assessed one week later as described 
in a. 
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The requirement for Stat6 can be overcome when CD4+ cells are stimulated through the 
Notch pathway and also upon certain genetic modifications. For example, CTLA-4 
deficient CD4+ cells are capable of generating Th2 effector cells even in the absence of 
Stat 6, as demonstrated by in vitro assays of CD4+ T cells from double deficient mice. 
To determine if Itch modulation of Th2 differentiation was Stat6 dependent, C57B1/6 Itch 
fl/fl CD4 Cre mice were crossed to Balb/c Stat 6 deficient mice. Itch fl/fl CD4 Cre Stat 
6 -/- mice were born at normal mendelian ratios. Strikingly, Itch fl/fl CD4 Cre Stat 6 -/-
cells were incapable of differentiating into Th2 cells in vitro, even under Th2 polarizing 
conditions (Figure 4-2). 
4.B.5 Itch pathology in vivo is Stat6 dependent 
The pathology of Itch deficient mice has been ascribed to an overwhelming Th2 
immune response in these mice. As Stat6 is critical for Th2 cell differentiation in vivo 
and in vitro, and as Stat6 deficiency inhibited Th2 differentiation of Itch deficient CD4+ 
T cells in vitro, Itch fl/fl CD4 Cre Stat 6-1- mice were compared to Itch fl/fl CD4 Cre 
Stat6 +/+ mice for the extent of their pathology. C57B1/6 x Balb/c mixed genetic 
background Itch fl/fl CD4 Cre mice developed a similar inflammatory pathology as their 
C57B1/6 counterparts. Itch fl/fl CD4 Cre Stat6 -/- mice, however, showed no grossly 
visibly signs of pathology. Analysis of organs sections from Itch fl/fl CD4 Cre Stat 6 -/-
mice further revealed that the Itch pathology was absent in Itch fl/fl CD4 Cre Stat 6 -/-
mice (Figure 4-3). All mucosal linings were free of inflammatory infiltrates, though 
only lung and esophageal sections are shown. The occasional focal infiltrates seen in Itch 
fl/fl CD4Cre Stat 6 -/- mice were consistent with the age (6 month old) of the mice and 
did not indicate pathology. Surprisingly, the inflammatory infiltrates were also 
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Figure 4-2. Stat6 is required for Itch dependent Th2 differentiation in vitro, a. CD4+ T cells were 
purified from Itch fl/fl CD4 Cre Stat 6 +/-, Itch fl/+ Stat 6 -/-, and Itch fl/fl CD4 Cre Stat 6 -/- mice. Cells 
were stimulated with plate bound anti-CD3e and anti-CD28 antibodies in medium containing IL-2, 
IL-4, and anti-IFNy antibodies (Th2 polarizing medium) for 2 days, rested for four days, washed, and 
restimulated for four hours in the presence of 10ng/ml Brefeldin A. Cytokine production was assessed 
by intracellular staining for IFNy and IL-4. Numbers indicate the percentage of cells in the gated 
subpopulation. b. Graph summarizing 3 independent experiments carried out as described in a. for 
Th2 polarizing conditions. Each dot represents CD4+ T cells purified from an Itch fl/fl CD4 Cre Stat 
6 +/- (triangle), Itch fl/fl C D 4 Cre Stat 6 -/- (square) or Stat 6 -/- (diamond) mouse. 
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Figure 4-3. Stat6 is required for the pathology seen in Itch fl/fl C D 4 Cre mice. Haematoxilin and 
eosin stainings of organ sections from mixed C57BI/6 x Balb/c genetic background 3-month old Itch 
fl/fl C D 4 Cre Stat 6 +/+ mice and 6-month old Itch fl/fl C D 4 Cre Stat 6 -/- mice. Lung sections (2x 
and 40x) reveal acidophilic macrophage pneumonia in Itch fl/fl C D 4 Cre stat 6 +/+ but not Itch fl/fl 
C D 4 Cre Stat 6 -/- mice. Esophagus sections reveal hyalinosis and eosinophilic infiltrates in Itch 
fl/fl C D 4 Cre Stat 6 +/+ mice but not Itch fl/fl C D 4 Cre Stat 6 -/- mice. Three Itch fl/fl C D 4 Cre Stat 
6 +/+ and six Itch fl/fl C D 4 Cre Stat 6 -/- mice were analyzed. Sections depicted are representative 
for each experimental group. 
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moderately decreased in Itch fl/fl C D 4 Cre Stat 6 +/- mice as well 
4.B.6 Increased antigen sensivity in Itch deficient CD4+ T cells: 
The decision to differentiate into a Thl or Th2 helper cell is in part determined by 
the strength of the signal from the TCR. To address the role of Itch in modulating the 
strength of the TCR signal, naive CD4+ T cells were purified from wild-type and Itch 
fl/fl CD4 Cre mice and cultured with titrated doses of plate bound a-CD3 or a-CD3 and 
a-CD28 antibodies. Sensitivity to antigen was measured by the proliferation of cells in 
response to different amounts of antigen (Figure 4-4, Table 4-1). CD441oCD4+ Itch 
deficient cells showed increased sensitivity to antigenic stimulation as assessed by 
proliferation. 
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Figure 4-4. Itch deficiency leads to an increased proliferative responses in response to antigenic 
stimulation in vitro. Purified CD44loCD4+ cells were labeled with C F S E and cultured with indicated 
concentrations of plate bound anti-CD3e (left panel) or plate bound anti-CD3s and anti-CD28 
antibodies (right panel). The extent of proliferation was measured after three days by flow cytometric 
analysis of C F S E dilution. 
Table 4-1: Increased proliferative responses in purified CD44lo C D 4 + cells from Itch fl/fl C D 4 Cre 
mice shows variation between mice. The percentage of cells that divided and the proliferation 
index (the number of divisions a cell that had begun dividing made) in the experiment described 

















































4.C.1 Itch regulates Th2 differentiation in CD4+ T cells: 
Previous work has shown that CD4+ T cells from Itch deficient mice show a bias 
towards Th2 differentiation in vivo. Because of the inherent limitations of working with 
Itch deficient mice, it was unclear whether this bias was the cause of the Itch 
inflammatory pathology or a consequence of it. The data provided in this chapter provide 
the first definitive evidence that Itch deficiency directly leads to a bias towards Th2 
differentiation. Firstly, purified CD441o CD4+ cells from four-week old Itch fl/fl CD4 
Cre mice, which displayed no visible signs of inflammation, showed a bias towards Th2 
differentiation. Secondly, in vitro deletion of Itch using cell permeable TAT-Cre also led 
to a bias towards Th2 differentiation. Combined, these data strongly argue that Itch is 
directly involved in modulating signals that regulate Thl versus Th2 differentiation 
decisions. Furthermore, the data generated using TAT-Cre argue that the bias towards 
Th2 differentiation is not secondary to differences that may occur in the selection of Itch 
deficient thymocytes. 
4.C.2 Itch modulation of Th2 differentiation is along the IL-4-Stat6 
pathway: 
There are numerous pathways that regulate Th2 differentiation. Broadly 
speaking, these include signals downstream of cytokine receptors, signals from the TCR, 
signals from co-stimulatory ligands, and signals involving the Notch pathway. The role 
of Stat6 in Th2 differentiation is well established for in vitro differentiation of wild-type 
cells; however, it is also clear that Notch signaling, constitutive Stat5 signaling, and the 
absence of CTLA-4 regulation of TCR signaling all lead to Stat6 independent Th2 
differentiation in vitro. Itch deficiency does not modulate signaling along these 
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pathways, as Th2 differentiation in the absence of Itch is Stat6 dependent. This 
observation is particularly relevant for the Notch pathway, where data exists to support a 
role for Itch in negatively regulating Notch signaling (Qiu JBC 2000) and recently a role 
for the Notch pathway in regulating Th differentiation has been established (Maekawa, 
Tsukumo et al. 2003; Amsen, Blander et al. 2004). There is no data that speaks 
definitively on the connection between JunB and Stat6 in Th2 differentiation. Thus it is 
difficult to ascertain whether the increased JunB levels reported in Itch deficient mice are 
indeed the mechanism by which the bias towards Th2 differentiation occurs. 
4.C.3 Stat6 dependence of inflammatory pathology seen in Itch 
deficient mice: 
Although a bias towards Th2 differentiation was consistent with the Itch 
pathology, it remained unclear whether this bias was sufficient to cause the inflammatory 
phenotype seen in these mice. Indeed, recent data using an in vitro model system has 
suggested that Itch deficient T cells may have a more general problem with anergy 
induction (Heissmeyer, Macian et al. 2004). Analysis of Itch fl/fl CD4 Cre Stat6-/- mice 
provides data in support of a dysregulated Th2 immune response and speaks less 
favorably towards a general problem in tolerance. Itch fl/fl CD4 Cre Stat 6-1- mice have 
shown no visible signs of inflammation at the latest time points that have been assessed 
thus far (8 months). Histological analysis of six-month old mice revealed no acidophilic 
macrophage pneumonia in the lungs and no significant accumulation of lymphocytes in 
any organs. The lack of changes are not due to the mixed genetic background of these 
mice, as Itch fl/fl CD4 Cre Stat 6 +/+ from the same mixed genetic background show 
similar inflammation as C57B1/6 Itch fl/fl CD4 Cre mice. Surprisingly, Itch fl/fl CD4 Cre 
Stat 6 +/- mice also showed reduced inflammation compared to 
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Itch fl/fl C D 4 Cre Stat 6 +/+ controls. These data suggest that there may be a dosage 
effect for Stat 6 in Th2 differentiation 
It is important to note that no novel inflammatory lesions or novel 
immunopathologies were seen in Itch fl/fl CD4 Cre Stat 6 -/- mice. If Itch deficiency 
caused a general problem with inappropriate activation of T cells, then crossing Itch 
fl/flCD4 Cre mice to Stat 6 -/- mice might have been expected to cause a severe 
autoimmune pathology, as activated T cells would have been forced to differentiate along 
a Thl pathway. Examples exist of Thl mediated pathologies that are exacerbated in Stat 
6 deficient mice (Chitnis, Najafian et al. 2001; Wang, Ostlie et al. 2004). The fact that 
Itch fl/fl CD4 Cre Stat 6-1- mice seem healthy argues against a problem with general 
tolerance mechanisms. 
So, is the inflammatory response in Itch deficient mice entirely due to the Th2 
bias? While the data speak clearly in favor of a Th2 mediated pathology, it is presently 
unclear why these cells become activated Th2 effector cells. Although JNK1 deficient, 
MEKK7 deficient, and DR6 deficient CD4+ T cells all display a bias towards Th2 
differentiation similar to or greater than the bias mediated by Itch deficiency, no 
accompanying pathology has been reported in these mice. Thus tolerance mechanisms 
specific to regulation of Th2 cells must be addressed. 
4.C.4 Itch deficient CD4+ cells display increased antigen sensitivity: 
At lower doses of titrated antigen, there was a clear increase in the sensitivity of 
Itch deficient purified CD441oCD4+ cells as compared to wild-type cells. These results 
can be interpreted in two different ways. If one takes the cell surface activation marker 
phenotype as a true reflection of the naive status of these cells, then one would have to 
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conclude that Itch deficient cells are more sensitive to antigen. As Th2 differentiation 
occurs at the extremes of antigenic stimulation, this data could suggest that more CD4+ 
cells from Itch fl/fl CD4 Cre mice are stimulated sufficiently to favor Th2 differentiation. 
These data are also consistent with the data described above with Itch fl/fl CD4 Cre 
Stat 6 -/- mice, as signals from the TCR and IL-4 receptor need to be integrated for Th2 
differentiation to occur. 
The caveat that must be considered with this model of increased antigen 
sensitivity in Itch deficient CD4+ T cells is that cell surface marker expression may not 
necessarily reflect the activation status of a cell. The wide variation in the antigen 
sensitivity of CD441oCD4+ cells purified from Itch fl/fl CD4 Cre mice suggests that the 
populations that are being purified are not homogenous. This data could be interpreted to 
suggest that the variations in antigen sensitivity noted are reflective of the purity of the 
naive Itch deficient CD4+ cells used for the assay. Conclusive data regarding changes in 
antigen threshold will come from Rag deficient TCR transgenic Itch fl/fl CD4 Cre mice, 
assuming that these mice do not develop spontaneous inflammation. CD4+ cells purified 
from Rag deficient TCR transgenic mice can be functionally defined as antigen 
inexperienced. Furthermore, the cells will be homogenous with regards to the TCR that 
is expressed on their surface. Therefore, proliferation analysis of CD4+ T cells from 
these mice will provide more decisive answers regarding the role of Itch in antigen 
sensitivity. 
4.D Summary: 
The results presented in this chapter of the thesis provide definitive evidence that 
Itch directly modulates Thl versus Th2 differentiation decisions in naive CD4+ T cells. 
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In addition, evidence is provided that this modulation occurs upstream of the Stat6 
pathway in Th2 differentiation. Finally, genetic proof is provided for the importance of 
Th2 differentiation in the pathology of Itch mice. Combined, these data argue strongly 
that the pathology of Itch deficient mice is driven by a dysregulated Th2 immune 
response. 
123 
C h a p t e r 5: T h e role of Itch In C D 8 + m e m o r y cell 
generation 
5.A Introduction: 
5.A.1 CD8+ memory cells: 
A critical difference between the adaptive and the innate immune systems is the 
generation of immunological memory during an immune response. Because of the 
importance of CD8+ cells in the generation of immune responses against intracellular 
pathogens, the generation of CD8+ memory cells is of key interest in the field of 
vaccination. Although the cellular events and cytokines involved in CD8+ memory cell 
formation have been elucidated, the molecular pathways that regulate CD8+ memory cell 
generation and maintenance remain poorly understood. 
5.A.2. Factors regulating CD8+ memory cell generation 
Many factors influence the generation of CD8+ memory cells. The amount of 
antigen encountered initially is important. CD8+ cells undergo a programmed 
proliferative response after antigen encounter, and the extent of proliferation is 
determined in part by the antigen dose (Ludewig, Ehl et al. 1998; Wherry, Puorro et al. 
1999; Kedl, Rees et al. 2000; Kaech and Ahmed 2001). The number of memory CD8+ 
cells is reflective of the initial expansion (Hou, Hyland et al. 1994; Busch, Pilip et al. 
1998). Part of the signal for generating memory cells comes from CD4+ cells, as in their 
absence CD8+ cells generate effector cells but not memory cells (Janssen, Lemmens et 
al. 2003; Shedlock and Shen 2003; Sun and Bevan 2003). Survival of memory precursors 
during the contraction phase following the proliferative phase is also important. After 
surviving the contraction phase, memory precursor cells continue to differentiate into 
memory cells. They become able to proliferate slowly. This proliferation is important 
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for homeostatic maintenance of memory CD8+ cells for the lifetime of the organism. 
Proliferation occurs in response to the cytokines IL-7 and IL-15 (Goldrath, Sivakumar et 
al. 2002; Kieper, Tan et al. 2002). 
5.A.3 Aims of this study: 
Conditional deletion of Itch using CD4-Cre leads to deletion of Itch at the double 
positive stage of thymocyte development. Therefore both CD4+ and CD8+ cells are Itch 
deficient in Itch fl/fl CD4 Cre mice. During the course of analysis of Itch fl/fl CD4 Cre 
mice, it was serendipitously noted that there was a dramatic increase in CD44hiCD8+ 
cells in Itch fl/fl CD4 Cre mice. Since the role of Itch in CD8+ cells has not been 
previously addressed, the aim of experiments described in this section was to provide 
evidence for a direct role for Itch in regulating CD8+ T cells. 
5.B. Results: 
5.B.1 Accumulation of memory-like CD8 cells in secondary lymphoid 
organs of 8-week old Itch fl/fl C D 4 Cre mice. 
Cell surface marker stainings of CD8+ cells from the spleen and lymph node of 
Itch fl/fl CD4 Cre mice showed a dramatic increase in the percentage of CD44hi CD8+ 
cells. Although CD44 upregulation can be a marker for activated cells, these cells were 
neither larger by forward scatter nor positive for other activation markers such as CD25, 
CD69, or CD62L (Figure 5-1 a,b). These preliminary surface stainings suggested that 
there was an increase in memory-like CD8+ cells in Itch fl/fl CD4 Cre mice. Along with 
CD44 upregulation, CD 122 (the p subunit of the IL-15 receptor) and Ly6C upregulation 
also occurs selectively on memory CD8+ cells. Surface staining of CD8+ cells with 
CD 122 and Ly6C showed similar increases in their surface expression (Figure 5-la,b). 
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Figure 5-1. Expansion of C D 8 + m e m o r y cell population in 8 w e e k old Itch fl/fl C D 4 Cre mice. a. 
spleen b. lymph nodes. Left panel. Flow cytometric analysis of lymphocyte populations. All 
stainings are gated o n live C D 8 + cells. N u m b e r s indicate the percentage of cells falling within the 
gated subpopulation. Middle panel. Cell surface expression of activation markers in C D 8 + cells. 
Right panel. Increase in absolute n u m b e r s of m e m o r y C D 8 + cells in Itch fl/fl C D 4 Cre mice. 
Absolute C D 8 + cell n u m b e r s were calculated using absolute splenic and lymph node n u m b e r s and 
percentages of C D 8 + lymphocytes in the spleen and lymph node. E ach data point represents an 
independent experiment consisting of average cell counts of two Itch fl/fl C D 4 Cre mice and two 
littermate controls. 
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Calculation and comparison of absolute numbers of memory-like CD8+ cells in 
spleenand lymph nodes of Itch fl/fl CD4 Cre mice and littermate controls reveals an 
average 1.6 fold increase in CD8+ cell numbers in both the spleen and lymph node of 
Itch fl/fl CD4 Cre mice, and a 4 fold increase in the absolute number of memory like-
cells in both spleen and lymph nodes. Collectively, these data demonstrate a significant 
(p < 0.001 by student's t-test) accumulation of memory-like CD8+ cells in Itch fl/fl CD4 
Cre mice as judged by surface marker staining. 
5.B.2 Increased frequency of CD44hi CD8 SP cells in the thymi of Itch 
fl/fl C D 4 Cre mice. 
Normally, memory cells are generated in response to antigen in the periphery. In 
the absence of Itch, it was possible that the activation of CD8+ cells could occur prior to 
the cell encountering its cognate antigen in the periphery. Preliminary analysis of 
thymocyte development based on thymocyte population analysis and cell surface 
expression of CD3, CD5, CD69, and CD24 revealed no significant differences between 
wild-type and Itch fl/fl CD4 Cre mice (Figure 5-2a,b). To determine if Itch deficiency is 
sufficient to cause an increase in CD44 expression in the absence of cognate antigenic 
stimulation, recently positively selected CD41o CD81o double positive thymocytes, CD4 
SP thymocytes and CD8+ SP thymocytes were stained for CD44. These stainings reveal 
that Itch fl/fl CD4 Cre have a small but significant increase in the percentage of CD44hi 
cells amongst recently positively selected 
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Figure 5-2. Normal T cell development but early C D 8 + cell activation in Itch fl/fl C D 4 Cre mice. 
Flow cytometric analysis of thymocyte populations, a. Percentages of Double Negative ( D N ) , 
Double Positive (DP), C D 4 l o C D 8 l o positively-selected Double Positive (CD4loCD8lo D P ) , C D 4 
Single Positive ( C D 4 S P ) , and C D 8 Single Positive ( C D 8 S P ) populations are equivalent in wild-
type and Itch fl/fl C D 4 C r e mice. b. Upregulation of cell surface expression of C D 3 , C D 5 , a n d 
C D 6 9 a n d downregulation of C D 2 4 during transition from D P to S P stages of development is 
equivalent between wild-type and Itch fl/fl C D 4 Cre mice. c. Significant increase in frequency 
of CD44hi CD8 SP thymocytes in Itch fl/fl CD4 Cre mice. CD44 expression in CD8 SP (top 
panel) and CD4 SP (bottom panel). * denotes p<0.01 by student's t-test. The percentages of 
CD44hi CD4 SP cells is not significantly increased in Itch fl/fl CD4 Cre mice (p=0.3 by students 
t-test). d. CD44 expression in recently positively selected CD4loCD8lo DP thymocytes is 
increased in Itch fl/fl CD4 Cre mice. Positive selection of CD4loCD8lo DP thymocytes was 
judged by CD69 upregulation and CD24 downregulation. Itchfl/fl CD4 Cre mice have a significant 
increase in the percentage of CD44hi CD4loCD8lo DP thymocytes (* p<0.01 by student's t-
test). Stainings are representative of two independent experiments of three 6-8 week old mice. 
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CD41o CD8I0 double positive thymocytes and CD8+ SP thymocytes, but not among CD4 
SP thymocytes (Figure 5-2c,d). These data are consistent with the hypothesis Itch 
deficiency modulates signaling such that CD8+ cells are activated in the thymus, prior to 
encountering their cognate antigen in the periphery. 
5.B.3 The increased frequency of memory like CD8+ cells is 
independent of the inflammatory pathology in Itch fl/fl C D 4 Cre mice 
The cytokine milieu can play a role in the proliferation rate of memory like CD8+ 
cells. Naive cells placed into a lymphopenic environment acquire a memory-like 
phenotype and proliferate. Furthermore, naive cells from adult mice placed into a 
neonate also develop a memory phenotype and undergo proliferation as if they were in a 
lymphopenic environment (Ichii, Sakamoto et al. 2002), suggesting that the cytokine 
environment in neonates leads to expansion of memory like cells through a process 
potentially similar to a lymphopenic expansion. In particular, IL-15 has been shown to 
play a critical role in CD8+ memory cell proliferation (Zhang, Sun et al. 1998), and one 
of the main producers of IL-15 are macrophages (Kennedy and Park 1996). The 
accumulation of macrophages in Itch fl/fl CD4 Cre mice (Jonsson 2002) made it 
important to consider the possibility that the accumulation of memory phenotype CD8+ 
cells is secondary to the inflammatory disease in these mice. 
Three pieces of evidence speak against this argument. Firstly, CD8+ memory 
cell accumulation is seen in two-week old Itch fl/fl CD4 Cre mice, prior to any visble 
activation of CD4+ T cells as judged by surface marker stainings (Figure 5-3a). Transfer 
studies have made it clear that CD4+ T cells initiate the inflammation in Itch fl/fl CD4 
Cre mice. Secondly, Itch fl/fl CD4 Cre mice do not show an increase in NK 
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Figure 5-3. CD8+ memory-like cell accumulation in Itch deficient mice is independent of the 
Itch inflammatory pathology, a. Increased frequency of memory-like CD8+ cells is the first 
population change in Itch fl/fl CD4 Cre mice. Flow cytometric anlaysis of two week old Itch fl/fl 
CD4 Cre mice. B cell accumulation and CD4+ T cell activation is not evident (left panel) 
whereas memory-like CD8+ cell accumulation is evident (right panel) b. NK and NKT cell 
accumulation is unaffected in Itch fl/fl CD4 Cre mice c. Maintenance of Itch deficient CD44hi 
CD8+ cells in the periphery of wild-type mice. CFSE labeled Itch deficient (MT) or wild-type 
(WT) CD8+ SP cells were transferred into wild-type mice. Recipient mice were sacrificed four 
weeks after transfer and splenocytes were stained for surface expression of CD8 and CD44. 
The percentage of CD44hi CFSE labeled CD8+ cells is shown. 
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and N K T cells (Figure 5-3b), whose homeostatic proliferation is also controlled by IL-15 
(Ranson, Vosshenrich et al. 2003); nor do they develop fatal leukemias like IL-15 
transgenic mice (Fehniger, Suzuki et al. 2001). Finally, transferred CD8+ SP thymocytes 
from Itch fl/fl CD4 Cre mice accumulate as CD44hi transferred cells in wild-type 
recipients (Figure 5-3c). 
5.B.4 Itch deficient memory-like cells CD8+ cells function like 
m e m o r y cells in response to IL-15 stimulation in vitro. 
Although cell surface marker stainings suggested an accumulation of memory-
like CD8+ cells in Itch fl/fl CD4 Cre mice, it remained a possibility that these cells were 
only "masquerading" as memory cells but had no functional properties of memory cells. 
In the absence of MHC I restricted TCR transgenic mice lacking Itch, it was impossible 
to track in vivo CD8+ memory cell generation in response to an antigen or measure 
memory cell function in secondary responses to an antigen. Therefore, proliferation in 
response to IL-15 was used as a functional readout of the memory like cells seen in Itch 
fl/fl CD4 Cre mice. CD441o and CD44hi CD8+ cells were purified and stimulated with 
titrated concentrations of IL-15. As is the case for wild-type CD8+ cells, Itch deficient 
CD441o CD8+ cells proliferated minimally in response to IL-15, whereas CD44hi cells 
proliferated vigorously (Figure 5-4a). Comparison of CD441o and CD44hi proliferation 
rates from Itch fl/fl CD4 Cre mice to wild-type mice revealed a slight increase in the 
sensitivity of Itch deficient CD8+ cells to IL-15 in vitro (Figure 5-4b); however, this data 
was confounded by the fact that the purification procedure left more contaminating 
CD441o cells in the CD44hi population of wild-type cells. Thus no conclusive arguments 
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Figure 5-4. The memory-like C D 8 + cells accumulating in Itch fl/fl C D 4 Cre mice have functional 
properties of memory C D 8 cells, a. Proliferation of CD44hi but not CD44lo C D 8 + cells in response 
to IL-15. Purified CD44lo (traingle) and C D 4 4 hi (square) C D 8 + cells from Itch fl/fl C D 4 Cre mice 
were incubated with indicated concentrations of recombinant IL-15 for three days. Proliferation was 
measured by [3H] thymidine incorporation during the last eight hours of culture. Standard error of 
the mean of triplicates is provided, b. Equivalent proliferation of wild-type and Itch fl/fl C D 4 Cre 
CD44hi C D 8 + cells in response to titrated concentrations of IL-15. Purified and C F S E labeled cells 
were cultured for three days prior to flow cytometric analysis of proliferation. Results are representative 
of two independent experiments. 
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can be made about the sensitivity of Itch deficient CD8+ cells to IL-15 in vitro. 
5.B.5 Itch deficient memory-like CD8+ cells have the same basal 
homeostatic proliferation rate as wild-type cells 
To determine if the increased proliferation in response to IL-15 seen in vitro had 
any correlate in vivo, Itch fl/fl CD4 Cre mice and littermate controls were fed 0.8 mg/ml 
of the DNA precursor analog bromodeoxyuridine (BrdU) in their water for 10 days. 
Mice were then sacrificed and the percentage of BrdU positive cells was ascertained by 
intracellular staining. Concomittant staining of surface markers allowed for the analysis 
of proliferation rates of naive and memory cells separately. Although Itch fl/fl CD4 Cre 
mice had an increase in the proliferation rate of CD8+ cells in total, no difference was 
seen between the memory and naive compartments when compared to wild-type controls 
(Figure 5-5). The overall difference reflects simply the increased percentage of memory 
cells, which have a higher proliferative rate than naive cells. These data show that there 
is no increase in the homeostatic proliferation rate of memory-like CD8+ cells in Itch fl/fl 
CD4 Cre mice. 
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Figure 5-5. T h e rate of homeostatic proliferation of m e m o r y C D 8 + cells is unaffected in Itch fl/fl C D 4 
Cre mice. a. Spleen b. Lymph nodes. Mice were given 0.8 mg/ml of the D N A analog bromodeoxyuridine 
(BrdU) in their drinking water for ten days. The percentage of cells that proliferated in this time period 
w a s assessed by flow cytometric analysis of BrdU incorporation. T o p panel. Flow cytometric analysis 
of naive (CD44loCD122lo) and m e m o r y (CD44hiCD122hi) C D 8 + subpopulations in wild-type and Itch 
fl/fl C D 4 Cre mice given BrdU. Numbers indicate the percentage of cells falling in the gated subpopulations. 
Bottom panel. BrdU incorporation in total C D 8 + , naive C D 8 + , and m e m o r y C D 8 + of wild-type (open 
bars) and Itch fl/fl C D 4 Cre (closed bars) mice is shown. Four mice were used per experimental group. 
Error bars denote the standard deviation of the m e a n of groups. T h e percentage of proliferating C D 8 + 
cells is significantly increased in both the spleen and lymph nodes of Itch fl/fl C D 4 Cre mice (p<0.01 
by student's student's t-test). N o difference w a s observed in the proliferation rate of m e m o r y C D 8 cells. 
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5.B.7 Itch does not regulate antigen sensitivity in C D 8 + cells 
The generation of memory cells is dependent on the initial proliferation of naive 
cells. If more naive cells were triggered in Itch fl/fl CD4 Cre mice, then presumably the 
number of memory CD8+ cells would also be increased. To address the role of antigen 
sensitivity in the extent of proliferation and hence memory cell formation in Itch fl/fl 
CD4 Cre mice, CD441o naive CD8+ cells were purified from Itch fl/fl CD4 Cre mice and 
littermate controls and stimulated with titrated doses of plate bound a-CD3 antibody or 
plate bound a -CD3 and a -CD28 antibodies. Antigen sensitivity was assessed by 
proliferation (Figure 5-6). No difference was seen between naive WT and Itch deficient 
CD8+ cells. These data are consistent with the hypothesis that Itch does not modulate 
antigen sensitivity in CD8+ cells. 
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Figure 5-6. Proliferative capacity in response to antigenic stimulation is unaffected in Itch deficient 
C D 8 + cells. Purified CD44lo naive C D 8 + were labeled with C F S E and incubated with indicated 
concentrations of plate-bound anti-CD3e (left panel) or plate-bound anti-CD3e and anti-CD28 (right 
panel) antibodies. Flow cytometric analysis of C F S E dilution upon proliferation was performed after 
three days of culture. The results are representative of two independent experiments. 
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S.C Discussion: 
5.C.1 Accumulation of memory-like CD8+ cells in the secondary 
lymphoid organs of Itch fl/fl C D 4 Cre mice: 
Accumulation of CD25"CD62LhiCD69"CD44hiCD122hiLy6C+ memory-like 
CD8+ cells occurred in both the spleen and lymph nodes of Itch fl/fl CD4 Cre mice. Itch 
is expressed at similar levels between CD4+ and CD8+ cells and Itch conditional deletion 
using CD4 Cre leads to its deletion in both T cell subpopulations. Thus, it was possible 
that Itch played an as yet unidentified role in regulating CD8+ memory cell generation. 
The expression of CD62L and the accumulation of these memory-like cells in the lymph 
nodes as well as in the spleen suggest that these are central memory cells. Although 
these memory-like cells phenotypically resemble CD8+ memory cells and even have 
functional attributes of CD8+ memory cells, their definitive description as memory CD8+ 
cells will require crossing Itch fl/fl CD4 Cre mice to an MHC I restricted TCR transgenic 
background and infection of these mice so that memory responses can be traced. An 
ideal TCR transgene to cross these mice to is PI4, which encodes a MHC I restricted 
TCR specific for an epitope of the LCMV virus (Pircher, Burki et al. 1989). Numerous 
CD8+ memory studies have been performed using this system, making it an ideal model 
system for defining the function of Itch. 
One can invisage two potential outcomes from this cross. In one scenario, TCR 
transgenic mice will have no CD8+ memory cells, which will suggest that Itch regulates 
memory cell formation through an antigen-dependent manner. Infection of mice will 
provide insight into which aspect of CD8+ memory cell generation is affected in Itch 
deficient mice. 
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A second scenario is that Itch fl/fl C D 4 Cre mice will continue to accumulate 
CD8+ memory like cells even in the absence of cognate antigen stimulation. This result 
will imply that Itch regulates CD8+ memory cell generation in a TCR independent 
manner, perhaps through cytokine signaling. The role of Itch in regulating memory 
responses can still be studied by adoptively transferring CD441o naive TCR transgenic 
CD8+ cells into recipient hosts before viral infection. Of more interest will be 
determining which cytokine is responsible for the TCR independent memory cell 
accumulation in the absence of Itch. The two cytokines that are critically important for 
memory CD8+ cell generation are IL-7 and IL-15. Both may play a role in homeostatic 
proliferation, but IL-7 is also critical for the survival of memory-precursor cells. Since 
Itch has been implicated in regulating the protein levels of the IL-7 receptor in B cells 
(Liu 2004), it is an important target to test in Itch deficient CD8+ cells. 
Recently, a role for CD4 cells in CD8+ memory cell generation has been 
described. The requirement for CD4 cells in the accumulation of CD8+ memory like 
cells in Itch fl/fl CD4 Cre mice could be addressed by the analysis of Itch fl/fl CD4Cre 
MHC II-/- mice. Breedings to generate these mice are currently underway. 
5.C.2 Itch deficiency leads to upregulation of CD44 on CD8 SP cells 
in the thymus: 
Stainings of thymi from Itch fl/fl C D 4 Cre mice reveal a small but significant 
increase in the number of CD44hi CD8+ single positive (SP) cells in the thymus. These 
data suggest that CD8+ cells are being activated inappropriately soon after their 
generation. Further multi-color stainings are required to deterimine if these CD44hi cells 
have also upregulated other memory cell markers such as CD 122 and Ly6C or other 
activation markers such as CD25. Already, this data is consistent with Itch modulating 
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CD8+ cell development prior to the cells encountering antigen in the periphery. 
Experiments to determine which cytokine is responsible for this activation will be 
difficult to design. One possible approach would be to look at signaling events 
downstream of the IL-15 or IL-7 receptor. Changes in signaling thresholds for these 
cytokines would lead to memory cell accumulation, and perhaps biochemical analysis of 
signaling pathways downstream of the cytokine receptors could shed light on the role of 
Itch in CD8+ memory cell generation In particular, Stat5 signaling should be considered, 
as it is involved in both CD4+ Th2 differerntiation and CD8+ memory cell generation. 
5.C.3 Accumulation of Itch deficient memory-like CD8+ cells is 
independent of the inflammatory pathology in Itch fl/fl C D 4 Cre mice: 
Although B cells accumulate in Itch fl/fl C D 4 Cre mice, it is clear that this 
accumulation is secondary to the inflammatory pathology initiated in these mice by 
CD4+ T cells. The accumulation of memory-like CD8+ T cells could also have been 
secondary to the Itch pathology. Two pieces of data argue against this hypothesis. 
Firstly, the accumulation of memory-like CD8+ cells is seen in two week old mice, when 
neither splenomegaly not CD4+ T cell activation as assessed by surface marker staining 
is evident. Secondly, transfer of Itch deficient CD8+ single positive cells into wild-type 
mice leads to an accumulation of CD44hi CD8+ cells even in the periphery of wild-type 
mice. Thus, it seems that the accumulation of memory-like Itch deficient CD8+ cells is 
independent of the Itch pathology. Ofcourse, the cytokine environment in the thymus of 
Itch fl/fl CD4 Cre mice may be altered such that it leads to CD8+ cell activation. 
Definitive proof that Itch has a direct role in regulating CD8+ memory cells independent 
of its function in CD4+ T cells requires crossing of Itch deficient mice to a CD8+ T cell 
specific Cre. Unfortunately, such a Cre transgene does not yet exist. 
139 
5.C.4 Itch deficient memory-like C D 8 + cells behave like m e m o r y 
C D 8 + cells 
Although Itch fl/fl C D 4 Cre mice accumulated CD8+ cells that looked like 
memory cells by surface phenotype, proof that they behaved like memory CD8+ cells 
was missing. In the absence of an in vivo model system to study CD8+ memory cell 
generation, in vitro proliferation in response to IL-15 was chosen as a functional read-out. 
It has been shown that memory CD8+ cells are unique in their ability to proliferate in 
response to IL-15 (Zhang, Sun et al. 1998). Purification of Itch deficient CD441o and 
CD44hi CD8+ cells and culture in the presence of IL-15 demonstrated that Itch deficient 
CD44hi CD8+ cells proliferated in response to IL-15, whereas CD441o cells did not. 
Furthermore, comparison of proliferation rates between wild-type and Itch deficient 
CD44hi cells revealed that Itch deficient cells were as sensitive if not more sensitive in 
vitro. Thus the memory-like CD8+ cells accumulating in Itch fl/fl CD4 Cre mice have 
memory CD8+ cell functional characteristics as well as phenotypic similarities. 
5.C.5 CD8+ memory cell homeostatic proliferation is unaffected in 
Itch fl/fl C D 4 Cre mice: 
One potential mechanism by which CD8+ memory cells might accumulate in Itch 
fl/fl CD4 Cre mice is through an increased rate of homoestatic proliferation. This 
hypothesis was consistent with the increased proliferation rate of Itch deficient CD44hi 
CD8+ cells in response to IL-15 in vitro. A potential caveat in the interpretation of the in 
vitro data was the consistent contamination of a higher percentage of CD441o cells in the 
CD44 hi population of wild-type cells. To determine if there was an increased rate of 
homeostatic proliferation of memory CD8+ cells in Itch fl/fl CD4 Cre mice in vivo, mice 
were given drinking water containing the DNA analog Bromodeoxyuridine (BrdU) for 
ten days, and incorporation of this analog in proliferating cells was assessed. As has been 
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previously published, approximately 15% of memory CD8+ cells undergo proliferation in 
this time period. There was no difference between Itch fl/fl CD4 Cre and wild-type 
memory CD8+ cells in the percentage of BrdU+ cells, suggesting that the proliferation 
rate is equivalent. Since all existing evidence suggests that the homeostatic proliferation 
rate is controlled predominantly by IL-15, these data argue that there is neither an 
increase in the levels of IL-15 in Itch fl/fl CD4 Cre mice nor an increase in the sensitivity 
to IL-15 of Itch deficient CD8+ cells. 
5.C.6 Antigen sensitivity is unaffected by Itch deficiency in CD8+ 
cells: 
Since the number of memory cells generated is dependent on the initial 
proliferation burst, it seemed plausible that the accumulation of memory-like CD8+ cells 
in Itch fl/fl CD4 Cre mice was due to an increase in the antigen sensitivity of Itch 
deficient CD8+ cells. In order to address this hypothesis naive CD441o CD8+ cells were 
purified from wild-type and Itch fl/fl CD4 Cre mice and proliferation in response to 
titrated concentrations of plate-bound antibodies was assessed. No difference was seen in 
antigen sensitivity, suggesting that the accumulation of memory-like CD8+ cells is not 
due to an increase in antigen sensitivity. One potential caveat of this experiment is that 
purification of CD441o cells from Itch fl/fl CD4 Cre mice may select for only those cells 
whose antigen sensitivity was not affected such that they did not proliferate and 
eventually give rise to memory CD8+ cells. One way to circument this problem would 
be to delete Itch in vitro using cell permeable TAT-Cre and then assess proliferation. 
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5.D S u m m a r y : 
The data provided in this chapter of the thesis provide preliminary evidence in 
favor of a role for the E3 ligase Itch in regulating CD8+ memory cell generation. 
Collectively these data show that Itch fl/fl CD4 Cre mice have an accumulation of 
memory-like CD8+ cells, both by phenotype and by function. Furthermore, this 
accumulation is shown to be independent of the Itch inflammatory pathology. Antigen 
sensitivity of naive CD8+ cells and homeostatic proliferation of memory CD8+ cells 
were found to be equivalent to wild-type in Itch fl/fl CD4 Cre mice. However, 
accumulation was found to begin in the thymi of Itch fl/fl CD4 Cre mice, shortly after 
positive selection. These data can be interpreted to suggest two different mechanisms for 
the accumulation of memory like CD8+ cells. The first is that this accumulation is 
cytokine driven, perhaps through increased IL-7 sensitivity. The second is that antigen 
sensitivity may be modified such that upon positive selection CD8+ T cells are becoming 
activated and acquiring memory like phenotypes. 
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C h a p t e r 6: Discussion 
6.A Itch fl/fl CD4 Cre mice develop a spontaneous inflammatory 
disorder: 
The study of spontaneously occurring inflammatory disorders in mice is 
considered of particular clinical significance because they resemble idiopathic 
inflammatory diseases seen in humans (at least in their idiopathic nature). In the case of 
the E3 ligase Itch, this approach is made all the more appealing based on the highly 
polymorphic nature of the Itch gene (Jonsson 2002). It would be of great interest to see if 
Itch polymorphisms within the human population correlate with atopic diseases. 
The spontaneous inflammatory disease seen in Itch fl/fl CD4 Cre mice could be 
explained by a number of models. The least exciting of these is that Itch regulates T cell 
activation in the most general way possible, such that in the absence of Itch, CD4+ T 
cells are spontaneously activated. This hypothesis is less appealing to immunologists 
because it brings the regulation of CD4+ T cells to questions of cell biology rather than 
systems regulation. Fortunately, the role of Itch in immune response regulation is not so 
blunt. Analysis of TCR transgenic mice has revealed that TCR transgenic CD4+ T cells 
are not spontaneously activated, at least as judged by cell surface activation marker 
analysis. This suggests that Itch regulates immune responses in response to antigens. In 
addition, the location of the inflammation seen in Itch deficient mice, which occurs along 
mucosal linings, suggests that Itch may be involved in regulating immune responses to 
external antigens. Further analysis of Itch deficient mice could provide insight into the 
physiological mechanisms involved in regulating local inflammatory responses in the 
absence of pathogens. 
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The inflammatory phenotype in Itch deficient mice suggested that Itch could also 
be involved in general processes such as CD4+CD25+ regulatory T cell function. The 
experiments provided in this thesis also speak against such a role for Itch. At least by in 
vitro assays, no functional defect in CD4+CD25+ regulatory T cells was found. This is 
consistent with the differences in phenotypes observed between mice deficient in 
CD4+CD25+ regulatory T cells, which develop multi-organ autoimmune diseases, and 
mice deficient in Itch, which display inflammatory infiltrates along their mucosal linings. 
Itch deficient CD4+ T cells display problems with tolerance induced in response 
to an antigen. Induction of tolerant CD4+ T cells in response oral tolerization with 
ovalubmin failed in Itch fl/fl CD4 Cre DO 11.10 mice. In addition, Itch deficient CD4+ T 
cells show decreased sensitivity to TGF-P , a cytokine which has been linked to induced 
tolerance. Surprisingly, the decrease in sensitivity to TGF-(3 seemed to be more due to 
changes in the sensitivity of activated Itch deficient CD4+ cells rather than naive Itch 
deficient CD4+ T cells. Combined these data may argue that Itch regulates the extent of 
immune responses once an antigen is encountered. 
6.B Dysregulated Thl immune response in Itch fl/fl CD4 Cre 
mice: 
Are these problems with peripheral tolerance mechanisms general, or are they 
more specific? Intriguingly, it seems that Itch fl/fl CD4 Cre mice have only a 
dysregulated Th2 immune response. Analysis of CD4+ T cells in which Itch was deleted 
in vitro confirmed that Itch deficiency does indeed affect Th2 differentiation. It should 
be noted, though, that these data and data from naive Itch deficient CD4+T cells reveal a 
significant but small increase in the total number of Th2 effector cells, at least in vitro. 
Similar, if not greater, changes in Th2 bias have been reported for DR6 or JNK1 deficient 
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mice, but no inflammatory pathology has been published for these mice. Overall, these 
data argue that Itch must regulate more than Th2 differentiation in order to lead to the 
spontaneous inflammatory pathology seen in Itch deficient mice. 
Analysis of Itch fl/fl CD4 Cre Stat 6-1- mice revealed that in the absence of Stat6, 
Itch deficient CD4+ T cells cannot differentiate into Th2 cells in vitro. Furthermore, 
analysis of Itch fl/fl CD4 Cre Stat 6 -/- mice revealed that the inflammatory phentoype of 
Itch fl/fl CD4 Cre mice disappeared in the absence of Stat6. Firstly, these data argue 
strongly that the inflammatory pathology was Th2 driven. Secondly, they argue that Itch 
deficient T cells are not generally activated. If the Th2 bias were a marginal side issue in 
Itch fl/fl CD4 Cre mice, and if the underlying reason for the inflammatory disorder were 
a universal problem in peripheral tolerance, then one might have expected manifestations 
of auto-immune disease in Itch fl/fl CD4 Cre mice. Since Thl and Th2 differentiation are 
reciprocally regulated, an inability to generate Th2 effector cells would have led to Thl 
effector cells in these mice. It is widely accepted that dysregulated Thl immune 
responses mediated auto-immune diseases while dysregulated Th2 responses lead to 
inflammatory disorders of an atopic nature. Therefore, one might have expected that Itch 
fl/fl CD4 Cre Stat 6 -/- mice would develop a sever auto-immune disease. This was not 
the case. Combined, these data argue that if there is a problem with tolerance 
mechanisms in Itch fl/fl CD4 Cre mice, it is restricted to tolerance of Th2 effector cells. 
Definitive proof regarding the role of Itch in regulation of Th2 effector responses 
requires the generation of TCR transgenic Rag deficient Itch fl/fl CD4 Cre mice. These 
mice, which presumably will contain naive Itch deficient CD4+ T cells, can be analyzed 
for Thl and Th2 immune responses generated in vivo. It is the author's prediction that 
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immunization with antigen favoring Thl differentiation may lead to normal immune 
responses, assuming that Itch deficient mice don't generate Th2 effector cells under Thl 
favoring conditions. In contrast, immunization with antigen that favors Th2 
differentiation will lead to an unregulated inflammatory response. 
The study of peripheral tolerance mechanisms that are induced upon antigen 
exposure and are specific to either Thl or Th2 effector cells is a relatively new concept in 
immunology (Akbari, Stock et al. 2003). The ability to regulate specific effector 
responses without affecting others would be of considerable clinical interest, as many 
diseases are due to dysregulation of either Thl or Th2 immune responses. Skewing 
immune responses towards the opposite effector phenotype has been attempted in the 
past, but brings with it the risk of causing different pathologies. The ability to 
specifically regulate Thl or Th2 effector responses would provide a more controlled 
regulation of the immune system. 
6.C The role of Itch in C D 8 + m e m o r y cell generation: 
Serendipitously, it was noticed that Itch fl/fl C D 4 Cre mice have an increase in 
the number of CD44hiCD122hiLy6C+ CD8+ memory-like cells in their secondary 
lymphoid organs. Although Itch is expressed in CD8+ cells, its role in CD8+ cell 
function has previously gone unstudied. The experiments described in this thesis attempt 
to lay the groundwork for further studies about the role of Itch in CD8+ memory cell 
generation. These data suggest that Itch deficient CD8+ memory cells accumulate not 
because of the pathology in Itch fl/fl CD4 Cre mice but because of an inherent difference 
in Itch deficient CD8+ cells. The rate of homeostatic proliferation of Itch deficient CD8+ 
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memory-like cells in the periphery was found to be unaffected, suggesting that Itch does 
not regulate CD8+ memory cell homeostasis once they are formed. Instead, Itch may 
regulate the generation of memory-like CD8+ cells. Consistent with this hypothesis is 
the finding that an increase in CD44hiCD8+ was observed as soon as positive selection 
occurs in the thymus. The exact mechanims by which Itch regulates the CD8+ memory 
like formation requires analysis of MHC I TCR transgenic mice, in which antigen 
dependence of this process will be tested, and MHC II deficient mice, in which the 
requirement for CD4+ help will be tested. It is hoped that by discovering the 
mechanisms by which Itch modulates CD8+ memory cell generation, further insight into 
the general mechanisms whereby CD 8+ memory cells are formed will be provided. 
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